UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 
FORM 20-F/A
(Amendment No. 1)
 
(Mark One)
 
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
 
OR
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2019
 
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
OR
 
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of event requiring this shell company report………………………………
 
For the transition period from ______ to ______
 
Commission File Number 001-33129
 
 
ALLOT LTD
(Exact Name of Registrant as specified in its charter)
  
N/A
(Translation of Registrant’s name into English)

ISRAEL
(Jurisdiction of incorporation or organization)
 
22 Hanagar Street
Neve Ne’eman Industrial Zone B
Hod-Hasharon 45240
Israel
(Address of principal executive offices)

Rael Kolevsohn, Adv.
VP Legal Affairs & General Counsel
Allot Ltd.
22 Hanagar Street
Hod-Hasharon 4501317, Israel
Tel/Fax: +972 (9) 762-8419
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
 

Securities registered or to be registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary Shares, par value ILS 0.10 per share
ALLT
The NASDAQ Stock Market, LLC
 
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
 
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
 
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of December 31, 2019:
34,520,728 ordinary shares, ILS 0.10 par value per share
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
 
Yes ☐            No ☒
 
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
 
Yes ☐            No ☒
 
Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes ☒            No ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
 
Yes ☒           No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer ☐
Accelerated filer ☒
Non-accelerated filer ☐
 
Emerging growth company ☐
 
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
 
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
 
U.S. GAAP ☒
International Financial Reporting
Standards as issued by the
International Accounting
Standards Board ☐
Other ☐
 
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.
 
Item 17 ☐           Item 18 ☐
 
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes ☐             No ☒
 
2

EXPLANATORY NOTE
 
This Amendment No. 1 on Form 20-F/A (the “Amendment No. 1”) amends Allot Ltd.’s (the “Company”) Annual Report on Form 20-F for the fiscal year ended December 31, 2019 (the “Form 20-F”), as filed with the Securities and Exchange Commission on March 26, 2020, and is being filed solely to correct a typographical error in the date of the Report of Independent Registered Public Accounting Firm from March 26, 2019 to March 26, 2020.

Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended, the Company has repeated the entire text of Item 8 and Item 18 of the Form 20-F in this Amendment No.1. There have been no changes to the text of such items other than the change in the date of the auditor’s report.

In addition, this Amendment No. 1 includes currently dated certifications by our Principal Executive Officer and Principal Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, attached as Exhibits 12.1, 12.2 and 13.1 hereto, and a currently dated consent of Kost Forer Gabbay & Kasierer, attached as Exhibit 15.1 hereto.

Except as expressly set forth above, this Amendment No. 1 does not, and does not purport to, amend, update or restate the information in any other item of the Form 20-F or reflect any events that have occurred after the filing of the Form 20-F.
 
3

TABLE OF CONTENTS
 
5
5
5
5
5

4

PART I

ITEM 8: Financial Information
 
A.           Consolidated Financial Statements and Other Financial Information.
 
Consolidated Financial Statements
 
For our audited consolidated balance sheets as of December 31, 2019 and 2018, and the related consolidated statements of comprehensive income, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2019, please see pages F-4 to F-46 of this report.
 
Export Sales
 
See “ITEM 4: Operating and Financial Review and Prospects” under the caption “Customers” for certain details of export sales for the last three fiscal years.
 
Legal Proceedings
 
We may, from time to time in the future be involved in legal proceedings in the ordinary course of business. Such matters are generally subject to many uncertainties and outcomes are not predictable with assurance. We accrue for contingencies when the loss is probable and it can reasonably estimate the amount of any such loss. Except as set forth in Note 11 to our consolidated financial statements for the fiscal year ended December 31, 2019 included elsewhere in this report, we are currently not a party to any material legal or administrative proceedings for which an appropriate accrual has not been made, and is not aware of any pending or threatened material legal or administrative proceedings against us.
 
Dividends
 
We have never declared or paid any cash dividends on our ordinary shares and we do not anticipate paying any cash dividends on our ordinary shares in the future. We currently intend to retain all future earnings to finance our operations and to expand our business. Any future determination relating to our dividend policy will be made at the discretion of our board of directors and will depend on a number of factors, including future earnings, capital requirements, financial condition and future prospects and other factors our board of directors may deem relevant.
 
B.           Significant Changes
 
Since the date of our audited financial statements included elsewhere in this annual report, there have not been any significant changes in our financial position.
 
PART III
 
ITEM 18: Financial Statements
 
See Financial Statements included at the end of this report.
 
ITEM 19: Exhibits
 
See exhibit index incorporated herein by reference. 

5

SIGNATURES
 
The registrant certifies that it meets all of the requirements for filing on Form 20-F/A and has duly caused this annual report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Allot Ltd
 
 
 
By:
/s/ Erez Antebi 
 
 
 
 Erez Antebi
Chief Executive Officer and President
 
 
Dated: July 1, 2020
 
6

INDEX OF EXHIBITS
 
Number
 
Description
     

     

     

     

     
     

 
     

     

     

     

     

     

     

     
     

     
     
     


7

101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.PRE
 
XBRL Taxonomy Presentation Linkbase Document
101.CAL
 
XBRL Taxonomy Calculation Linkbase Document
101.LAB
 
XBRL Taxonomy Label Linkbase Document
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
____________
(1)
Previously filed with the Securities and Exchange Commission on October 31, 2006 pursuant to a registration statement on Form F-1 (File No. 333-138313) and incorporated by reference herein.
(2)
Previously included in Exhibit 99.3 to the report of foreign private issuer on Form 6-K furnished to the Securities and Exchange Commission on November 1, 2018 and incorporated by reference herein.
(3)
Previously filed with the Securities and Exchange Commission on March 26, 2015 as Exhibit 4.8 to the annual report on Form 20-F for the year ended December 31, 2014 and incorporated by reference herein.
(4)
Previously filed with the Securities and Exchange Commission on March 28, 2016 as Exhibit 5.1 to the annual report on Form 20-F for the year ended December 31, 2015 and incorporated by reference herein.
(5)
Previously included in Exhibit A-1 to Proxy statement included in Exhibit 99.1 to the report of foreign private issuer on Form 6-K furnished to the Securities and Exchange Commission on August 15, 2016 and incorporated by reference herein.
(6)
Previously filed with the Securities and Exchange Commission on March 23, 2017 as Exhibit 4.2 to the annual report on Form 20-F for the year ended December 31, 2016 and incorporated by reference herein.
(7)
Previously filed with the Securities and Exchange Commission on March 23, 2017 as Exhibit 4.3 to the annual report on Form 20-F for the year ended December 31, 2016 and incorporated by reference herein.
(8)
Previously filed with the Securities and Exchange Commission on March 23, 2017 as Exhibit 4.4 to the annual report on Form 20-F for the year ended December 31, 2016 and incorporated by reference herein.
(9)
Previously included in Exhibit 99.1 to the report of foreign private issuer on Form 6-K furnished to the Securities and Exchange Commission on November 1, 2018 and incorporated by reference herein.
(10)
Previously included in Exhibit 99.2 to the report of foreign private issuer on Form 6-K furnished to the Securities and Exchange Commission on November 1, 2018 and incorporated by reference herein.
(11)
Previously filed with the Securities and Exchange Commission on March 22, 2018 as Exhibit 4.6 to the annual report on Form 20-F for the year ended December 31, 2017 and incorporated by reference herein.
(12)
Previously filed with the Securities and Exchange Commission on March 26, 2020 with the annual report on Form 20-F for the year ended December 31, 2019 and incorporated by reference herein.
 
8

ALLOT LTD.

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2019

U.S. DOLLARS IN THOUSANDS


ALLOT LTD.

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2019

U.S. DOLLARS IN THOUSANDS

INDEX

 
Page
 
 
F-2 - F-3
   
F-4 - F-5
   
F-6
   
F-7
   
F-8 - F-9
   
F-10 - F-46

- - - - - - - -


Kost Forer Gabbay & Kasierer
144 Menahem Begin Road, Building A
Tel-Aviv 6492102, Israel
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of

ALLOT LTD.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Allot Ltd. (the “Company“) as of December 31, 2019 and 2018, the related consolidated statements of comprehensive loss, changes in stockholders‘ equity and cash flows, for each of the three years in the period ended December 31, 2019, and the related notes (collectively referred to as the “consolidated financial statements“). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2019 and 2018, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with US generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated March 26, 2020 expressed an unqualified opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company‘s management. Our responsibility is to express an opinion on the Company‘s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB“) and are required to be independent with respect to the Company in accordance with the US federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global

We have served as the Company‘s auditor since 2006.
Tel Aviv, Israel
 
March 26, 2020
 

F - 2

 
Kost Forer Gabbay & Kasierer
144 Menahem Begin Road, Building A
Tel-Aviv 6492102, Israel
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of

ALLOT LTD.

Opinion on Internal Control over Financial Reporting

We have audited Allot Ltd. (the "Company") internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the "COSO Criteria"). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2019 and 2018 and the related consolidated statements of comprehensive loss, Changes in Stockholders’ Equity and cash flows for each of the three years in the period ended December 31, 2019, and the related notes of the Company and our report dated March 26, 2020 expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures, as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global

Tel-Aviv, Israel
March 26, 2020

F - 3


ALLOT LTD.

CONSOLIDATED BALANCE SHEETSU.S.
U.S. dollars in thousands

   
December 31,
 
   
2019
   
2018
 
ASSETS
           
             
 CURRENT ASSETS:
           
Cash and cash equivalents
 
$
16,930
   
$
16,336
 
Restricted deposits
   
23,183
     
465
 
Short-term bank deposits
   
5,557
     
22,543
 
Available-for-sale marketable securities
   
61,012
     
64,290
 
Trade receivables (net of allowance for doubtful accounts of $ 1,867 and $ 1,415 at December 31, 2019 and 2018, respectively)
   
29,008
     
26,093
 
Other receivables and prepaid expenses
    6,528      
3,647
 
Inventories
   
10,668
     
11,345
 
                 
Total current assets
   
152,886
     
144,719
 
                 
NON-CURRENT ASSETS:
               
Restricted deposits
   
10,913
     
257
 
Severance pay fund
   
387
     
345
 
Operating lease right-of-use assets
   
6,368
     
-
 
Deferred taxes
   
517
     
281
 
Other assets
    926      
600
 
Property and equipment
   
8,135
     
6,249
 
  Intangible assets, net
   
3,354
     
4,961
 
  Goodwill
   
31,683
     
32,432
 
                 
Total non-current assets
    62,283
     
45,125
 
                 
Total assets
 
$
215,169
   
$
189,844
 

The accompanying notes are an integral part of the consolidated financial statements.

F - 4

ALLOT LTD.

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands, except share and per share data


   
December 31,
 
   
2019
   
2018
 
LIABILITIES AND SHAREHOLDERS' EQUITY
           
             
CURRENT LIABILITIES:
           
Trade payables
 
$
11,676
   
$
7,813
 
Employees and payroll accruals
   
12,041
     
7,357
 
Deferred revenues
   
36,360
     
13,855
 
Short-term operating lease liabilities
   
3,151
     
-
 
Other payables and accrued expenses
   
10,214
     
13,695
 
                 
Total current liabilities
   
73,442
     
42,720
 
                 
LONG-TERM LIABILITIES:
               
Deferred revenues
   
5,262
     
4,247
 
Long-term operating lease liabilities
   
3,820
     
-
 
Accrued severance pay
   
794
     
806
 
Other long-term liability
   
-
     
6,168
 
                 
Total long-term liabilities
   
9,876
     
11,221
 
                 
COMMITMENTS AND CONTINGENT LIABILITIES
               
                 
SHAREHOLDERS' EQUITY:
               
Share capital -
               
Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at December 31, 2019 and 2018; Issued: 35,336,728 and 34,712,261 shares at December 31, 2019 and 2018, respectively; Outstanding: 34,520,728 and 33,896,261 shares at December 31, 2019 and 2018, respectively
   
871
     
853
 
Additional paid-in capital
   
276,112
     
271,765
 
Treasury stock at cost - 816,000 shares at December 31, 2019 and 2018.
   
(3,998
)
   
(3,998
)
Accumulated other comprehensive income (loss)
   
(525
)
   
(767
)
Accumulated deficit
   
(140,609
)
   
(131,950
)
                 
Total shareholders' equity
   
131,851
     
135,903
 
                 
Total liabilities and shareholders' equity
 
$
215,169
   
$
189,844
 

The accompanying notes are an integral part of the consolidated financial statements.

F - 5

ALLOT LTD.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
U.S. dollars in thousands, except share and per share data

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
Revenues:
                 
Products
 
$
67,440
   
$
56,169
   
$
48,727
 
Services
   
42,660
     
39,668
     
33,265
 
Total revenues
   
110,100
     
95,837
     
81,992
 
                         
Cost of revenues:
                       
Products
   
22,743
     
20,061
     
19,258
 
Services
   
11,091
     
9,288
     
9,272
 
                         
Total cost of revenues
   
33,834
     
29,349
     
28,530
 
                         
Gross profit
   
76,266
     
66,488
     
53,462
 
                         
Operating expenses:
                       
Research and development (net of grant participations of $ 378, $ 374 and $ 392 for the years ended December 31, 2019, 2018 and 2017, respectively)
   
31,461
     
25,418
     
21,852
 
Sales and marketing
   
47,105
     
40,849
     
38,316
 
General and administrative
   
6,678
     
10,416
     
10,696
 
                         
Total operating expenses
   
85,244
     
76,683
     
70,864
 
                         
Operating loss
   
(8,978
)
   
(10,195
)
   
(17,402
)
Financial income, net
   
1,960
     
2,208
     
894
 
                         
Loss before income tax expense
   
(7,018
)
   
(7,987
)
   
(16,508
)
Income tax expense
   
1,641
     
2,428
     
1,564
 
                         
Net loss
 
$
(8,659
)
 
$
(10,415
)
 
$
(18,072
)
                         
Unrealized gain (loss) on available-for-sale marketable securities
   
670
     
(226
)
   
(35
)
Unrealized gain (loss) on foreign currency cash flow hedges transactions
   
(332
)
   
(1,480
)
   
1,016
 
Net amount reclassified to earnings
   
(96
)
   
903
     
(796
)
Total comprehensive loss from hedge transactions
   
(428
)
   
(577
)
   
220
 
                         
Total comprehensive loss
 
$
(8,417
)
 
$
(11,218
)
 
$
(17,887
)
                         
Net loss per share:
Basic and diluted
 
$
(0.25
)
 
$
(0.31
)
 
$
(0.54
)
                         
Weighted average number of shares used in per share computations of net loss:
                       
Basic and diluted
   
34,250,582
     
33,710,507
     
33,253,158
 


The accompanying notes are an integral part of the consolidated financial statements.

F - 6

ALLOT LTD.
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
U.S. dollars in thousands, except share data

   
Ordinary shares
   
Additional
paid-in capital
     
Treasury stock
   
Accumulated other
comprehensive income (loss)
     
Accumulated deficit
   

Total shareholders' equity
 
   
Outstanding shares
   
Amount
                     
                                           
Balance at January 1, 2017
   
33,057,719
     
843
     
264,782
     
(3,998
)
   
(149
)
   
(104,175
)
   
157,303
 
                                                         
Exercise of stock options
   
425,543
     
8
     
354
     
-
     
-
     
-
     
362
 
Stock-based compensation
   
-
     
-
     
3,351
     
-
     
-
     
-
     
3,351
 
Other comprehensive income
   
-
     
-
     
-
     
-
     
185
     
-
     
185
 
Net loss
   
-
     
-
     
-
     
-
     
-
     
(18,072
)
   
(18,072
)
                                                         
Balance at December 31, 2017
   
33,483,262
     
851
     
268,487
     
(3,998
)
   
36
     
(122,247
)
   
143,129
 
                                                         
Cumulative effect of new accounting standard (See Note 1)
   
-
     
-
     
-
     
-
     
-
     
712
     
712
 
Exercise of stock options
   
412,999
     
2
     
416
     
-
     
-
     
-
     
418
 
Stock-based compensation
   
-
     
-
     
2,862
     
-
     
-
     
-
     
2,862
 
Other comprehensive income
   
-
     
-
     
-
     
-
     
(803
)
   
-
     
(803
)
Net loss
   
-
     
-
     
-
     
-
     
-
     
(10,415
)
   
(10,415
)
                                                         
Balance at December 31, 2018
   
33,896,261
     
853
     
271,765
     
(3,998
)
   
(767
)
   
(131,950
)
   
135,903
 
                                                         
Exercise of stock options
   
624,467
     
18
     
974
     
-
     
-
     
-
     
992
 
Stock-based compensation
   
-
     
-
     
3,373
     
-
     
-
     
-
     
3,373
 
Other comprehensive income
   
-
     
-
     
-
     
-
     
242
     
-
     
242
 
Net loss
   
-
     
-
     
-
     
-
     
-
     
(8,659
)
   
(8,659
)
                                                         
Balance at December 31, 2019
   
34,520,728
     
871
     
276,112
     
(3,998
)
   
(525
)
   
(140,609
)
   
131,851
 

Accumulated other comprehensive loss:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Accumulated unrealized gain (loss) on available-for-sale marketable securities
 
$
321
   
$
(349
)
 
$
(123
)
Accumulated unrealized loss on foreign currency cash flows hedge transactions gain (loss)
   
(846
)
   
(418
)
   
159
 
                         
Accumulated other comprehensive gain (loss)
 
$
(525
)
 
$
(767
)
 
$
36
 

The accompanying notes are an integral part of the consolidated financial statements.

F - 7

ALLOT LTD.
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands


   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
Cash flows from operating activities:
                 
                   
Net loss
 
$
(8,659
)
 
$
(10,415
)
 
$
(18,072
)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                       
Depreciation and amortization
   
4,359
     
3,834
     
3,668
 
Stock-based compensation
   
3,420
     
2,862
     
3,366
 
Capital loss
   
-
     
39
     
27
 
Increase (decrease) in accrued severance pay, net
   
(54
)
   
16
     
105
 
Decrease in other assets
   
(326
)    
535
     
1
 
Decrease in accrued interest and amortization of premium on available-for sale marketable securities
   
343
     
804
     
913
 
Changes in operating lease right-of-use asset
   
(6,368
)
   
-
     
-
 
Changes in operating leases liability
   
6,971
                 
Decrease (increase) in trade receivables
   
(2,915
)
   
(3,356
)
   
1,421
 
Decrease (increase) in other receivables and prepaid expenses
   
(3,168
)
   
(1,101
)
   
1,350
 
Increase in inventories
   
(253
)
   
(3,448
)
   
(662
)
    Decrease (increase) in long-term deferred taxes, net
   
(236
)
   
20
     
(34
)
Increase in trade payables
   
3,863
     
1,945
     
2,582
 
Increase (decrease) in employees and payroll accruals
   
4,635
     
(1,178
)
   
1,140
 
Increase in deferred revenues
   
23,520
     
3,566
     
518
 
Increase (decrease) in other payables and accrued expenses
   
(9,040
)
   
6,906
     
3,449
 
                         
Net cash provided by (used in) operating activities
   
16,092
     
1,029
     
(228
)
                         
Cash flows from investing activities:
                       
                         
Investment in restricted deposits
   
(33,374
)
   
(294
)
   
(428
)
Redemption of (Investment in) short-term deposits
   
16,986
     
8,500
     
(1,222
)
Purchase of property and equipment
   
(3,708
)
   
(3,485
)
   
(2,833
)
Investment in available-for sale marketable securities
   
(39,950
)
   
(34,777
)
   
(30,123
)
Proceeds from redemption or sale of available-for sale marketable securities
   
43,555
     
32,651
     
26,488
 
Acquisition of Netonomy, net of cash
   
-
     
(3,048
)
   
-
 
                         
Net cash used in by investing activities
   
(16,491
)
   
(453
)
   
(8,118
)

F - 8

ALLOT LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
Cash flows from financing activities:
                 
                   
Proceeds from exercise of stock options
   
993
     
418
     
362
 
                         
Net cash provided by financing activities
   
993
     
418
     
362
 
                         
Increase (decrease) in cash and cash equivalents
   
594
     
994
     
(7,984
)
Cash and cash equivalents at the beginning of the year
   
16,336
     
15,342
     
23,326
 
                         
Cash and cash equivalents at the end of the year
 
$
16,930
   
$
16,336
   
$
15,342
 
                         
Supplementary cash flow information:
                       
                         
Cash paid during the year for:
                       
                         
Taxes
 
$
473
   
$
347
   
$
342
 
                         
Non cash activity:
                       
                         
Changes in operating lease right-of-use singed during 2019
 
$
(1,208
)
               
Changes in operating leases liability singed during 2019
 
$
1,208
                 

The accompanying notes are an integral part of the consolidated financial statements.

F - 9

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 1:-
GENERAL


a.
Allot Ltd. (the "Company") was incorporated in November 1996 under the laws of the State of Israel. The Company is engaged in developing, selling and marketing network intelligence and security solutions for mobile, fixed and cloud service providers, as well as enterprises, and helping them enhance value to their customers. The Company’s flexible and highly scalable hardware platforms and software applications are deployed globally for network and application analytics, traffic control and shaping, network-based security including mobile security, DDoS protection, IoT security and more. The Company's main platforms include Allot Service Gateway service delivery platform and Allot Secure. Allot SG enables network operators to learn about users and network behaviors to improve quality of service and reduce costs; and Allot Secure enables customers to detect security breaches and protect networks and network users from attacks. These platforms and the solutions they provide empower service providers and enterprises to get more out of their networks, to secure and to manage them better, to clearly see and understand their networks from within, and to innovate, optimize, and capitalize on every opportunity, all the while deploying new services faster and constantly increasing value to their customers.

The Company's Ordinary Shares are listed in the NASDAQ Global Select Market under the symbol "ALLT" from its initial public offering in November 2006. Since November 2010, the Company's Ordinary Shares have been listed for trading in the Tel Aviv Stock Exchange as well.

The Company holds fourteen wholly-owned subsidiaries (the Company together with said subsidiaries shall collectively be referred to as "Allot"): Allot Communications, Inc. in Burlington, Massachusetts, United-States (the "U.S. subsidiary"), which was incorporated in 1997 under the laws of the State of California, Allot Communication Europe SARL in Sophia, France (the "European subsidiary"), which was incorporated in 1998 under the laws of France, Allot Communications Japan K.K. in Tokyo, Japan (the "Japanese subsidiary"), which was incorporated in 2004 under the laws of Japan, Allot Communication (UK) Limited (the "UK subsidiary"), which was incorporated in 2006 under the laws of England and Wales, Allot Communications (Asia Pacific) Pte. Ltd. ("the Singaporean subsidiary"), which was incorporated in 2006 under the laws of Singapore, Allot Communications (New Zealand) Limited. (the "NZ subsidiary"), which was incorporated in 2007 under the laws of New Zealand, Allot India Private Limited. (the "Indian subsidiary”), which was incorporated in 2012 under the laws of India and commenced its activity in 2013, Allot Communications Africa (PTY) Ltd. (the "African subsidiary”), which was incorporated in 2013 under the laws of South Africa, Allot Communications (Hong Kong) Limited (the "HK subsidiary”), which was incorporated in 2013 under the laws of Hong-Kong, Allot Communications Spain, S.L. Sociedad Unipersonal (the "Spanish subsidiary”), which was incorporated in 2015 under the laws of Spain, Allot Communications (Colombia) S.A.S (the "Colombian subsidiary”), which was incorporated in 2015 under the laws of Colombia and Allot MexSub (the "Mexican subsidiary"), which was incorporated in 2015 under the laws of Mexico, Allot Turkey Komunikasion Hizmeleri limited (the “Turkish subsidiary”), which was incorporated in 2018 under laws of Turkey, Allot Australia (PTY) LTD (the “Australian subsidiary”), which was incorporated in 2018 under the laws of Australia.

F - 10

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 1:-
GENERAL (Cont.)

The U.S., Spanish, Colombian and Indian subsidiaries are engaged in the sale, marketing and technical support services of the Company's products in the Americas, Colombia and India, respectively. The European (excluding Spanish), Japanese, NZ, UK, Singaporean, HK, African, Turkish and Australian subsidiaries are engaged in marketing and technical support services of the Company's products in Europe, Japan, Oceania, UK, Asia and Africa, respectively.

The Spanish and Mexican subsidiaries commenced operations in 2015 and are engaged in the marketing, technical support and development activities of one of the Company's product lines.


b.
Acquisition:

On January 14, 2018 (the "Netonomy acquisition date"), the Company entered into a purchase agreement with the shareholders of Netonomy LTD ("Netonomy"), a developer of software-based cybersecurity solutions for the connected home.

The total consideration for the acquisition was $ 3,765, which consisted of $ 3,180 paid in cash, holdback amount summing to $ 303 and additional contingent consideration at a fair value of $ 282 at the Netonomy acquisition date. As of December 31, 2019, the contingent consideration is estimated at a fair value of $ 1,081, The change in fair value of the contingent consideration was recorded to operating expenses.

The holdback amount (“Holdback Amount”) summing to $ 1,100 would be held to partially satisfy any claims for indemnification. Such amount shall be paid in three installments consisting each one 40%, 40% and 20% of the Holdback amount following the first, second and 30-months anniversaries of the Closing Date, respectively. Notwithstanding the aforementioned, a sum of $ 797 thousand out of the Holdback Amount shall be paid provided that certain employees keep working in the Company during the here mentioned periods (“the Restricted Holdback Amount”).

The contingent consideration is payable over a two-and-a-half-year term, starting April 1, 2018 and ending September 30, 2020 depending on the Company’s revenues from Netonomy’s technology, and has payments cap of $ 1,100. A sum of $ 797 thousand out of the contingent consideration Amount shall be paid provided that certain employees keep working in the Company during the mentioned periods under the “Restricted Holdback Amount”. The obligations in respect of the holdback amount and the contingent consideration are presented under Other payables and accrued expenses.

F - 11

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 1:-
GENERAL (Cont.)

The acquisition was accounted for using the purchase method of accounting in accordance with ASC No. 805, “Business Combinations” ("ASC No. 805"). Accordingly, the purchase price was allocated according to the estimated fair values of the assets acquired and liabilities assumed and the excess of the purchase price over the net tangible and identified intangible assets was assigned to goodwill. The fair value of intangible assets was determined by management with the assistance of a third-party valuation.

On July 2018, the merger of Netonomy with the Company was approved by the Israeli tax authorities with Allot as the receiving company and Netonomy as the transferring company and March 31, 2018 as the Merger Date.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

   
Fair value
 
       
Non-current assets
 
$
4
 
Account Payable
   
(11
)
Other Payables
   
(142
)
IPR&D
   
3,659
 
Goodwill
   
121
 
         
Net assets acquired
 
$
3,631
 

The acquired assets are net of cash balance of $ 132.

IPR&D is related to new technology that is still under development. Netonomy’s solution provides a simple, reliable and secure network for connected homes through a minimal footprint agent installed on the home router, which provides visibility into the network and blocks external and internal attacks.Acquisition costs in a total amount of $49 were recorded to operating expenses.  The Company started to depreciate the IPR&D asset from Q3 2019 as the R&D phase was completed and the product was ready to sell.

Unaudited pro forma condensed results of operations:

Pro forma results of operations related to this acquisition have not been prepared because they are not material to the Company’s consolidated statements of income.

The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").
F - 12

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES

a.        Use of estimates:

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

b.        Financial statements in U.S. dollars:

The majority of the revenues of the Company and its subsidiaries are generated in U.S. dollars ("dollar") or linked to the dollar. In addition, a major portion of the Company's and certain of its subsidiaries' costs are incurred or determined in dollars. The Company's management believes that the dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the dollar.

Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into U.S. dollars in accordance with Accounting Standards Codification No. 830, "Foreign Currency Matters" ("ASC No. 830"). All transactions gains and losses from the remeasurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses as appropriate.

c.        Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.

d.        Cash and cash equivalents:

The Company considers all unrestricted highly liquid investments which are readily convertible into cash, with a maturity of three months or less at the date of acquisition, to be cash equivalents.

e.        Restricted deposits:

The restricted deposits are held in favor of financial institutions in respect of fulfillment of forward contracts and operating obligations. As of December 31, 2019, a major prepayment received from a client was classified as a restricted deposit due to the contractual terms with the client.

F - 13

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)


f.
Short-term bank deposits:

Short-term bank deposits are deposits with maturities of more than three months but less than one year at the balance sheet date. The deposits are in dollars and bear interest at an annual weighted average rate of 2.33% and 2.82% at December 31, 2019 and 2018, respectively. In connection with the Company's hedging transactions, the Company is required to maintain compensating deposits balances in the bank. Out of the short-term bank deposits, a total of $2,500 is due to the hedging transactions as of December 31, 2019 and 2018.

g.        Marketable securities:

The Company accounts for investments in marketable securities in accordance with ASC 320, "Investments - Debt and Equity Securities". Management determines the appropriate classification of its investments in debt securities at the time of purchase and re-evaluates such determinations at each balance sheet date.

Marketable securities classified as "available-for-sale" are carried at fair value, based on quoted market prices. Unrealized gains and losses are reported in a separate component of shareholders' equity in accumulated other comprehensive income (loss). Gains and losses are recognized when realized, on a specific identification basis, in the Company's consolidated statements of comprehensive loss.

The Company's securities are reviewed for impairment in accordance with ASC 320-10-35. If such assets are considered to be impaired, the impairment charge is recognized in earnings when a decline in the fair value of its investments below the cost basis is judged to be Other-Than-Temporary Impairment (OTTI). Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company's intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. Based on the above factors, the Company concluded that unrealized losses on its available-for-sale securities, for the years ended 2019, 2018 and 2017, were not OTTI.

h.        Inventories:

Inventories are stated at the lower of cost or net realizable value. Inventory write-offs are provided to cover risks arising primarily from end of life products and from slow-moving items, technological obsolescence, and excess inventory. Inventory write-offs during the years ended December 31, 2019, 2018 and 2017 amounted to $ 629, $ 2,231 and $ 1,260, respectively, and were recorded in cost of revenues.

Inventory write-off provision as of December 31, 2019 and 2018 amounted to $ 2,839 and $ 2,818, respectively.

Inventory cost is determined using the weighted average cost method.

F - 14

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

i.         Property and equipment, net:

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates:

   
%
     
Lab equipment
 
16 - 25
Computers and peripheral equipment
 
33
Office furniture
 
6
Leasehold improvements
 
Over the shorter of the term of the lease or the useful life of the asset


j.
Goodwill impairment:

Goodwill represents the excess of the purchase price over the fair value of net assets of purchased businesses. Under Accounting Standards Codification No. 350, "Intangibles-Goodwill and Other" ("ASC No. 350"), goodwill is not amortized, but rather subject to an annual impairment test, or more often if there are indicators of impairment present. In accordance with ASC No. 350 the Company performs an annual impairment test at December 31 each year.

ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the two-step impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test.

The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step would need to be performed; otherwise, no further step is required. The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill. Any excess of the goodwill carrying amount over the applied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value.

The Company operates in one operating segment, and this segment comprises its only reporting unit. The Company has performed an annual impairment analysis as of December 31, 2019 and determined that the carrying value of the reporting unit was less than the fair value of the reporting unit. Fair value is determined using market capitalization. During years 2019, 2018 and 2017, no impairment losses were recorded.

F - 15

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)


k.
Impairment of long-lived assets and intangible assets subject to amortization:

Property and equipment and intangible assets subject to amortization are reviewed for impairment in accordance with ASC No. 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Some of the acquired intangible assets are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer relationships as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis.

During the years ended December 31, 2019, 2018 and 2017, no impairment losses were recorded.


l.
Revenue recognition:

The Company generates revenues mainly from selling its products along with related maintenance and support services. At times, these arrangements may also include professional services, such as installation services or training. Some of the Company’s product sells is done through resellers, distributors, OEMs and system integrators, all of whom are considered end-users.

The Company adopted accounting standards codification 606, "Revenue from Contracts with Customers" ("ASC 606"), effective on January 1, 2018. The Company recognizes revenue under the core principle that transfer of control to the Company’s customers should be depicted in an amount reflecting the consideration the Company expects to receive. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.

F - 16

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company enters into contracts that can include combinations of products and services, that are capable of being distinct and accounted for as separate performance obligations.  The products are distinct as the customer can derive the economic benefit of it without any professional services, updates or technical support. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price out of the total consideration of the contract. For support, the Company determines the standalone selling prices based on the price at which the Company separately sells a renewal contract on a stand-alone basis. For professional services, the Company determines the standalone selling prices based on the price at which the Company separately sells those services on a stand-alone basis. If the SSP is not observable, the Company estimates the SSP taking into account available information such as geographic or regional specific factors, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation.

Maintenance and support related revenues are deferred and recognized on a straight-line basis over the term of the applicable maintenance and support agreement. Other services are recognized upon the completion of installation or when the service is provided.

Deferred revenue includes amounts received from customers for which revenue has not yet been recognized. Deferred revenues are classified as short and long-term based on their contractual term and recognized as revenues at the time the respective elements are provided.

Transaction price allocated to remaining performance obligations represents non-cancelable contracts that have not yet been recognized that include deferred revenue and amounts not yet received that will be recognized as revenue in future periods. The aggregate amount of the transaction price allocated to remaining performance obligations that the Company expects to recognize after the year ending December 31, 2020 is approximately $37,875.

The Company pays sales commissions to sales and marketing personnel based on their certain predetermined sales goals. Sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions earned by its employees are capitalized and amortized in over the revenue recognition period. Amortization expenses related to these costs are included in sales and marketing expenses in the consolidated statements of operations. For the year ended December 31, 2019, the amortization of deferred commission was $1,351. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less.

The Company estimated variable consideration related to product returns based on its experience with historical product returns and other known factors. Such provisions amounted to $163 and $191 as of December 31, 2019 and 2018, respectively. Following the adoption of ASC 606, As of December 31, 2019 and 2018, this provision was recorded as part of other payables and accrued expenses.

F - 17

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Following the adoption of ASC 606 in January 1, 2018, the Company recognizes for term-based license agreements at the point in time when control transfers and the associated maintenance revenues over the contract period. Adoption of the standard has resulted in a reduction of deferred revenues of $712 that was recorded in accumulated deficit due to upfront recognition of license revenues from term licenses.

The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of Topic 606-10 was as follows:

   
December 31, 2017
   
Adjustments
   
January 1, 2018
 
   
(in thousands)
 
Deferred revenue, short term
   
11,370
     
(311
)
   
11,059
 
Deferred revenue, long term
   
3,878
     
(75
)
   
3,803
 
Trade receivables
   
22,737
     
326
     
23,063
 
Accumulated deficit
   
122,247
     
(712
)
   
121,535
 

In accordance with Topic 606-10, the disclosure of the impact of adoption on the consolidated balance sheet as of December 31, 2018 was as follows:

   
Amounts under
Topic 605
   
Impact of Adoption
   
As Reported
 
   
(in thousands)
 
Consolidated Balance Sheet
                 
Deferred revenue, short term
   
14,152
     
(297
)
   
13,855
 
Deferred revenue, long term
   
4,264
     
(17
)
   
4,247
 
Trade receivables
   
25,603
     
490
     
26,093
 
Accumulated deficit
   
132,754
     
(804
)
   
131,950
 

In addition, following the adoption of ASC 606, the Company’s consolidated statement of operations for the year ended December 31, 2018, included an increase of revenue in the amount of $ 92, net, compared to the accounting treatment under ASC 605.

m.       Cost of revenues:

Cost of revenues consists primarily of costs of materials and the cost of maintenance and services, resulting from costs associated with support, customer success and professional services.

n.         Advertising expenses:

Advertising expenses are charged to the statement of comprehensive loss, as incurred. Advertising expenses for the years ended December 31, 2019, 2018 and 2017 amounted to $ 1,274, $ 1,270 and $ 1,236, respectively.


F - 18

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

o.        Research and development costs:

Accounting Standards Codification No. 985-20, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.

Based on the Company's product development process, technological feasibility is established upon the completion of a working model. The Company does not incur material costs between the completion of a working model and the point at which the products are ready for general release. Therefore, research and development costs are charged to the consolidated statement of comprehensive loss as incurred.

p.        Severance pay:

The liability in Israel for substantially all of the Company`s employees in respect of severance pay liability is calculated in accordance with Section 14 of the Severance Pay Law -1963 (herein- "Section 14"). Section 14 states that Company's contributions for severance pay shall be in line of severance compensation and upon release of the policy to the employee, no additional obligations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee.

Furthermore, the related obligation and amounts deposited on behalf of such obligation under Section 14, are not stated on the balance sheet, because pursuant to the current ruling, they are legally released from the obligation to employees once the deposits have been paid.

There are a limited number of employees in Israel, for whom the Company is liable for severance pay. The Company's liability for severance pay for its Israeli employees was calculated pursuant to Section 14, based on the most recent monthly salary of its Israeli employees multiplied by the number of years of employment as of the balance sheet date for such employees.

The Company's liability was partly provided by monthly deposits with severance pay funds and insurance policies and the remainder by an accrual.

Severance expense for the years ended December 31, 2019, 2018 and 2017, amounted to $ 2,249, $ 1,950 and $ 1,801, respectively.

q.        Accounting for stock-based compensation:

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification No. 718, "Compensation - Stock Compensation" ("ASC No. 718") that requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statement of comprehensive loss. The Company recognizes compensation expenses for the value of its awards based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures.

F - 19

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company accounted for changes in award terms as a modification in accordance with ASC 718. A modification to the terms of an award should be treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value measured at the same date. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances.

The Company estimated the forfeiture rate based on historical forfeitures of equity awards and adjusted the rate to reflect changes in facts and circumstances if any. The Company adopted ASU 2016-09 in the first quarter of the fiscal year 2017 and elected to retain its existing accounting policy and estimate expected forfeitures. The adoption of this ASU did not have a material impact on the Company's consolidated financial statements.

The following table sets forth the total stock-based compensation expense resulting from stock options, restricted share units ("RSUs") and Phantoms granted to employees included in the consolidated statements of comprehensive loss, for the years ended December 31, 2019, 2018 and 2017:
   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Cost of revenues
 
$
264
   
$
316
   
$
362
 
Research and development
   
847
     
678
     
648
 
Sales and marketing
   
1,257
     
928
     
1,166
 
General and administrative
   
1,052
     
940
     
1,190
 
                         
Total stock-based compensation expense
 
$
3,420
   
$
2,862
   
$
3,366
 

The Company selected the binomial option pricing model as the most appropriate fair value method for its stock-based compensation awards with the following assumptions for the years ended December 31, 2018 and 2017:

   
Year ended December 31,
 
   
2018
   
2017
 
             
Suboptimal exercise multiple
   
2.9-3.5
     
2.9-3.5
 
Risk free interest rate
   
2.09%-3.05%

   
0.80%-2.20%

Volatility
   
26%-47%

   
27%-49%

Dividend yield
   
0%

   
0%


The expected annual post-vesting and pre-vesting forfeiture rates affects the number of exercisable options. Based on the Company's historical experience, the annual pre-vesting and post-vesting are in the range of 0%-33% and 0%-41%, respectively, in the years 2018 and 2017. During 2019 no options were granted by the Company.

F - 20

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The computations of expected volatility and suboptimal exercise multiple is based on the average of the Company's realized historical stock price. The computation of the suboptimal exercise multiple and the forfeiture rates are based on the grantee's expected exercise prior and post vesting termination behavior. The interest rate for a period within the contractual life of the award is based on the U.S. Treasury Bills yield curve in effect at the time of grant.

The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business.

The expected life of the stock options represents the weighted-average period the stock options are expected to remain outstanding and is a derived output of the binomial model. The expected life of the stock options is impacted by all of the underlying assumptions used in the Company's model.

r.         Treasury stock:

The Company repurchases its Ordinary shares from time to time on the open market and holds such shares as treasury stock. The Company presents the cost to repurchase treasury stock as a reduction of shareholders' equity.

s.         Concentration of credit risks:

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, short-term bank deposits, trade receivables and derivative instruments.

The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits in major U.S. and Israeli banks. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the cash and cash equivalents and short-term bank deposits may be redeemed upon demand, and therefore, bear minimal risk.

Marketable securities include investments in dollar linked corporate and municipal bonds. Marketable securities consist of highly liquid debt instruments with high credit standing. The Company’s investment policy, approved by the Board of Directors, limits the amount the Group may invest in any one type of investment or issuer, thereby reducing credit risk concentrations. Management believes that the portfolio is well diversified and, accordingly, minimal credit risk exists with respect to these marketable debt securities

The Company's trade receivables are primarily derived from sales to customers located mainly in EMEA, as well as in APAC, Latin America and the United States. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and establishes an allowance for doubtful accounts on a specific basis. Allowance for doubtful accounts amounted to $ 1,867 and $ 1,415 as of December 31, 2019 and 2018, respectively.

F - 21

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company utilizes foreign currency forward contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financial institutions and its exposure is limited to the amount of any asset resulting from the forward contracts.

The Company has no significant off-balance sheet concentrations of credit risk.

t.         Grants from the Israel Innovation Authority:

Participation grants from the Israel Innovation Authority (Previously known as the Office of the Chief Scientist) for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 378, $ 374 and $ 392 in 2019, 2018 and 2017, respectively.

u.        Income taxes:

The Company accounts for income taxes in accordance with Accounting Standards Codification No. 740, "Income Taxes" ("ASC No. 740"). ASC No. 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The deferred tax assets and liabilities are classified to non-current assets and liabilities, respectively.

ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income

v.        Basic and diluted net income (loss) per share:

Basic net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year. Diluted net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus dilutive potential Ordinary Shares considered outstanding during the year, in accordance with FASB ASC 260 "Earnings Per Share".


F - 22

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

For the years ended December 31, 2019, 2018 and 2017, all outstanding options and RSUs have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive. See Note 16. The amount of those options and RSU’s was : 3,105,801,  2,998,174,  2,902,387 respectively.

w.        Comprehensive loss:

The Company accounts for comprehensive loss in accordance with Accounting Standards Codification No. 220, "Comprehensive Income" ("ASC No. 220"). This statement establishes standards for the reporting and display of comprehensive loss and its components in a full set of general purpose financial statements. Comprehensive loss represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to shareholders. The Company determined that its items of comprehensive loss relate to unrealized gains and losses on hedging derivative instruments and unrealized gains and losses on available-for-sale marketable securities.

The following table shows the components and the effects on net loss of amounts reclassified from accumulated other comprehensive loss as of December 31, 2019:

   
Year ended
December 31, 2019
 
   
Unrealized gain (losses) on marketable securities
   
Unrealized gains (losses) on cash flow hedges
   
Total
 
                   
Balance as of December 31, 2018
 
$
(349
)
 
$
(418
)
 
$
(767
)
Changes in other comprehensive income (loss) before reclassifications
   
666
     
(332
)
   
334
 
Amounts reclassified from accumulated other comprehensive income (loss) to:
                       
 Cost of revenues
   
-
     
(7
)
   
(7
)
Operating expenses
   
-
     
(89
)
   
(89
)
Financial income, net
   
4
     
-
     
4
 
                         
Net current-period other comprehensive income (loss)
   
670
     
(428
)
   
242
 
                         
Balance as of December 31, 2019
 
$
321
   
$
(846
)
 
$
(525
)

x.        Fair value of financial instruments:

The Company measures its cash and cash equivalents, marketable securities, derivative instruments, short-term bank deposits, trade receivables, other receivables, trade payables and other payables at fair value. The carrying amounts of short-term bank deposits, trade receivables, other receivables, trade payables and other payables approximate their fair value due to the short-term maturities of such instruments.

F - 23

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Fair value is an exit price, representing the amount that would be received if the Company were to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

The Company uses a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:


Level 1 -
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.


Level 2 -
Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and


Level 3 -
Unobservable inputs which are supported by little or no market activity.

The Company categorized each of its fair value measurements in one of those three levels of hierarchy. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The Company's earn-out considerations are classified within Level 3. The valuation methodology used by the Company to calculate the fair value consideration is the discounted cash flow using the Monte-Carlo simulation method by taking into account, forecast future revenues, expected volatility of 42.5% for Optenet and 20.7% for Netonomy and the weighted average cost of debt of 2%. As of December 31, 2019 the fair value of the consideration was determined according to discounted cash flow since the earn-out will be completely paid by the third quarter of 2020.

y.        Derivatives and hedging:

The Company accounts for derivatives and hedging based on Accounting Standards Codifiation No. 815, "Derivatives and Hedging" ("ASC No. 815").

The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value. Derivative instruments that are not designated and qualified as hedging instruments must be adjusted to fair value through earnings.

F - 24

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

For derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) in shareholders' equity and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As a result of adopting new accounting guidance discussed in Note 2, " Recently adopted accounting pronouncements," beginning January 1, 2019, gains and losses on the derivatives instruments that are designated and qualify as a cash flow hedge are recorded in accumulated other comprehensive income (loss) and reclassified into in the same accounting period in which the designated forecasted transaction or hedged item affects earnings. Prior to January 1, 2019, cash flow hedge ineffectiveness was separately measured and reported immediately in earnings. Cash flow hedge ineffectiveness was immaterial during 2018 and 2017. To apply hedge accounting treatment, cash flow hedges must be highly effective in offsetting changes to expected future cash flows on hedged transactions.


z.
Business combinations:

The Company accounts for business combinations in accordance with ASC No. 805. ASC No. 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. Any excess of the fair value of net assets acquired over the purchase price is recorded as goodwill and any subsequent changes in estimated contingencies are to be recorded in earnings. In addition, changes in valuation allowance related to acquired deferred tax assets and acquired income tax positions are to be recognized in earnings.

aa.       Lease:

On January 1, 2019, the Company adopted ASU No. 2016-02, Leases (ASC 842). The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases.

ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses the Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.

F - 25

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option.

Payments under our lease arrangements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in
the operating lease right-of-use assets and liabilities. Variable lease payments are primarily comprised of payments affected by common area maintenance and utility charges.

ab.      Warranty costs:

The Company generally provides three months software and a one-year hardware warranty for all of its products. A provision is recorded for estimated warranty costs at the time revenues are recognized based on the Company's experience. Warranty expenses for the years ended December 31, 2019, 2018 and 2017 were immaterial.

 ac.       Recently Adopted Accounting Pronouncements:

In February 2016, the FASB issued ASU No. 2016-02, Leases (ASC 842). The standard requires the recognition of ROU assets and lease liabilities for all leases. The standard requires a modified retrospective transition approach to recognize and measure leases at the initial application.

The Company adopted the standard as of January 1, 2019, using a modified retrospective transition approach and elected to use the effective date as the date of initial application. The Company adopted the ”package of practical expedients”, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. As a result, the consolidated balance sheets as of December 31, 2018 were not restated, continue to be reported under ASC 840, which did not require recognition of operating lease assets and liabilities on the balance sheets, and are not comparative.

The standard had a material impact on the Company’s consolidated balance sheets which resulted in the recognition of ROU assets and lease liabilities of $6.7 million and $6.7 million, respectively, on January 1, 2019, which included reclassifying deferred rent and rent prepayments as components of the ROU assets. The standard did not have a material impact on the Company's consolidated statements of comprehensive income. See also Note 11a.

F - 26

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company adopted Accounting Standards Update (“ASU”) No. 2017- 12, “Derivatives and Hedging” (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amended the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements were adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships which existed on the date of adoption were applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and the adoption did not have a material impact on the Company’s consolidated financial statements.

In June 2018, the FASB issued Accounting Standards Update No. 2018-07, "Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting" (ASU 2018-07). ASU 2018-07 was issued to simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, Compensation – Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The Company adopted this standard as of December 31, 2019 and did not have material effect on its consolidated financial statements.

ad.      Recently Issued Accounting Pronouncement Not Yet Adopted:

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). The standard changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company will adopt this standard as of January 1, 2020 and does not expect this to have a material effect on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment" ("ASU 2017-04"). ASU 2017-04 eliminates the requirement to measure the implied fair value of goodwill by assigning the fair value of a reporting unit to all assets and liabilities within that unit (the "Step 2 test") from the goodwill impairment test. Instead, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited by the amount of goodwill in that reporting unit. ASU 2017-04 will become effective for the Company beginning January 1, 2020 and must be applied to any annual or interim goodwill impairment assessments after that date. Early adoption is permitted. The new guidance was effective for the Company on January 1, 2020. The adoption did not have a material impact on the Company’s consolidated financial statements.

In December 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): “Simplifying the Accounting for Income Taxes” (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for us in the first quarter of 2021 on a prospective basis, and early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

F - 27

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 3:-
AVAILABLE-FOR-SALE MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities:

   
December 31, 2019
   
December 31, 2018
 
   
Amortized cost
   
Gross unrealized gain
   
Gross unrealized
loss
   
Fair
value
   
Amortized cost
   
Gross
unrealized
gain
   
Gross unrealized
loss
   
Fair
value
 
                                                 
Available-for-sale - matures within one year:
                                               
Governmental debentures
 
$
449
   
$
1
   
$
-
   
$
450
   
$
1,799
   
$
-
   
$
(2
)
 
$
1,797
 
Corporate debentures
   
30,928
     
79
     
(8
)
   
30,999
     
37,808
     
6
     
(98
)
   
37,716
 
                                                                 
     
31,377
     
80
     
(8
)
   
31,449
     
39,607
     
6
     
(100
)
   
39,513
 
Available-for-sale - matures after one year through three years:
                                                               
Governmental debentures
   
855
     
1
     
-
     
856
     
476
     
-
     
(4
)
   
472
 
Corporate debentures
   
23,653
     
197
     
(7
)
   
23,843
     
24,455
     
4
     
(253
)
   
24,206
 
                                                                 
     
24,508
     
198
     
(7
)
   
24,699
     
24,931
     
4
     
(257
)
   
24,678
 
Available-for-sale - matures after three years through five years:
                                                               
Corporate debentures
   
4,806
     
58
     
-
     
4,864
     
101
     
-
     
(2
)
   
99
 
     
4,806
     
58
     
-
     
4,864
     
101
     
-
     
(2
)
   
99
 
   
$
60,691
   
$
336
   
$
(15
)
 
$
61,012
   
$
64,639
   
$
10
   
$
(359
)
 
$
64,290
 

As of December 31, 2019, the Company had no investments with a significant unrealized losses for more than 12 months.

F - 28

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 4:-
FAIR VALUE MEASUREMENTS

In accordance with ASC No. 820, the Company measures its marketable securities and foreign currency derivative instruments at fair value. Cash equivalents and available for sale marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs.

The earn-out liability related to the acquisitions of Optenet and Netonomy are classified within Level 3 because these liabilities are based on present value calculations and an external valuation model whose inputs include market interest rates, estimated operational capitalization rates and volatilities. As of December 31, 2019 the fair value of the consideration was determined according to discounted cash flow since the earn-out will be completely paid by the third quarter of 2020.

The Company's financial net assets measured at fair value on a recurring basis, including accrued interest components, consisted of the following types of instruments as of December 31, 2019 and 2018, respectively:

   
As of December 31, 2019
 
   
Fair value measurements using input type
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Available-for-sale marketable securities
 
$
-
   
$
61,012
   
$
-
   
$
61,012
 
Foreign currency derivative contracts
   
-
     
(871
)
   
-
     
(871
)
Earn-out liability
   
-
     
-
     
(1,100
)
   
(1,100
)
                                 
Total financial net assets
 
$
-
   
$
60,141
   
$
(1,100
)
 
$
59,041
 

   
As of December 31, 2018
 
   
Fair value measurements using input type
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Available-for-sale marketable securities
 
$
-
   
$
64,290
   
$
-
   
$
64,290
 
Foreign currency derivative contracts
   
-
     
(324
)
   
-
     
(324
)
Earn-out liability
   
-
     
-
     
(6,051
)
   
(6,051
)
                                 
Total financial net assets
 
$
-
   
$
63,966
   
$
(6,051
)
 
$
57,915
 

Fair value measurements using significant unobservable inputs (Level 3):

Balance at January 1, 2019
 
$
6,051
 
         
Earn Out liability adjustments due to exchange rates
   
(113
)
Adjustment due to change in forecast and time value of earn-out consideration
   
(4,838
)
         
Balance at December 31, 2019
 
$
1,100
 

F - 29

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 5:-
DERIVATIVE INSTRUMENTS

The Company enters into hedge transactions with a major financial institution, using derivative instruments, primarily forward contracts and options to purchase and sell foreign currencies, in order to reduce the net currency exposure associated with anticipated expenses (primarily salaries and related expenses that are designated as cash flow hedges), trade receivables and forecasted revenues denominated in currencies other than U.S. dollar.

The Company currently hedges such future exposures for a maximum period of two years. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.

The Company records all derivatives on the consolidated balance sheets at fair value in accordance with ASC No. 820 at Level 2. Cash flow hedges are recorded in other comprehensive income (loss) until the hedged item is recognized in earnings. The Company does not enter into derivative transactions for trading purposes. The net income (loss) recognized in "Financial income (expense), net" during the years ended December 31, 2019, 2018 and 2017 was $534, $1,480 and $(1,801), respectively.

The Company had a net unrealized loss associated with cash flow hedges of $845 and $418 recorded in other comprehensive loss as of December 31, 2019 and 2018, respectively. As of December 31, 2019 and 2018, the Company had outstanding hedge transactions in the net amount of $ 36,139 and $ 20,816, respectively.

The fair value of the outstanding foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2019 and 2018, as assets and liabilities is as follows:

Foreign exchange forward and
     
December 31,
 
options contracts
 
Balance sheet
 
2019
   
2018
 
                 
Fair value of foreign exchange hedge transactions
 
Other receivables and prepaid expenses
 
$
158
   
$
56
 
Fair value of foreign exchange hedge transactions
 
Other payables and accrued expenses
   
(1,041
)
   
(474
)
                     
Total derivatives designated as hedging instruments
 
Other Comprehensive loss
 
$
(846
)
 
$
(418
)

Gain or loss on the derivative instruments, which partially offset the foreign currency impact from the underlying exposures, reclassified from other comprehensive loss to operating expenses and cost of revenues for the years ended December 31, 2019, 2018 and 2017 were $ (96), $ 903 and $ (796), respectively.

F - 30

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 5:-
DERIVATIVE INSTRUMENTS (Cont.)

Non-designated hedges:

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies. These derivatives do not qualify for special hedge accounting treatment. These derivatives are carried at fair value with changes recorded in financial income, net. Changes in the fair value of these derivatives are largely offset by the re-measurement of the underlying assets and liabilities. The derivatives have maturities of approximately twelve months. As of December 31, 2019 and 2018, the Company’s outstanding non-hedge transactions  were $ 15,741 and $ 16,023, respectively.

The fair value of the outstanding non-designated foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2019 and 2018, as assets and liabilities are as follows:

Foreign exchange forward and
     
December 31,
 
options contracts
 
Balance sheet
 
2019
   
2018
 
                 
Fair value of foreign exchange non-designated hedge transactions
 
Other receivables and prepaid expenses
 
$
12
   
$
94
 
                     
Total derivatives non-designated as hedging instruments
       
12
     
94
 

NOTE 6:-
OTHER RECEIVABLES AND PREPAID EXPENSES

   
December 31,
 
   
2019
   
2018
 
             
Prepaid expenses
 
$
3,957
   
$
1,635
 
Government authorities
   
1,773
     
1,327
 
Short-term lease deposits
   
195
     
159
 
Foreign currency derivative contracts
   
170
     
150
 
Others
   
433
     
376
 
                 
   
$
6,528
   
$
3,647
 

F - 31

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 7:-
INVENTORIES

   
December 31,
 
   
2019
   
2018
 
             
Raw materials
 
$
1,264
   
$
551
 
Finished goods
   
9,404
     
10,794
 
                 
   
$
10,668
   
$
11,345
 

As of December 31, 2019 and 2018, the finished products line item above includes deferral of the cost of goods sold for which revenue was not yet recognized in the amount of approximately $ 1,335 and $ 1,336, respectively.

NOTE 8:-     PROPERTY AND EQUIPMENT, NET

   
December 31,
 
   
2019
   
2018
 
Cost:
           
Lab equipment
 
$
17,548
   
$
16,038
 
Computers and peripheral equipment
   
22,374
     
20,680
 
Office furniture and equipment
   
1,356
     
1,197
 
Leasehold improvements
   
2,557
     
2,212
 
Lease equipment
   
930
     
-
 
                 
     
44,765
     
40,127
 
Accumulated depreciation:
               
Lab equipment
   
14,548
     
13,273
 
Computers and peripheral equipment
   
20,145
     
19,039
 
Office furniture and equipment
   
659
     
598
 
Leasehold improvements
   
1,162
     
968
 
Lease equipment
   
116
     
-
 
                 
     
36,630
     
33,878
 
                 
Depreciated cost
 
$
8,135
   
$
6,249
 

Depreciation expense for the years ended December 31, 2019, 2018 and 2017 was $ 2,752, $ 2,203 and $ 2,191, respectively.

F - 32

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 9:-
INTANGIBLE ASSETS, NET


a.
The following table shows the Company's intangible assets for the periods presented:

   
Weighted Average
Useful life
   
December 31,
 
   
(Years)
   
2019
   
2018
 
Original Cost:
                 
                   
 Technology
   
3.8
   
$
9,111
   
$
9,111
 
Backlog
   
2.8
     
1,877
     
1,877
 
Customer relationships
   
4.4
     
3,592
     
3,592
 
IP R&D
   
6
     
3,659
     
3,659
 
                         
           
$
18,239
   
$
18,239
 
Accumulated amortization:
                       
                         
 Technology
         
$
9,111
   
$
8,563
 
Backlog
           
1,877
     
1,877
 
Customer relationships
           
3,592
     
2,838
 
IP R&D
           
305
     
-
 
                         
           
$
14,885
   
$
13,278
 
                         
Amortized cost
         
$
3,354
   
$
4,961
 


b.
Amortization expense for the years ended December 31, 2019, 2018 and 2017 were $ 1,607, $ 1,631 and $ 1,477, respectively.


c.
Estimated amortization expense for the years ending:

Year ending December 31,
     
       
2020
   
610
 
2021
   
610
 
2022
   
610
 
Thereafter
   
1,524
 
         
Total
   
3,354
 

F - 33

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 10:-
OTHER PAYABLES AND ACCRUED EXPENSES

   
December 31,
 
   
2019
   
2018
 
             
Advances from customers
 
$
253
   
$
5,700
 
Accrued expenses
   
3,887
     
3,346
 
Government authorities
   
3,061
     
3,356
 
Holdback and contingent earnout
   
1,575
     
484
 
Foreign currency derivative contracts
   
1,041
     
474
 
Provision for returns
   
163
     
191
 
Others
   
234
     
144
 
                 
   
$
10,214
   
$
13,695
 

NOTE 11:-
COMMITMENTS AND CONTINGENT LIABILITIES

a.         Lease commitments:

The Group's facilities are leased under several lease agreements for periods ending up to 2023, with options to extend the leases ending up to 2025.

In addition, the Company has various operating lease agreements with respect to motor vehicles.

Lease expenses of office rent and vehicles for the years ended December 31, 2019, 2018 and 2017 were approximately $3,129, $2,934 and $3,126, respectively. Expenses for short- term leases in 2019 were $ 278.

The following table represents the weighted-average remaining lease term and discount rate:

 
Year ended
December 31, 2019
   
Weighted average remaining lease term
     2.52 years
Weighted average discount rate
1.54%

The discount rate was determined based on the estimated collateralized borrowing rate of the Company, adjusted to the specific lease term and location of each lease.

F - 34

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 11:-
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

Maturities of operating lease liabilities were as follows:

Year ending December 31,
     
2020
 
$
3,170
 
2021
   
2,641
 
2022
   
1,019
 
2023
   
211
 
2024 and thereafter
   
78
 
         
Total lease payments
 
$
7,119
 
         
Less - imputed interest
 
$
(148
)
         
Present value of lease liabilities
 
$
6,971
 

As of December 31, 2019 maturities of operating lease liabilities which were not recognized under ASU No. 2016-02, Leases (ASC 842) were $ 225.

b.        Major subcontractor:

The Company currently depends on one subcontractor to manufacture and provide certain hardware, warranty and support components for its traffic management systems. If the subcontractor experiences delays, disruptions, quality control problems or a loss in capacity, shipments of products may be delayed and the Company's ability to deliver such products could be materially adversely affected. In the event that the Company terminates its business connection with the subcontractor, it will have to compensate the subcontractor for certain inventory costs, as specified in the agreement with the subcontractor.


c.
Liens and guarantees:

As of December 31, 2019, the Company has provided bank guarantees in respect of    prepayments from customers in an aggregate amount of approximately $ 26 million, in addition to bank guarantees in favor of leases agreements in an aggregate amount of approximately $ 501 .

d.        Litigations:

On February 18, 2016, a former employee filed a claim against the Company alleging that he is entitled to compensation for unlawful dismissal by the Company. In September 2019, the parties filed a request to approve a settlement agreement which the Court approved in October 2019.

NOTE 12:-
SHAREHOLDERS' EQUITY


a.
Company's shares:

As of December 31, 2019, the Company's authorized share capital consists of NIS 20,000,000 divided into 200,000,000 Ordinary Shares, par value NIS 0.1 per share. Ordinary Shares confer on their holders the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company, and the right to receive dividends if declared.

F - 35

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 12:-
SHAREHOLDERS' EQUITY (Cont.)


b.
Stock option plan:

A summary of the Company's stock option activity, pertaining to its option plans for employees and related information is as follows:

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
   
Number
of shares upon exercise
   
Weighted average exercise price
   
Number
of shares upon exercise
   
Weighted average exercise price
   
Number
of shares upon exercise
   
Weighted average exercise price
 
                                     
Outstanding at beginning of year
   
1,736,143
   
$
7.26
     
2,189,297
   
$
7.63
     
1,959,014
   
$
8.24
 
Granted
   
-
   
$
-
     
62,200
   
$
5.91
     
676,550
   
$
4.93
 
Forfeited
   
(59,107
)
 
$
10.05
     
(414,617
)
 
$
9.79
     
(346,750
)
 
$
7.01
 
Exercised
   
(223,295
)
 
$
4.36
     
(100,737
)
 
$
4.07
     
(99,517
)
 
$
3.56
 
                                                 
Outstanding at end of year
   
1,453,741
   
$
7.59
     
1,736,143
   
$
7.26
     
2,189,297
   
$
7.63
 
                                                 
Exercisable at end of year
   
1,240,005
   
$
8.01
     
1,281,665
   
$
8.02
     
1,274,649
   
$
9.26
 
                                                 
Vested and expected to vest
   
1,442,990
   
$
7.61
     
1,464,802
   
$
7.65
     
1,607,782
   
$
8.44
 

The aggregate intrinsic value represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the fiscal years 2019, 2018 and 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders exercised their options on December 31, 2019, 2018 and 2017, respectively. This amount may change based on the fair market value of the Company's stock. The total intrinsic value of options outstanding at December 31, 2019, 2018 and 2017, were $ 3,510, $ 1,518 and $ 1,063, respectively. The total intrinsic value of exercisable options at December 31, 2019, 2018 and 2017, were approximately $ 2,791, $ 1,058 and $ 684, respectively. The total intrinsic value of options vested and expected to vest at December 31, 2019, 2018 and 2017, were approximately $ 3,399, $ 1,246 and $ 819, respectively.

The total intrinsic value (the difference between the Company's closing stock price on the exercise date and the exercise price)  of options exercised during the years ended December 31, 2019, 2018 and 2017 were approximately $ 769, $ 201 and $ 176, respectively. The weighted-average grant-date fair value of the options granted during the years ended December 31, 2018 and 2017 were $ 2.89 and $ 2.36, respectively. No options were granted during 2019. The number of options vested during the year ended December 31, 2019 was 226,317. The weighted-average remaining contractual life of the outstanding options as of December 31, 2019 is 3.45 years. The weighted-average remaining contractual life of exercisable options as of December 31, 2019 is 3.25 years.

F - 36

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 12:-
SHAREHOLDERS' EQUITY (Cont.)

The options outstanding as of December 31, 2019, have been classified by exercise price, as follows:

Exercise price
   
Shares upon exercise of options outstanding as of December 31, 2019
   
Weighted average remaining contractual life
   
Shares upon exercise of options exercisable as of December 31, 2019
 
           
Years
       
                     
$
23.31-27.58
     
64,500
     
2.63
     
64,500
 
$
15.2-17.07
     
49,936
     
1.97
     
49,936
 
$
10.0 -14.68
     
173,250
     
3.92
     
173,250
 
$
5.01-9.7
     
508,083
     
2.84
     
435,487
 
$
0.1-4.95
     
657,972
     
4.00
     
516,832
 
                             
         
1,453,741
             
1,240,005
 

The following provides a summary of the restricted stock unit activity for the Company for the two years ended December 31, 2019:

   
Year ended December 31,
 
   
2019
   
2018
 
   
Number
of shares upon exercise
   
Weighted average share price
   
Number
of shares upon exercise
   
Weighted average share price
 
                         
Outstanding at beginning of year
   
1,252,031
   
$
5.45
     
713,090
   
$
6.04
 
Granted
   
1,001,000
   
$
7.53
     
996,200
   
$
5.54
 
Vested
   
(401,904
)
 
$
7.53
     
(312,201
)
 
$
5.72
 
Forfeited
   
(199,067
)
 
$
7.61
     
(145,058
)
 
$
5.01
 
                                 
Unvested at end of year
   
1,652,060
   
$
6.53
     
1,252,031
   
$
5.45
 

As of December 31, 2019, $ 402 and $ 8,001 unrecognized compensation cost related to stock options and RSUs respectively is expected to be recognized over a weighted average vesting period of 3.01 years.

Under the terms of the above option plans, options may be granted to employees, officers, directors and various service providers of the Company and its subsidiaries. The options vest over a four-year period, subject to the continued employment of the employee. The options generally expire no later than ten years from the date of the grant. The exercise price of the options at the date of grant under the plans may not be less than the nominal value of the shares into which such options are exercised, any options, which are forfeited or cancelled before expiration, become available for future grants. As of December 31, 2019, 34,652 Ordinary shares are available for future issuance under the option plans.

In addition to granting stock options, the Company granted 1,001,000 and 996,200 RSUs in 2019 and 2018, respectively under the 2016 option plan. RSUs vest over a four-year period subject to the continued employment of the employee. RSUs that are cancelled or forfeited become available for future grants.

F - 37

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME


a.
Corporate tax rates:

The Israeli corporate income tax rate was 23% in 2019, 23% in 2018 and 24% in 2017.

In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which reduces the corporate income tax rate to 24% (instead of 25%) effective from January 1, 2017 and to 23% effective from January 1, 2018

b.        Foreign Exchange Regulations:

Commencing in taxable year 2012, the Company has elected to measure its taxable income and file its tax return under the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income) 1986 ("Foreign Exchange Regulations"). Under the Foreign Exchange Regulations, an Israeli company must calculate its tax liability in U.S. Dollars according to certain rules. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year.


c.
Tax benefits under Israel's law for the Encouragement of Capital Investments, 1959 ("the Law"):

In 1998, the production facilities of the Company related to its computational technologies were granted the status of an "Approved Enterprise" under the Law. In 2004, an expansion program was granted the status of "Approved Enterprise". According to the provisions of the Law, the Company has elected the alternative track of benefits and has waived Government grants in return for tax benefits. The period of tax benefits, detailed above, is limited to the earlier of 12 years from the commencement of production, or 14 years from the approval date.

According to the provisions of the Law under the alternative track, the Company's income may be tax-exempt for a period of two years commencing with the year it first earns taxable income, and subject to corporate taxes at the reduced rate of 10% to 25%, for an additional period of five to eight years depending upon the level of foreign ownership of the Company.

F - 38

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME (Cont.)

The Law was significantly amended effective April 1, 2005 ("the  2005 - Amendment"). The 2005 - Amendment includes revisions to the criteria for investments qualified to receive tax benefits as a Beneficiary Enterprise and among other things, simplifies the approval process. The Amendment applies to new investment programs. Therefore, investment programs commencing after December 31, 2004, do not affect the approved programs of the Company.

In addition, the Law provides that terms and benefits included in any letter of approval already granted will remain subject to the provisions of the Law as they were on the date of such approval. Therefore, the Company's existing Approved Enterprise will generally not be subject to the provisions of the 2005 - Amendment. The Company elected 2006 and 2009 as "year of election" under the 2005 - Amendment.

The entitlement to the above benefits is contingent upon the fulfillment of the conditions stipulated in the Law, regulations published thereunder and the criteria set forth in the specific letters of approval. In the event of failure to comply with these conditions, the benefits may be canceled and the Company may be required to refund the amount of the benefits, in whole or in part, including interest and linked to changes in the Israeli CPI. As of December 31, 2019, management believes that the Company meets the aforementioned conditions.

If the Company pays a dividend out of exempt income derived from the Approved and Beneficiary Enterprise, it will be subject to corporate tax in respect of the gross amount distributed, including any taxes thereon, at the rate which would have been applicable had it not enjoyed the alternative benefits, generally 10%-25%, depending on the percentage of the Company's Ordinary shares held by foreign shareholders. The dividend recipient is subject to withholding tax at the rate of 15% applicable to dividends from approved enterprises, if the dividend is distributed during the tax exemption period or within twelve years thereafter. The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business.

As of December 31, 2019, there is no income earned by the Company Israel’s “Approved Enterprises” and “Beneficiary Enterprise”.

Income from sources other than the "Approved and Beneficiary Enterprise" during the benefit period will be subject to tax at the regular corporate tax rate.

As of January 1, 2011, new legislation amending the Law came into effect (the "2011 Amendment"). The 2011 Amendment introduced a new status of "Preferred Company" and "Preferred Enterprise", replacing the then existing status of "Beneficiary Company" and "Beneficiary Enterprise". Similarly to "Beneficiary Company", a Preferred Company is an industrial company owning a Preferred Enterprise which meets certain conditions (including a minimum threshold of 25% export). However, under this legislation the requirement for a minimum investment in productive assets was cancelled.

F - 39

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME (Cont.)

Under the 2011 Amendment, a uniform corporate tax rate will apply to all qualifying income of the Preferred Company, as opposed to the former law, which was limited to income from the Approved Enterprises and Beneficiary Enterprise during the benefits period. The uniform corporate tax rate was 9% in areas in Israel designated as Development Zone A and 16% elsewhere in Israel during 2016 and 2017.

A dividend distributed from income which is attributed to a Preferred Enterprise/Special Preferred Enterprise will be subject to withholding tax at source at the following rates: (i) Israeli resident corporation – 0%, (ii) Israeli resident individual – 20% as of 2014 and thereafter (iii) non-Israeli resident - 20% as of 2014 and thereafter subject to a reduced tax rate under the provisions of an applicable double tax treaty.

In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments ("the 2016 - Amendment") was published. According to the 2016 - Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%).

The December 2016 amendment also prescribes special tax tracks for technological enterprises, the new tax tracks under the amendment are as follows:

Technological preferred enterprise - an enterprise whose total consolidated revenues (parent company and all subsidiaries) is less than NIS 10 billion. A technological preferred enterprise, as defined in the Law, which is located in the center of Israel will be subject to tax at a rate of 12% on profits deriving from intellectual property (in development area A - a tax rate of 7.5%).

Special technological preferred enterprise - an enterprise whose total consolidated revenues (parent company and all subsidiaries) exceeds NIS 10 billion. Such enterprise will be subject to tax at a rate of 6% on profits deriving from intellectual property, regardless of the enterprise’s geographical location.

Under the transition provisions of the 2016 Amendment, the Company may decide to irrevocably implement the new law while waiving benefits provided under the current law or to remain subject to the current law.


d.
Tax benefits under the law for the Encouragement of Industry (Taxes), 1969 (the "Encouragement Law"):

The Encouragement Law, provides several tax benefits for industrial companies. An industrial company is defined as a company resident in Israel, at least 90% of the income of which in a given tax year exclusive of income from specified Government loans, capital gains, interest and dividends, is derived from an industrial enterprise owned by it. An industrial enterprise is defined as an enterprise whose major activity in a given tax year is industrial production activity.

F - 40

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME (Cont.)

Management believes that the Company is currently qualified as an "industrial company" under the Encouragement Law and as such, enjoys tax benefits, including: (1) deduction of purchase of know-how and patents and/or right to use a patent over an eight-year period; (2) the right to elect, under specified conditions, to file a consolidated tax return with additional related Israeli industrial companies and an industrial holding company; (3) accelerated depreciation rates on equipment and buildings; and (4) expenses related to a public offering on the Tel-Aviv Stock Exchange and on recognized stock markets outside of Israel, are deductible in equal amounts over three years.

Eligibility for benefits under the Encouragement Law is not subject to receipt of prior approval from any governmental authority. No assurance can be given that the Israeli tax authorities will agree that the Company qualifies, or, if the Company qualifies, then the Company will continue to qualify as an industrial company or that the benefits described above will be available to the Company in the future.


e.
Pre-tax income (loss) is comprised as follows:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Domestic
 
$
(8,934
)
 
$
(9,877
)
 
$
(17,539
)
Foreign
   
1,916
     
1,890
     
1,031
 
                         
   
$
(7,018
)
 
$
(7,987
)
 
$
(16,508
)

F - 41

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME (Cont.)


f.
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Loss before taxes on income
 
$
(7,018
)
 
$
(7,987
)
 
$
(16,508
)
                         
Theoretical tax income computed at the Israeli statutory tax rate
(23%, 23% and 24% for the years 2019, 2018 and 2017, respectively)
 
$
(1,614
)
 
$
(1,837
)
 
$
(3,962
)
                         
Changes in valuation allowance
   
951
     
1,189
     
8,946
 
Increase in losses and temporary differences due to change in Israeli
corporate and “Approved Enterprise" tax
    -
     
659
     
(5,376
)
Previous years
                       
Write off of prepaid and withholding taxes
   
1,536
     
1,828
     
909
 
Foreign tax rates differences related to subsidiaries
   
44
     
50
     
(48
)
Non-deductible expenses and other
   
327
     
65
     
684
 
Non-deductible share-based compensation expense
   
397
     
474
     
411
 
                         
Actual tax expense
 
$
1,641
   
$
2,428
   
$
1,564
 


g.
Income tax expense is comprised as follows:

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
                   
Current taxes
 
$
341
   
$
580
   
$
689
 
Deferred taxes expense (benefit)
   
(236
)
   
20
     
(34
)
Write off of prepaid and withholding taxes
   
1,536
     
1,828
     
909
 
                         
   
$
1,641
   
$
2,428
   
$
1,564
 

F - 42

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME (Cont.)

h.        Net operating losses carry forward:

The Company has accumulated net operating losses for tax purposes as of December 31, 2019, in the amount of approximately $62,128, which may be carried forward and offset against taxable income in the future for an indefinite period. In December 2014, the Israeli Tax Authorities approved a final tax ruling with respect to the Company’s acquisition of Oversi. According to the ruling, the net operating losses on the merger date may be offset against taxable income annually with a limitation of up to 14% of the total accumulated losses but no more than 50% of the Company's taxable income. As of December 31, 2019, the Company recorded a full valuation allowance with respect to its deferred tax assets in Allot Ltd. and wrote-off prepaid and withholding taxes of $7,182 as the Company does not expect to utilize these tax assets in the near future. In addition, the Company has accumulated capital losses for tax purposes as of December 31, 2019, of approximately $27,243, which may be carried forward and offset against taxable capital gains in the future for an indefinite period but are limited as stated above with regard to the Oversi merger. Management currently believes that since the Company has a history of losses, and uncertainty with respect to future taxable income, it is more likely than not that the deferred tax assets regarding the loss carry forwards will not be utilized in the foreseeable future. Thus, a valuation allowance was provided to reduce deferred tax assets to their realizable value.

The U.S. subsidiary has accumulated losses for U.S. federal income tax return purposes of approximately $ 5,524 and $ 7,438 for state taxes. The federal accumulated losses for tax purposes expire between 2026 and 2037. The state accumulated losses for tax purposes began to expire in 2014. As of December 31, 2019, the Company recorded a partial valuation allowance with respect to its deferred tax assets in the US Subsidiary.

A portion of the losses are subject to limitations of Internal Revenue Code, Section 382, which in general provides that utilization of net operating losses is subject to an annual limitation if an ownership change results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period.  The annual limitations may result in the expiration of losses before utilization.

In December 2017 the U.S. Tax Cuts and Jobs Act of 2017 was signed into law. This legislation makes significant changes to the U.S. Internal Revenue Code. Such changes include a reduction in the corporate tax rate, changes in U.S. international taxation and limitations on certain corporate deductions and credits, among other changes. The deferred tax asset at December 31, 2019 reflects the impact of the US Tax reform.


F - 43

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:-
TAXES ON INCOME (Cont.)


i.
Deferred income taxes:

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred income taxes are as follows:.

   
December 31,
 
   
2019
   
2018
 
Deferred tax assets:
           
Operating and capital loss carryforwards
 
$
22,353
   
$
21,348
 
Reserves and allowances including lease liability
   
9,071
     
3,723
 
                 
Deferred tax asset before valuation allowance
   
31,424
     
25,071
 
Valuation allowance
   
(25,880
)
   
(24,790
)
Deferred tax asset net of valuation allowance
   
5,544
     
281
 
                 
Deferred tax liability including ROU asset
   
5,027
     
-
 
Net deferred tax asset
 
$
517
   
$
281
 


j.
As of December 31, 2019, the Company’s provision in respect of ASC 740-10 is $243. The accrued interest and penalties related to the provision in income taxes are immaterial.

The Company conducts business globally and, as a result, the Company or one or more of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as Israel, France, and the United States. With a few exceptions, the Company is no longer subject to Israeli tax assessment through the year 2013 and the Spanish and U.S. subsidiaries have final tax assessments through 2014 and 2015, respectively. The Company is currently under audit by the Israeli Tax Authorities for the years 2015– 2016.

NOTE 14:-
GEOGRAPHIC INFORMATION

Allot operates in a single reportable segment. Revenues are based on the location of the Company's channel partners which are considered as end customers, as well as direct customers of the Company:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Europe
 
$
36,199
   
$
45,730
   
$
40,394
 
Asia and Oceania
   
42,994
     
22,018
     
13,936
 
Americas
   
16,576
     
14,363
     
15,532
 
Middle East and Africa
   
14,331
     
13,726
     
12,130
 
                         
   
$
110,100
   
$
95,837
   
$
81,992
 

F - 44

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 14:-
GEOGRAPHIC INFORMATION (Cont.)

The following are the Company’s major customers:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Customer A
   
16
%
   
22
%
   
32
%
Customer B
   
11
%
   
-
     
-
 
                         
     
27
%
   
22
%
   
32
%

A total percentage of 76% of the Company’s revenues for the year ended December 31, 2019 is attributed to network intelligence solutions, while 24% is attributed to security solutions.

The following presents total long-lived assets as of December 31, 2019 and 2018:

   
December 31,
 
   
2019
   
2018
 
Long-lived assets:
           
Israel
 
$
7,614
   
$
5,931
 
Other
   
521
     
317
 
                 
   
$
8,135
   
$
6,249
 

NOTE 15:-
FINANCIAL INCOME (EXPENSES), NET

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Financial income:
                 
Interest income
 
$
2,551
   
$
2,696
   
$
2,513
 
Exchange rate differences and other
   
-
     
305
     
-
 
                         
Financial expenses:
                       
Exchange rate differences and other
   
334
     
-
     
602
 
Amortization/accretion of premium/discount on marketable securities, net
   
257
     
793
     
1,017
 
                         
   
$
1,960
   
$
2,208
   
$
894
 

F - 45

ALLOT LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 16:-   EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
Numerator:
                 
Net loss
 
$
(8,659
)
 
$
(10,415
)
 
$
(18,072
)
                         
Denominator:
                       
Weighted average number of shares outstanding used in computing basic and diluted net loss per share
   
34,250,582
     
33,710,507
     
33,253,158
 
                         
Basic and diluted net loss per share
 
$
(0.25
)
 
$
(0.31
)
 
$
(0.54
)

Note 17:-       SUBSEQUENT EVENT


a.
In January 2020, inventory stored in the one of the Company’s warehouses suffered water damage. The Company is currently evaluating the effect of the event on its inventories value and does not expect it to have a material impact.

F - 46



EXHIBIT 12.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
EXCHANGE ACT RULE 13a-14(a)/15d-14(d)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Erez Antebi, certify that:
 
1.
I have reviewed this annual report on Form 20-F/A of Allot Ltd;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report.
 
 
/s/ Erez Antebi
Erez Antebi
President and Chief Executive Officer
(Principal Executive Officer)
 
Date: July 1, 2020
 



Exhibit 12.2
 
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
EXCHANGE ACT RULE 13a-14(a)/15d-14(d)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Ziv Leitman, certify that:
 
1.
I have reviewed this annual report on Form 20-F/A of Allot Ltd;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report.

 
/s/ Ziv Leitman
Ziv LeitmanChief Financial Officer
(Principal Financial Officer)
 
Date: July 1, 2020




EXHIBIT 13.1
 
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL
FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Allot Ltd (the “Company”) on Form 20-F/A for the period ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Erez Antebi, and I, Ziv Leitman, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Erez Antebi
Erez Antebi
President and Chief Executive Officer
(Principal Executive Officer)

Date:  July 1, 2020
 
 
/s/ Ziv Leitman
Ziv Leitman
Chief Financial Officer
(Principal Financial Officer)
 
Date:  July 1, 2020
 
A signed original of this written statement required by Section 906 has been provided to Allot Ltd and will be retained by Allot Ltd and furnished to the Securities and Exchange Commission or its staff upon request.




EXHIBIT 15.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the incorporation by reference in the Registration Statements (Form S-8 File Nos. 333-140701, 333-149237, 333-159306, 333-165144, 333-172492, 333-180770, 333-187406, 333-194833, 333-203028, 333-210420, 333-216893, 333-223838, 333-230391 and 333-237405) pertaining to the 2016 Incentive Compensation Plan (formerly 2006 Incentive Compensation Plan) of Allot Ltd, of our report dated March 26, 2020, with respect to the consolidated financial statements of Allot Ltd. and the effectiveness of internal control over financial reporting of Allot Ltd included in this annual report (Form 20-F/A) for the year ended December 31, 2019.
 
 
/s/ KOST FORER GABBAY & KASIERER
 
 
KOST FORER GABBAY & KASIERER
 
 
A Member of Ernst & Young Global
 
 
Tel Aviv, Israel
 
July 1, 2020


v3.20.2
Document and Entity Information
12 Months Ended
Dec. 31, 2019
shares
Document and Entity Information [Abstract]  
Document Type 20-F/A
Amendment Flag true
Amendment Description This Amendment No. 1 on Form 20-F/A (the “Amendment No. 1”) amends Allot Ltd.’s (the “Company”) Annual Report on Form 20-F for the fiscal year ended December 31, 2019 (the “Form 20-F”), as filed with the Securities and Exchange Commission on March 26, 2020, and is being filed solely to correct a typographical error in the date of the Report of Independent Registered Public Accounting Firm from March 26, 2019 to March 26, 2020. Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended, the Company has repeated the entire text of Item 8 and Item 18 of the Form 20-F in this Amendment No.1. There have been no changes to the text of such items other than the change in the date of the auditor’s report. In addition, this Amendment No. 1 includes currently dated certifications by our Principal Executive Officer and Principal Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, attached as Exhibits 12.1, 12.2 and 13.1 hereto, and a currently dated consent of Kost Forer Gabbay & Kasierer, attached as Exhibit 15.1 hereto. Except as expressly set forth above, this Amendment No. 1 does not, and does not purport to, amend, update or restate the information in any other item of the Form 20-F or reflect any events that have occurred after the filing of the Form 20-F.
Document Period End Date Dec. 31, 2019
Entity Registrant Name Allot Ltd.
Entity Central Index Key 0001365767
Current Fiscal Year End Date --12-31
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2019
Entity Filer Category Accelerated Filer
Entity Shell Company false
Entity Emerging Growth Company false
Entity Voluntary Filers No
Entity Common Stock, Shares Outstanding 34,520,728
Entity Current Reporting Status Yes
Entity Well-known Seasoned Issuer No
Entity Interactive Data Current Yes
Entity Incorporation State Country Code IL
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-33129
v3.20.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
CURRENT ASSETS:    
Cash and cash equivalents $ 16,930 $ 16,336
Restricted deposits 23,183 465
Short-term bank deposits 5,557 22,543
Available-for-sale marketable securities 61,012 64,290
Trade receivables (net of allowance for doubtful accounts of $ 1,867 and $ 1,415 at December 31, 2019 and 2018, respectively) 29,008 26,093
Other receivables and prepaid expenses 6,528 3,647
Inventories 10,668 11,345
Total current assets 152,886 144,719
NON-CURRENT ASSETS:    
Restricted deposits 10,913 257
Severance pay fund 387 345
Operating lease right-of-use assets 6,368
Deferred taxes 517 281
Other assets 926 600
Property and equipment 8,135 6,249
Intangible assets, net 3,354 4,961
Goodwill 31,683 32,432
Total non-current assets 62,283 45,125
Total assets 215,169 189,844
CURRENT LIABILITIES:    
Trade payables 11,676 7,813
Employees and payroll accruals 12,041 7,357
Deferred revenues 36,360 13,855
Short-term operating lease liabilities 3,151  
Other payables and accrued expenses 10,214 13,695
Total current liabilities 73,442 42,720
LONG-TERM LIABILITIES:    
Deferred revenues 5,262 4,247
Long-term operating lease liabilities 3,820
Accrued severance pay 794 806
Other long-term liability 6,168
Total long-term liabilities 9,876 11,221
COMMITMENTS AND CONTINGENT LIABILITIES
SHAREHOLDERS' EQUITY:    
Share capital - Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at December 31, 2019 and 2018; Issued: 35,336,728 and 34,712,261 shares at December 31, 2019 and 2018, respectively; Outstanding: 34,520,728 and 33,896,261 shares at December 31, 2019 and 2018, respectively 871 853
Additional paid-in capital 276,112 271,765
Treasury stock at cost - 816,000 shares at December 31, 2019 and 2018. (3,998) (3,998)
Accumulated other comprehensive income (loss) (525) (767)
Accumulated deficit (140,609) (131,950)
Total shareholders' equity 131,851 135,903
Total liabilities and shareholders' equity $ 215,169 $ 189,844
v3.20.2
CONSOLIDATED BALANCE SHEETS (Parenthetical)
$ in Thousands
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
shares
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts | $ $ 1,867 $ 1,415
Ordinary shares, shares authorized 200,000,000 200,000,000
Ordinary shares, shares issued 35,336,728 34,712,261
Ordinary shares, shares outstanding 34,520,728 33,896,261
Treasury stock, shares 816,000 816,000
v3.20.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:      
Total revenues $ 110,100 $ 95,837 $ 81,992
Cost of revenues:      
Total cost of revenues 33,834 29,349 28,530
Gross profit 76,266 66,488 53,462
Operating expenses:      
Research and development (net of grant participations of $ 378, $ 374 and $ 392 for the years ended December 31, 2019, 2018 and 2017, respectively) 31,461 25,418 21,852
Sales and marketing 47,105 40,849 38,316
General and administrative 6,678 10,416 10,696
Total operating expenses 85,244 76,683 70,864
Operating loss (8,978) (10,195) (17,402)
Financial income, net 1,960 2,208 894
Loss before income tax expense (7,018) (7,987) (16,508)
Income tax expense 1,641 2,428 1,564
Net loss (8,659) (10,415) (18,072)
Unrealized gain (loss) on available-for-sale marketable securities 670 (226) (35)
Unrealized gain (loss) on foreign currency cash flow hedges transactions (332) (1,480) 1,016
Net amount reclassified to earnings (96) 903 (796)
Total comprehensive loss from hedge transactions (428) (577) 220
Total comprehensive loss $ (8,417) $ (11,218) $ (17,887)
Net loss per share:      
Basic and diluted $ (0.25) $ (0.31) $ (0.54)
Weighted average number of shares used in per share computations of net loss:      
Basic and diluted 34,250,582 33,710,507 33,253,158
Product [Member]      
Revenues:      
Total revenues $ 67,440 $ 56,169 $ 48,727
Cost of revenues:      
Total cost of revenues 22,743 20,061 19,258
Service [Member]      
Revenues:      
Total revenues 42,660 39,668 33,265
Cost of revenues:      
Total cost of revenues $ 11,091 $ 9,288 $ 9,272
v3.20.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Grants participations excluded from research and development costs $ 378 $ 374 $ 392
v3.20.2
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Ordinary shares [Member]
Additional paid-in capital [Member]
Treasury Stock [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated deficit [Member]
Total
Balance at Dec. 31, 2016 $ 843 $ 264,782 $ (3,998) $ (149) $ (104,175) $ 157,303
Balance, shares at Dec. 31, 2016 33,057,719          
Exercise of stock options $ 8 354 $ 362
Exercise of stock options, shares 425,543         99,517
Stock-based compensation 3,351 $ 3,351
Other comprehensive income 185 185
Net loss (18,072) (18,072)
Balance at Dec. 31, 2017 $ 851 268,487 (3,998) 36 (122,247) $ 143,129
Balance, shares at Dec. 31, 2017 33,483,262         33,483,262
Cumulative effect of new accounting standard (See Note 1) 712 $ 712
Exercise of stock options $ 2 416 $ 418
Exercise of stock options, shares 412,999         100,737
Stock-based compensation 2,862 $ 2,862
Other comprehensive income (803) (803)
Net loss (10,415) (10,415)
Balance at Dec. 31, 2018 $ 853 271,765 (3,998) (767) (131,950) $ 135,903
Balance, shares at Dec. 31, 2018 33,896,261         33,896,261
Exercise of stock options $ 18 974 $ 992
Exercise of stock options, shares 624,467         223,295
Stock-based compensation 3,373 $ 3,373
Other comprehensive income 242 242
Net loss (8,659) (8,659)
Balance at Dec. 31, 2019 $ 871 $ 276,112 $ (3,998) $ (525) $ (140,609) $ 131,851
Balance, shares at Dec. 31, 2019 34,520,728         34,520,728
v3.20.2
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accumulated other comprehensive loss:      
Accumulated unrealized gain (loss) on available-for-sale marketable securities $ 321 $ (349) $ (123)
Accumulated unrealized loss on foreign currency cash flows hedge transactions gain (loss) (846) (418) 159
Accumulated other comprehensive gain (loss) $ (525) $ (767) $ 36
v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net loss $ (8,659) $ (10,415) $ (18,072)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 4,359 3,834 3,668
Stock-based compensation 3,420 2,862 3,366
Capital loss 39 27
Increase (decrease) in accrued severance pay, net (54) 16 105
Decrease in other assets (326) 535 1
Decrease in accrued interest and amortization of premium on available-for sale marketable securities 343 804 913
Changes in operating lease right-of-use asset (6,368)
Changes in operating leases liability 6,971    
Decrease (increase) in trade receivables (2,915) (3,356) 1,421
Decrease (increase) in other receivables and prepaid expenses (3,168) (1,101) 1,350
Increase in inventories (253) (3,448) (662)
Decrease (increase) in long-term deferred taxes, net (236) 20 (34)
Increase in trade payables 3,863 1,945 2,582
Increase (decrease) in employees and payroll accruals 4,635 (1,178) 1,140
Increase in deferred revenues 23,520 3,566 518
Increase (decrease) in other payables and accrued expenses (9,040) 6,906 3,449
Net cash provided by (used in) operating activities 16,092 1,029 (228)
Cash flows from investing activities:      
Investment in restricted deposits (33,374) (294) (428)
Redemption of (Investment in) short-term deposits 16,986 8,500 (1,222)
Purchase of property and equipment (3,708) (3,485) (2,833)
Investment in available-for sale marketable securities (39,950) (34,777) (30,123)
Proceeds from redemption or sale of available-for sale marketable securities 43,555 32,651 26,488
Acquisition of Netonomy, net of cash (3,048)
Net cash used in by investing activities (16,491) (453) (8,118)
Cash flows from financing activities:      
Proceeds from exercise of stock options 993 418 362
Net cash provided by financing activities 993 418 362
Increase (decrease) in cash and cash equivalents 594 994 (7,984)
Cash and cash equivalents at the beginning of the year 16,336 15,342 23,326
Cash and cash equivalents at the end of the year 16,930 16,336 15,342
Cash paid during the year for:      
Taxes 473 $ 347 $ 342
Non cash activity:      
Changes in operating lease right-of-use singed during the year (1,208)    
Changes in operating leases liability singed during the year $ 1,208    
v3.20.2
GENERAL
12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL
NOTE 1:-
GENERAL


a.
Allot Ltd. (the "Company") was incorporated in November 1996 under the laws of the State of Israel. The Company is engaged in developing, selling and marketing network intelligence and security solutions for mobile, fixed and cloud service providers, as well as enterprises, and helping them enhance value to their customers. The Company’s flexible and highly scalable hardware platforms and software applications are deployed globally for network and application analytics, traffic control and shaping, network-based security including mobile security, DDoS protection, IoT security and more. The Company's main platforms include Allot Service Gateway service delivery platform and Allot Secure. Allot SG enables network operators to learn about users and network behaviors to improve quality of service and reduce costs; and Allot Secure enables customers to detect security breaches and protect networks and network users from attacks. These platforms and the solutions they provide empower service providers and enterprises to get more out of their networks, to secure and to manage them better, to clearly see and understand their networks from within, and to innovate, optimize, and capitalize on every opportunity, all the while deploying new services faster and constantly increasing value to their customers.

The Company's Ordinary Shares are listed in the NASDAQ Global Select Market under the symbol "ALLT" from its initial public offering in November 2006. Since November 2010, the Company's Ordinary Shares have been listed for trading in the Tel Aviv Stock Exchange as well.

The Company holds fourteen wholly-owned subsidiaries (the Company together with said subsidiaries shall collectively be referred to as "Allot"): Allot Communications, Inc. in Burlington, Massachusetts, United-States (the "U.S. subsidiary"), which was incorporated in 1997 under the laws of the State of California, Allot Communication Europe SARL in Sophia, France (the "European subsidiary"), which was incorporated in 1998 under the laws of France, Allot Communications Japan K.K. in Tokyo, Japan (the "Japanese subsidiary"), which was incorporated in 2004 under the laws of Japan, Allot Communication (UK) Limited (the "UK subsidiary"), which was incorporated in 2006 under the laws of England and Wales, Allot Communications (Asia Pacific) Pte. Ltd. ("the Singaporean subsidiary"), which was incorporated in 2006 under the laws of Singapore, Allot Communications (New Zealand) Limited. (the "NZ subsidiary"), which was incorporated in 2007 under the laws of New Zealand, Allot India Private Limited. (the "Indian subsidiary”), which was incorporated in 2012 under the laws of India and commenced its activity in 2013, Allot Communications Africa (PTY) Ltd. (the "African subsidiary”), which was incorporated in 2013 under the laws of South Africa, Allot Communications (Hong Kong) Limited (the "HK subsidiary”), which was incorporated in 2013 under the laws of Hong-Kong, Allot Communications Spain, S.L. Sociedad Unipersonal (the "Spanish subsidiary”), which was incorporated in 2015 under the laws of Spain, Allot Communications (Colombia) S.A.S (the "Colombian subsidiary”), which was incorporated in 2015 under the laws of Colombia and Allot MexSub (the "Mexican subsidiary"), which was incorporated in 2015 under the laws of Mexico, Allot Turkey Komunikasion Hizmeleri limited (the “Turkish subsidiary”), which was incorporated in 2018 under laws of Turkey, Allot Australia (PTY) LTD (the “Australian subsidiary”), which was incorporated in 2018 under the laws of Australia.

The U.S., Spanish, Colombian and Indian subsidiaries are engaged in the sale, marketing and technical support services of the Company's products in the Americas, Colombia and India, respectively. The European (excluding Spanish), Japanese, NZ, UK, Singaporean, HK, African, Turkish and Australian subsidiaries are engaged in marketing and technical support services of the Company's products in Europe, Japan, Oceania, UK, Asia and Africa, respectively.

The Spanish and Mexican subsidiaries commenced operations in 2015 and are engaged in the marketing, technical support and development activities of one of the Company's product lines.


b.
Acquisition:

On January 14, 2018 (the "Netonomy acquisition date"), the Company entered into a purchase agreement with the shareholders of Netonomy LTD ("Netonomy"), a developer of software-based cybersecurity solutions for the connected home.

The total consideration for the acquisition was $ 3,765, which consisted of $ 3,180 paid in cash, holdback amount summing to $ 303 and additional contingent consideration at a fair value of $ 282 at the Netonomy acquisition date. As of December 31, 2019, the contingent consideration is estimated at a fair value of $ 1,081, The change in fair value of the contingent consideration was recorded to operating expenses.

The holdback amount (“Holdback Amount”) summing to $ 1,100 would be held to partially satisfy any claims for indemnification. Such amount shall be paid in three installments consisting each one 40%, 40% and 20% of the Holdback amount following the first, second and 30-months anniversaries of the Closing Date, respectively. Notwithstanding the aforementioned, a sum of $ 797 thousand out of the Holdback Amount shall be paid provided that certain employees keep working in the Company during the here mentioned periods (“the Restricted Holdback Amount”).

The contingent consideration is payable over a two-and-a-half-year term, starting April 1, 2018 and ending September 30, 2020 depending on the Company’s revenues from Netonomy’s technology, and has payments cap of $ 1,100. A sum of $ 797 thousand out of the contingent consideration Amount shall be paid provided that certain employees keep working in the Company during the mentioned periods under the “Restricted Holdback Amount”. The obligations in respect of the holdback amount and the contingent consideration are presented under Other payables and accrued expenses.

The acquisition was accounted for using the purchase method of accounting in accordance with ASC No. 805, “Business Combinations” ("ASC No. 805"). Accordingly, the purchase price was allocated according to the estimated fair values of the assets acquired and liabilities assumed and the excess of the purchase price over the net tangible and identified intangible assets was assigned to goodwill. The fair value of intangible assets was determined by management with the assistance of a third-party valuation.

On July 2018, the merger of Netonomy with the Company was approved by the Israeli tax authorities with Allot as the receiving company and Netonomy as the transferring company and March 31, 2018 as the Merger Date.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

   
Fair value
 
       
Non-current assets
 
$
4
 
Account Payable
   
(11
)
Other Payables
   
(142
)
IPR&D
   
3,659
 
Goodwill
   
121
 
         
Net assets acquired
 
$
3,631
 

The acquired assets are net of cash balance of $ 132.

IPR&D is related to new technology that is still under development. Netonomy’s solution provides a simple, reliable and secure network for connected homes through a minimal footprint agent installed on the home router, which provides visibility into the network and blocks external and internal attacks.Acquisition costs in a total amount of $49 were recorded to operating expenses.  The Company started to depreciate the IPR&D asset from Q3 2019 as the R&D phase was completed and the product was ready to sell.

Unaudited pro forma condensed results of operations:

Pro forma results of operations related to this acquisition have not been prepared because they are not material to the Company’s consolidated statements of income.

The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES

a.        Use of estimates:

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

b.        Financial statements in U.S. dollars:

The majority of the revenues of the Company and its subsidiaries are generated in U.S. dollars ("dollar") or linked to the dollar. In addition, a major portion of the Company's and certain of its subsidiaries' costs are incurred or determined in dollars. The Company's management believes that the dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the dollar.

Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into U.S. dollars in accordance with Accounting Standards Codification No. 830, "Foreign Currency Matters" ("ASC No. 830"). All transactions gains and losses from the remeasurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses as appropriate.

c.        Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.

d.        Cash and cash equivalents:

The Company considers all unrestricted highly liquid investments which are readily convertible into cash, with a maturity of three months or less at the date of acquisition, to be cash equivalents.

e.        Restricted deposits:

The restricted deposits are held in favor of financial institutions in respect of fulfillment of forward contracts and operating obligations. As of December 31, 2019, a major prepayment received from a client was classified as a restricted deposit due to the contractual terms with the client.


f.
Short-term bank deposits:

Short-term bank deposits are deposits with maturities of more than three months but less than one year at the balance sheet date. The deposits are in dollars and bear interest at an annual weighted average rate of 2.33% and 2.82% at December 31, 2019 and 2018, respectively. In connection with the Company's hedging transactions, the Company is required to maintain compensating deposits balances in the bank. Out of the short-term bank deposits, a total of $2,500 is due to the hedging transactions as of December 31, 2019 and 2018.

g.        Marketable securities:

The Company accounts for investments in marketable securities in accordance with ASC 320, "Investments - Debt and Equity Securities". Management determines the appropriate classification of its investments in debt securities at the time of purchase and re-evaluates such determinations at each balance sheet date.

Marketable securities classified as "available-for-sale" are carried at fair value, based on quoted market prices. Unrealized gains and losses are reported in a separate component of shareholders' equity in accumulated other comprehensive income (loss). Gains and losses are recognized when realized, on a specific identification basis, in the Company's consolidated statements of comprehensive loss.

The Company's securities are reviewed for impairment in accordance with ASC 320-10-35. If such assets are considered to be impaired, the impairment charge is recognized in earnings when a decline in the fair value of its investments below the cost basis is judged to be Other-Than-Temporary Impairment (OTTI). Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company's intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. Based on the above factors, the Company concluded that unrealized losses on its available-for-sale securities, for the years ended 2019, 2018 and 2017, were not OTTI.

h.        Inventories:

Inventories are stated at the lower of cost or net realizable value. Inventory write-offs are provided to cover risks arising primarily from end of life products and from slow-moving items, technological obsolescence, and excess inventory. Inventory write-offs during the years ended December 31, 2019, 2018 and 2017 amounted to $ 629, $ 2,231 and $ 1,260, respectively, and were recorded in cost of revenues.

Inventory write-off provision as of December 31, 2019 and 2018 amounted to $ 2,839 and $ 2,818, respectively.

Inventory cost is determined using the weighted average cost method.

i.         Property and equipment, net:

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates:

   
%
     
Lab equipment
 
16 - 25
Computers and peripheral equipment
 
33
Office furniture
 
6
Leasehold improvements
 
Over the shorter of the term of the lease or the useful life of the asset


j.
Goodwill impairment:

Goodwill represents the excess of the purchase price over the fair value of net assets of purchased businesses. Under Accounting Standards Codification No. 350, "Intangibles-Goodwill and Other" ("ASC No. 350"), goodwill is not amortized, but rather subject to an annual impairment test, or more often if there are indicators of impairment present. In accordance with ASC No. 350 the Company performs an annual impairment test at December 31 each year.

ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the two-step impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test.

The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step would need to be performed; otherwise, no further step is required. The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill. Any excess of the goodwill carrying amount over the applied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value.

The Company operates in one operating segment, and this segment comprises its only reporting unit. The Company has performed an annual impairment analysis as of December 31, 2019 and determined that the carrying value of the reporting unit was less than the fair value of the reporting unit. Fair value is determined using market capitalization. During years 2019, 2018 and 2017, no impairment losses were recorded.


k.
Impairment of long-lived assets and intangible assets subject to amortization:

Property and equipment and intangible assets subject to amortization are reviewed for impairment in accordance with ASC No. 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Some of the acquired intangible assets are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer relationships as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis.

During the years ended December 31, 2019, 2018 and 2017, no impairment losses were recorded.


l.
Revenue recognition:

The Company generates revenues mainly from selling its products along with related maintenance and support services. At times, these arrangements may also include professional services, such as installation services or training. Some of the Company’s product sells is done through resellers, distributors, OEMs and system integrators, all of whom are considered end-users.

The Company adopted accounting standards codification 606, "Revenue from Contracts with Customers" ("ASC 606"), effective on January 1, 2018. The Company recognizes revenue under the core principle that transfer of control to the Company’s customers should be depicted in an amount reflecting the consideration the Company expects to receive. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.

The Company enters into contracts that can include combinations of products and services, that are capable of being distinct and accounted for as separate performance obligations.  The products are distinct as the customer can derive the economic benefit of it without any professional services, updates or technical support. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price out of the total consideration of the contract. For support, the Company determines the standalone selling prices based on the price at which the Company separately sells a renewal contract on a stand-alone basis. For professional services, the Company determines the standalone selling prices based on the price at which the Company separately sells those services on a stand-alone basis. If the SSP is not observable, the Company estimates the SSP taking into account available information such as geographic or regional specific factors, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation.

Maintenance and support related revenues are deferred and recognized on a straight-line basis over the term of the applicable maintenance and support agreement. Other services are recognized upon the completion of installation or when the service is provided.

Deferred revenue includes amounts received from customers for which revenue has not yet been recognized. Deferred revenues are classified as short and long-term based on their contractual term and recognized as revenues at the time the respective elements are provided.

Transaction price allocated to remaining performance obligations represents non-cancelable contracts that have not yet been recognized that include deferred revenue and amounts not yet received that will be recognized as revenue in future periods. The aggregate amount of the transaction price allocated to remaining performance obligations that the Company expects to recognize after the year ending December 31, 2020 is approximately $37,875.

The Company pays sales commissions to sales and marketing personnel based on their certain predetermined sales goals. Sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions earned by its employees are capitalized and amortized in over the revenue recognition period. Amortization expenses related to these costs are included in sales and marketing expenses in the consolidated statements of operations. For the year ended December 31, 2019, the amortization of deferred commission was $1,351. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less.

The Company estimated variable consideration related to product returns based on its experience with historical product returns and other known factors. Such provisions amounted to $163 and $191 as of December 31, 2019 and 2018, respectively. Following the adoption of ASC 606, As of December 31, 2019 and 2018, this provision was recorded as part of other payables and accrued expenses.

Following the adoption of ASC 606 in January 1, 2018, the Company recognizes for term-based license agreements at the point in time when control transfers and the associated maintenance revenues over the contract period. Adoption of the standard has resulted in a reduction of deferred revenues of $712 that was recorded in accumulated deficit due to upfront recognition of license revenues from term licenses.

The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of Topic 606-10 was as follows:

   
December 31, 2017
   
Adjustments
   
January 1, 2018
 
   
(in thousands)
 
Deferred revenue, short term
   
11,370
     
(311
)
   
11,059
 
Deferred revenue, long term
   
3,878
     
(75
)
   
3,803
 
Trade receivables
   
22,737
     
326
     
23,063
 
Accumulated deficit
   
122,247
     
(712
)
   
121,535
 

In accordance with Topic 606-10, the disclosure of the impact of adoption on the consolidated balance sheet as of December 31, 2018 was as follows:

   
Amounts under
Topic 605
   
Impact of Adoption
   
As Reported
 
   
(in thousands)
 
Consolidated Balance Sheet
                 
Deferred revenue, short term
   
14,152
     
(297
)
   
13,855
 
Deferred revenue, long term
   
4,264
     
(17
)
   
4,247
 
Trade receivables
   
25,603
     
490
     
26,093
 
Accumulated deficit
   
132,754
     
(804
)
   
131,950
 

In addition, following the adoption of ASC 606, the Company’s consolidated statement of operations for the year ended December 31, 2018, included an increase of revenue in the amount of $ 92, net, compared to the accounting treatment under ASC 605.

m.       Cost of revenues:

Cost of revenues consists primarily of costs of materials and the cost of maintenance and services, resulting from costs associated with support, customer success and professional services.

n.         Advertising expenses:

Advertising expenses are charged to the statement of comprehensive loss, as incurred. Advertising expenses for the years ended December 31, 2019, 2018 and 2017 amounted to $ 1,274, $ 1,270 and $ 1,236, respectively.

o.        Research and development costs:

Accounting Standards Codification No. 985-20, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.

Based on the Company's product development process, technological feasibility is established upon the completion of a working model. The Company does not incur material costs between the completion of a working model and the point at which the products are ready for general release. Therefore, research and development costs are charged to the consolidated statement of comprehensive loss as incurred.

p.        Severance pay:

The liability in Israel for substantially all of the Company`s employees in respect of severance pay liability is calculated in accordance with Section 14 of the Severance Pay Law -1963 (herein- "Section 14"). Section 14 states that Company's contributions for severance pay shall be in line of severance compensation and upon release of the policy to the employee, no additional obligations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee.

Furthermore, the related obligation and amounts deposited on behalf of such obligation under Section 14, are not stated on the balance sheet, because pursuant to the current ruling, they are legally released from the obligation to employees once the deposits have been paid.

There are a limited number of employees in Israel, for whom the Company is liable for severance pay. The Company's liability for severance pay for its Israeli employees was calculated pursuant to Section 14, based on the most recent monthly salary of its Israeli employees multiplied by the number of years of employment as of the balance sheet date for such employees.

The Company's liability was partly provided by monthly deposits with severance pay funds and insurance policies and the remainder by an accrual.

Severance expense for the years ended December 31, 2019, 2018 and 2017, amounted to $ 2,249, $ 1,950 and $ 1,801, respectively.

q.        Accounting for stock-based compensation:

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification No. 718, "Compensation - Stock Compensation" ("ASC No. 718") that requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statement of comprehensive loss. The Company recognizes compensation expenses for the value of its awards based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures.

The Company accounted for changes in award terms as a modification in accordance with ASC 718. A modification to the terms of an award should be treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value measured at the same date. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances.

The Company estimated the forfeiture rate based on historical forfeitures of equity awards and adjusted the rate to reflect changes in facts and circumstances if any. The Company adopted ASU 2016-09 in the first quarter of the fiscal year 2017 and elected to retain its existing accounting policy and estimate expected forfeitures. The adoption of this ASU did not have a material impact on the Company's consolidated financial statements.

The following table sets forth the total stock-based compensation expense resulting from stock options, restricted share units ("RSUs") and Phantoms granted to employees included in the consolidated statements of comprehensive loss, for the years ended December 31, 2019, 2018 and 2017:
   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Cost of revenues
 
$
264
   
$
316
   
$
362
 
Research and development
   
847
     
678
     
648
 
Sales and marketing
   
1,257
     
928
     
1,166
 
General and administrative
   
1,052
     
940
     
1,190
 
                         
Total stock-based compensation expense
 
$
3,420
   
$
2,862
   
$
3,366
 

The Company selected the binomial option pricing model as the most appropriate fair value method for its stock-based compensation awards with the following assumptions for the years ended December 31, 2018 and 2017:

   
Year ended December 31,
 
   
2018
   
2017
 
             
Suboptimal exercise multiple
   
2.9-3.5
     
2.9-3.5
 
Risk free interest rate
   
2.09%-3.05%

   
0.80%-2.20%

Volatility
   
26%-47%

   
27%-49%

Dividend yield
   
0%

   
0%


The expected annual post-vesting and pre-vesting forfeiture rates affects the number of exercisable options. Based on the Company's historical experience, the annual pre-vesting and post-vesting are in the range of 0%-33% and 0%-41%, respectively, in the years 2018 and 2017. During 2019 no options were granted by the Company.

The computations of expected volatility and suboptimal exercise multiple is based on the average of the Company's realized historical stock price. The computation of the suboptimal exercise multiple and the forfeiture rates are based on the grantee's expected exercise prior and post vesting termination behavior. The interest rate for a period within the contractual life of the award is based on the U.S. Treasury Bills yield curve in effect at the time of grant.

The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business.

The expected life of the stock options represents the weighted-average period the stock options are expected to remain outstanding and is a derived output of the binomial model. The expected life of the stock options is impacted by all of the underlying assumptions used in the Company's model.

r.         Treasury stock:

The Company repurchases its Ordinary shares from time to time on the open market and holds such shares as treasury stock. The Company presents the cost to repurchase treasury stock as a reduction of shareholders' equity.

s.         Concentration of credit risks:

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, short-term bank deposits, trade receivables and derivative instruments.

The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits in major U.S. and Israeli banks. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the cash and cash equivalents and short-term bank deposits may be redeemed upon demand, and therefore, bear minimal risk.

Marketable securities include investments in dollar linked corporate and municipal bonds. Marketable securities consist of highly liquid debt instruments with high credit standing. The Company’s investment policy, approved by the Board of Directors, limits the amount the Group may invest in any one type of investment or issuer, thereby reducing credit risk concentrations. Management believes that the portfolio is well diversified and, accordingly, minimal credit risk exists with respect to these marketable debt securities

The Company's trade receivables are primarily derived from sales to customers located mainly in EMEA, as well as in APAC, Latin America and the United States. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and establishes an allowance for doubtful accounts on a specific basis. Allowance for doubtful accounts amounted to $ 1,867 and $ 1,415 as of December 31, 2019 and 2018, respectively.

The Company utilizes foreign currency forward contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financial institutions and its exposure is limited to the amount of any asset resulting from the forward contracts.

The Company has no significant off-balance sheet concentrations of credit risk.

t.         Grants from the Israel Innovation Authority:

Participation grants from the Israel Innovation Authority (Previously known as the Office of the Chief Scientist) for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 378, $ 374 and $ 392 in 2019, 2018 and 2017, respectively.

u.        Income taxes:

The Company accounts for income taxes in accordance with Accounting Standards Codification No. 740, "Income Taxes" ("ASC No. 740"). ASC No. 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The deferred tax assets and liabilities are classified to non-current assets and liabilities, respectively.

ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income

v.        Basic and diluted net income (loss) per share:

Basic net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year. Diluted net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus dilutive potential Ordinary Shares considered outstanding during the year, in accordance with FASB ASC 260 "Earnings Per Share".

For the years ended December 31, 2019, 2018 and 2017, all outstanding options and RSUs have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive. See Note 16. The amount of those options and RSU’s was : 3,105,801, 2,998,174, 2,902,387 respectively.

w.        Comprehensive loss:

The Company accounts for comprehensive loss in accordance with Accounting Standards Codification No. 220, "Comprehensive Income" ("ASC No. 220"). This statement establishes standards for the reporting and display of comprehensive loss and its components in a full set of general purpose financial statements. Comprehensive loss represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to shareholders. The Company determined that its items of comprehensive loss relate to unrealized gains and losses on hedging derivative instruments and unrealized gains and losses on available-for-sale marketable securities.

The following table shows the components and the effects on net loss of amounts reclassified from accumulated other comprehensive loss as of December 31, 2019:

   
Year ended
December 31, 2019
 
   
Unrealized gain (losses) on marketable securities
   
Unrealized gains (losses) on cash flow hedges
   
Total
 
                   
Balance as of December 31, 2018
 
$
(349
)
 
$
(418
)
 
$
(767
)
Changes in other comprehensive income (loss) before reclassifications
   
666
     
(332
)
   
334
 
Amounts reclassified from accumulated other comprehensive income (loss) to:
                       
 Cost of revenues
   
-
     
(7
)
   
(7
)
Operating expenses
   
-
     
(89
)
   
(89
)
Financial income, net
   
4
     
-
     
4
 
                         
Net current-period other comprehensive income (loss)
   
670
     
(428
)
   
242
 
                         
Balance as of December 31, 2019
 
$
321
   
$
(846
)
 
$
(525
)

x.        Fair value of financial instruments:

The Company measures its cash and cash equivalents, marketable securities, derivative instruments, short-term bank deposits, trade receivables, other receivables, trade payables and other payables at fair value. The carrying amounts of short-term bank deposits, trade receivables, other receivables, trade payables and other payables approximate their fair value due to the short-term maturities of such instruments.

Fair value is an exit price, representing the amount that would be received if the Company were to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

The Company uses a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:


Level 1 -
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.


Level 2 -
Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and


Level 3 -
Unobservable inputs which are supported by little or no market activity.

The Company categorized each of its fair value measurements in one of those three levels of hierarchy. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The Company's earn-out considerations are classified within Level 3. The valuation methodology used by the Company to calculate the fair value consideration is the discounted cash flow using the Monte-Carlo simulation method by taking into account, forecast future revenues, expected volatility of 42.5% for Optenet and 20.7% for Netonomy and the weighted average cost of debt of 2%. As of December 31, 2019 the fair value of the consideration was determined according to discounted cash flow since the earn-out will be completely paid by the third quarter of 2020.

y.        Derivatives and hedging:

The Company accounts for derivatives and hedging based on Accounting Standards Codifiation No. 815, "Derivatives and Hedging" ("ASC No. 815").

The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value. Derivative instruments that are not designated and qualified as hedging instruments must be adjusted to fair value through earnings.

For derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) in shareholders' equity and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As a result of adopting new accounting guidance discussed in Note 2, " Recently adopted accounting pronouncements," beginning January 1, 2019, gains and losses on the derivatives instruments that are designated and qualify as a cash flow hedge are recorded in accumulated other comprehensive income (loss) and reclassified into in the same accounting period in which the designated forecasted transaction or hedged item affects earnings. Prior to January 1, 2019, cash flow hedge ineffectiveness was separately measured and reported immediately in earnings. Cash flow hedge ineffectiveness was immaterial during 2018 and 2017. To apply hedge accounting treatment, cash flow hedges must be highly effective in offsetting changes to expected future cash flows on hedged transactions.


z.
Business combinations:

The Company accounts for business combinations in accordance with ASC No. 805. ASC No. 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. Any excess of the fair value of net assets acquired over the purchase price is recorded as goodwill and any subsequent changes in estimated contingencies are to be recorded in earnings. In addition, changes in valuation allowance related to acquired deferred tax assets and acquired income tax positions are to be recognized in earnings.

aa.       Lease:

On January 1, 2019, the Company adopted ASU No. 2016-02, Leases (ASC 842). The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases.

ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses the Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option.

Payments under our lease arrangements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in
the operating lease right-of-use assets and liabilities. Variable lease payments are primarily comprised of payments affected by common area maintenance and utility charges.

ab.      Warranty costs:

The Company generally provides three months software and a one-year hardware warranty for all of its products. A provision is recorded for estimated warranty costs at the time revenues are recognized based on the Company's experience. Warranty expenses for the years ended December 31, 2019, 2018 and 2017 were immaterial.

 ac.       Recently Adopted Accounting Pronouncements:

In February 2016, the FASB issued ASU No. 2016-02, Leases (ASC 842). The standard requires the recognition of ROU assets and lease liabilities for all leases. The standard requires a modified retrospective transition approach to recognize and measure leases at the initial application.

The Company adopted the standard as of January 1, 2019, using a modified retrospective transition approach and elected to use the effective date as the date of initial application. The Company adopted the ”package of practical expedients”, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. As a result, the consolidated balance sheets as of December 31, 2018 were not restated, continue to be reported under ASC 840, which did not require recognition of operating lease assets and liabilities on the balance sheets, and are not comparative.

The standard had a material impact on the Company’s consolidated balance sheets which resulted in the recognition of ROU assets and lease liabilities of $6.7 million and $6.7 million, respectively, on January 1, 2019, which included reclassifying deferred rent and rent prepayments as components of the ROU assets. The standard did not have a material impact on the Company's consolidated statements of comprehensive income. See also Note 11a.

The Company adopted Accounting Standards Update (“ASU”) No. 2017- 12, “Derivatives and Hedging” (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amended the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements were adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships which existed on the date of adoption were applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and the adoption did not have a material impact on the Company’s consolidated financial statements.

In June 2018, the FASB issued Accounting Standards Update No. 2018-07, "Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting" (ASU 2018-07). ASU 2018-07 was issued to simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, Compensation – Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The Company adopted this standard as of December 31, 2019 and did not have material effect on its consolidated financial statements.

ad.      Recently Issued Accounting Pronouncement Not Yet Adopted:

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). The standard changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company will adopt this standard as of January 1, 2020 and does not expect this to have a material effect on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment" ("ASU 2017-04"). ASU 2017-04 eliminates the requirement to measure the implied fair value of goodwill by assigning the fair value of a reporting unit to all assets and liabilities within that unit (the "Step 2 test") from the goodwill impairment test. Instead, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited by the amount of goodwill in that reporting unit. ASU 2017-04 will become effective for the Company beginning January 1, 2020 and must be applied to any annual or interim goodwill impairment assessments after that date. Early adoption is permitted. The new guidance was effective for the Company on January 1, 2020. The adoption did not have a material impact on the Company’s consolidated financial statements.

In December 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): “Simplifying the Accounting for Income Taxes” (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for us in the first quarter of 2021 on a prospective basis, and early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
v3.20.2
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
NOTE 3:-
AVAILABLE-FOR-SALE MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities:

   
December 31, 2019
   
December 31, 2018
 
   
Amortized cost
   
Gross unrealized gain
   
Gross unrealized
loss
   
Fair
value
   
Amortized cost
   
Gross
unrealized
gain
   
Gross unrealized
loss
   
Fair
value
 
                                                 
Available-for-sale - matures within one year:
                                               
Governmental debentures
 
$
449
   
$
1
   
$
-
   
$
450
   
$
1,799
   
$
-
   
$
(2
)
 
$
1,797
 
Corporate debentures
   
30,928
     
79
     
(8
)
   
30,999
     
37,808
     
6
     
(98
)
   
37,716
 
                                                                 
     
31,377
     
80
     
(8
)
   
31,449
     
39,607
     
6
     
(100
)
   
39,513
 
Available-for-sale - matures after one year through three years:
                                                               
Governmental debentures
   
855
     
1
     
-
     
856
     
476
     
-
     
(4
)
   
472
 
Corporate debentures
   
23,653
     
197
     
(7
)
   
23,843
     
24,455
     
4
     
(253
)
   
24,206
 
                                                                 
     
24,508
     
198
     
(7
)
   
24,699
     
24,931
     
4
     
(257
)
   
24,678
 
Available-for-sale - matures after three years through five years:
                                                               
Corporate debentures
   
4,806
     
58
     
-
     
4,864
     
101
     
-
     
(2
)
   
99
 
     
4,806
     
58
     
-
     
4,864
     
101
     
-
     
(2
)
   
99
 
   
$
60,691
   
$
336
   
$
(15
)
 
$
61,012
   
$
64,639
   
$
10
   
$
(359
)
 
$
64,290
 

As of December 31, 2019, the Company had no investments with a significant unrealized losses for more than 12 months.
v3.20.2
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 4:-
FAIR VALUE MEASUREMENTS

In accordance with ASC No. 820, the Company measures its marketable securities and foreign currency derivative instruments at fair value. Cash equivalents and available for sale marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs.

The earn-out liability related to the acquisitions of Optenet and Netonomy are classified within Level 3 because these liabilities are based on present value calculations and an external valuation model whose inputs include market interest rates, estimated operational capitalization rates and volatilities. As of December 31, 2019 the fair value of the consideration was determined according to discounted cash flow since the earn-out will be completely paid by the third quarter of 2020.

The Company's financial net assets measured at fair value on a recurring basis, including accrued interest components, consisted of the following types of instruments as of December 31, 2019 and 2018, respectively:

   
As of December 31, 2019
 
   
Fair value measurements using input type
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Available-for-sale marketable securities
 
$
-
   
$
61,012
   
$
-
   
$
61,012
 
Foreign currency derivative contracts
   
-
     
(871
)
   
-
     
(871
)
Earn-out liability
   
-
     
-
     
(1,100
)
   
(1,100
)
                                 
Total financial net assets
 
$
-
   
$
60,141
   
$
(1,100
)
 
$
59,041
 

   
As of December 31, 2018
 
   
Fair value measurements using input type
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Available-for-sale marketable securities
 
$
-
   
$
64,290
   
$
-
   
$
64,290
 
Foreign currency derivative contracts
   
-
     
(324
)
   
-
     
(324
)
Earn-out liability
   
-
     
-
     
(6,051
)
   
(6,051
)
                                 
Total financial net assets
 
$
-
   
$
63,966
   
$
(6,051
)
 
$
57,915
 

Fair value measurements using significant unobservable inputs (Level 3):

Balance at January 1, 2019
 
$
6,051
 
         
Earn Out liability adjustments due to exchange rates
   
(113
)
Adjustment due to change in forecast and time value of earn-out consideration
   
(4,838
)
         
Balance at December 31, 2019
 
$
1,100
 
v3.20.2
DERIVATIVE INSTRUMENTS
12 Months Ended
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS
NOTE 5:-
DERIVATIVE INSTRUMENTS

The Company enters into hedge transactions with a major financial institution, using derivative instruments, primarily forward contracts and options to purchase and sell foreign currencies, in order to reduce the net currency exposure associated with anticipated expenses (primarily salaries and related expenses that are designated as cash flow hedges), trade receivables and forecasted revenues denominated in currencies other than U.S. dollar.

The Company currently hedges such future exposures for a maximum period of two years. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.

The Company records all derivatives on the consolidated balance sheets at fair value in accordance with ASC No. 820 at Level 2. Cash flow hedges are recorded in other comprehensive income (loss) until the hedged item is recognized in earnings. The Company does not enter into derivative transactions for trading purposes. The net income (loss) recognized in "Financial income (expense), net" during the years ended December 31, 2019, 2018 and 2017 was $534, $1,480 and $(1,801), respectively.

The Company had a net unrealized loss associated with cash flow hedges of $845 and $418 recorded in other comprehensive loss as of December 31, 2019 and 2018, respectively. As of December 31, 2019 and 2018, the Company had outstanding hedge transactions in the net amount of $ 36,139 and $ 20,816, respectively.

The fair value of the outstanding foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2019 and 2018, as assets and liabilities is as follows:

Foreign exchange forward and
     
December 31,
 
options contracts
 
Balance sheet
 
2019
   
2018
 
                 
Fair value of foreign exchange hedge transactions
 
Other receivables and prepaid expenses
 
$
158
   
$
56
 
Fair value of foreign exchange hedge transactions
 
Other payables and accrued expenses
   
(1,041
)
   
(474
)
                     
Total derivatives designated as hedging instruments
 
Other Comprehensive loss
 
$
(846
)
 
$
(418
)

Gain or loss on the derivative instruments, which partially offset the foreign currency impact from the underlying exposures, reclassified from other comprehensive loss to operating expenses and cost of revenues for the years ended December 31, 2019, 2018 and 2017 were $ (96), $ 903 and $ (796), respectively.


Non-designated hedges:

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies. These derivatives do not qualify for special hedge accounting treatment. These derivatives are carried at fair value with changes recorded in financial income, net. Changes in the fair value of these derivatives are largely offset by the re-measurement of the underlying assets and liabilities. The derivatives have maturities of approximately twelve months. As of December 31, 2019 and 2018, the Company’s outstanding non-hedge transactions  were $ 15,741 and $ 16,023, respectively.

The fair value of the outstanding non-designated foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2019 and 2018, as assets and liabilities are as follows:

Foreign exchange forward and
     
December 31,
 
options contracts
 
Balance sheet
 
2019
   
2018
 
                 
Fair value of foreign exchange non-designated hedge transactions
 
Other receivables and prepaid expenses
 
$
12
   
$
94
 
                     
Total derivatives non-designated as hedging instruments
       
12
     
94
 
v3.20.2
OTHER RECEIVABLES AND PREPAID EXPENSES
12 Months Ended
Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER RECEIVABLES AND PREPAID EXPENSES
NOTE 6:-
OTHER RECEIVABLES AND PREPAID EXPENSES

   
December 31,
 
   
2019
   
2018
 
             
Prepaid expenses
 
$
3,957
   
$
1,635
 
Government authorities
   
1,773
     
1,327
 
Short-term lease deposits
   
195
     
159
 
Foreign currency derivative contracts
   
170
     
150
 
Others
   
433
     
376
 
                 
   
$
6,528
   
$
3,647
 
v3.20.2
INVENTORIES
12 Months Ended
Dec. 31, 2019
Inventory Disclosure [Abstract]  
INVENTORIES
NOTE 7:-
INVENTORIES

   
December 31,
 
   
2019
   
2018
 
             
Raw materials
 
$
1,264
   
$
551
 
Finished goods
   
9,404
     
10,794
 
                 
   
$
10,668
   
$
11,345
 

As of December 31, 2019 and 2018, the finished products line item above includes deferral of the cost of goods sold for which revenue was not yet recognized in the amount of approximately $ 1,335 and $ 1,336, respectively.
v3.20.2
PROPERTY AND EQUIPMENT, NET
12 Months Ended
Dec. 31, 2019
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET
NOTE 8:-     PROPERTY AND EQUIPMENT, NET

   
December 31,
 
   
2019
   
2018
 
Cost:
           
Lab equipment
 
$
17,548
   
$
16,038
 
Computers and peripheral equipment
   
22,374
     
20,680
 
Office furniture and equipment
   
1,356
     
1,197
 
Leasehold improvements
   
2,557
     
2,212
 
Lease equipment
   
930
     
-
 
                 
     
44,765
     
40,127
 
Accumulated depreciation:
               
Lab equipment
   
14,548
     
13,273
 
Computers and peripheral equipment
   
20,145
     
19,039
 
Office furniture and equipment
   
659
     
598
 
Leasehold improvements
   
1,162
     
968
 
Lease equipment
   
116
     
-
 
                 
     
36,630
     
33,878
 
                 
Depreciated cost
 
$
8,135
   
$
6,249
 

Depreciation expense for the years ended December 31, 2019, 2018 and 2017 was $ 2,752, $ 2,203 and $ 2,191, respectively.
v3.20.2
INTANGIBLE ASSETS, NET
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS, NET
NOTE 9:-
INTANGIBLE ASSETS, NET


a.
The following table shows the Company's intangible assets for the periods presented:

   
Weighted Average
Useful life
   
December 31,
 
   
(Years)
   
2019
   
2018
 
Original Cost:
                 
                   
 Technology
   
3.8
   
$
9,111
   
$
9,111
 
Backlog
   
2.8
     
1,877
     
1,877
 
Customer relationships
   
4.4
     
3,592
     
3,592
 
IP R&D
   
6
     
3,659
     
3,659
 
                         
           
$
18,239
   
$
18,239
 
Accumulated amortization:
                       
                         
 Technology
         
$
9,111
   
$
8,563
 
Backlog
           
1,877
     
1,877
 
Customer relationships
           
3,592
     
2,838
 
IP R&D
           
305
     
-
 
                         
           
$
14,885
   
$
13,278
 
                         
Amortized cost
         
$
3,354
   
$
4,961
 


b.
Amortization expense for the years ended December 31, 2019, 2018 and 2017 were $ 1,607, $ 1,631 and $ 1,477, respectively.


c.
Estimated amortization expense for the years ending:

Year ending December 31,
     
       
2020
   
610
 
2021
   
610
 
2022
   
610
 
Thereafter
   
1,524
 
         
Total
   
3,354
 
v3.20.2
OTHER PAYABLES AND ACCRUED EXPENSES
12 Months Ended
Dec. 31, 2019
Payables and Accruals [Abstract]  
OTHER PAYABLES AND ACCRUED EXPENSES
NOTE 10:-
OTHER PAYABLES AND ACCRUED EXPENSES

   
December 31,
 
   
2019
   
2018
 
             
Advances from customers
 
$
253
   
$
5,700
 
Accrued expenses
   
3,887
     
3,346
 
Government authorities
   
3,061
     
3,356
 
Holdback and contingent earnout
   
1,575
     
484
 
Foreign currency derivative contracts
   
1,041
     
474
 
Provision for returns
   
163
     
191
 
Others
   
234
     
144
 
                 
   
$
10,214
   
$
13,695
 
v3.20.2
COMMITMENTS AND CONTINGENT LIABILITIES
12 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES
NOTE 11:-
COMMITMENTS AND CONTINGENT LIABILITIES

a.         Lease commitments:

The Group's facilities are leased under several lease agreements for periods ending up to 2023, with options to extend the leases ending up to 2025.

In addition, the Company has various operating lease agreements with respect to motor vehicles.

Lease expenses of office rent and vehicles for the years ended December 31, 2019, 2018 and 2017 were approximately $3,129, $2,934 and $3,126, respectively. Expenses for short- term leases in 2019 were $ 278.

The following table represents the weighted-average remaining lease term and discount rate:

 
Year ended
December 31, 2019
   
Weighted average remaining lease term
     2.52 years
Weighted average discount rate
1.54%

The discount rate was determined based on the estimated collateralized borrowing rate of the Company, adjusted to the specific lease term and location of each lease.

Maturities of operating lease liabilities were as follows:

Year ending December 31,
     
2020
 
$
3,170
 
2021
   
2,641
 
2022
   
1,019
 
2023
   
211
 
2024 and thereafter
   
78
 
         
Total lease payments
 
$
7,119
 
         
Less - imputed interest
 
$
(148
)
         
Present value of lease liabilities
 
$
6,971
 

As of December 31, 2019 maturities of operating lease liabilities which were not recognized under ASU No. 2016-02, Leases (ASC 842) were $ 225.

b.        Major subcontractor:

The Company currently depends on one subcontractor to manufacture and provide certain hardware, warranty and support components for its traffic management systems. If the subcontractor experiences delays, disruptions, quality control problems or a loss in capacity, shipments of products may be delayed and the Company's ability to deliver such products could be materially adversely affected. In the event that the Company terminates its business connection with the subcontractor, it will have to compensate the subcontractor for certain inventory costs, as specified in the agreement with the subcontractor.


c.
Liens and guarantees:

As of December 31, 2019, the Company has provided bank guarantees in respect of    prepayments from customers in an aggregate amount of approximately $ 26 million, in addition to bank guarantees in favor of leases agreements in an aggregate amount of approximately $ 501 .

d.        Litigations:

On February 18, 2016, a former employee filed a claim against the Company alleging that he is entitled to compensation for unlawful dismissal by the Company. In September 2019, the parties filed a request to approve a settlement agreement which the Court approved in October 2019.
v3.20.2
SHAREHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 12:-
SHAREHOLDERS' EQUITY


a.
Company's shares:

As of December 31, 2019, the Company's authorized share capital consists of NIS 20,000,000 divided into 200,000,000 Ordinary Shares, par value NIS 0.1 per share. Ordinary Shares confer on their holders the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company, and the right to receive dividends if declared.


b.
Stock option plan:

A summary of the Company's stock option activity, pertaining to its option plans for employees and related information is as follows:

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
   
Number
of shares upon exercise
   
Weighted average exercise price
   
Number
of shares upon exercise
   
Weighted average exercise price
   
Number
of shares upon exercise
   
Weighted average exercise price
 
                                     
Outstanding at beginning of year
   
1,736,143
   
$
7.26
     
2,189,297
   
$
7.63
     
1,959,014
   
$
8.24
 
Granted
   
-
   
$
-
     
62,200
   
$
5.91
     
676,550
   
$
4.93
 
Forfeited
   
(59,107
)
 
$
10.05
     
(414,617
)
 
$
9.79
     
(346,750
)
 
$
7.01
 
Exercised
   
(223,295
)
 
$
4.36
     
(100,737
)
 
$
4.07
     
(99,517
)
 
$
3.56
 
                                                 
Outstanding at end of year
   
1,453,741
   
$
7.59
     
1,736,143
   
$
7.26
     
2,189,297
   
$
7.63
 
                                                 
Exercisable at end of year
   
1,240,005
   
$
8.01
     
1,281,665
   
$
8.02
     
1,274,649
   
$
9.26
 
                                                 
Vested and expected to vest
   
1,442,990
   
$
7.61
     
1,464,802
   
$
7.65
     
1,607,782
   
$
8.44
 

The aggregate intrinsic value represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the fiscal years 2019, 2018 and 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders exercised their options on December 31, 2019, 2018 and 2017, respectively. This amount may change based on the fair market value of the Company's stock. The total intrinsic value of options outstanding at December 31, 2019, 2018 and 2017, were $ 3,510, $ 1,518 and $ 1,063, respectively. The total intrinsic value of exercisable options at December 31, 2019, 2018 and 2017, were approximately $ 2,791, $ 1,058 and $ 684, respectively. The total intrinsic value of options vested and expected to vest at December 31, 2019, 2018 and 2017, were approximately $ 3,399, $ 1,246 and $ 819, respectively.

The total intrinsic value (the difference between the Company's closing stock price on the exercise date and the exercise price)  of options exercised during the years ended December 31, 2019, 2018 and 2017 were approximately $ 769, $ 201 and $ 176, respectively. The weighted-average grant-date fair value of the options granted during the years ended December 31, 2018 and 2017 were $ 2.89 and $ 2.36, respectively. No options were granted during 2019. The number of options vested during the year ended December 31, 2019 was 226,317. The weighted-average remaining contractual life of the outstanding options as of December 31, 2019 is 3.45 years. The weighted-average remaining contractual life of exercisable options as of December 31, 2019 is 3.25 years.

The options outstanding as of December 31, 2019, have been classified by exercise price, as follows:

Exercise price
   
Shares upon exercise of options outstanding as of December 31, 2019
   
Weighted average remaining contractual life
   
Shares upon exercise of options exercisable as of December 31, 2019
 
           
Years
       
                     
$
23.31-27.58
     
64,500
     
2.63
     
64,500
 
$
15.2-17.07
     
49,936
     
1.97
     
49,936
 
$
10.0 -14.68
     
173,250
     
3.92
     
173,250
 
$
5.01-9.7
     
508,083
     
2.84
     
435,487
 
$
0.1-4.95
     
657,972
     
4.00
     
516,832
 
                             
         
1,453,741
             
1,240,005
 

The following provides a summary of the restricted stock unit activity for the Company for the two years ended December 31, 2019:

   
Year ended December 31,
 
   
2019
   
2018
 
   
Number
of shares upon exercise
   
Weighted average share price
   
Number
of shares upon exercise
   
Weighted average share price
 
                         
Outstanding at beginning of year
   
1,252,031
   
$
5.45
     
713,090
   
$
6.04
 
Granted
   
1,001,000
   
$
7.53
     
996,200
   
$
5.54
 
Vested
   
(401,904
)
 
$
7.53
     
(312,201
)
 
$
5.72
 
Forfeited
   
(199,067
)
 
$
7.61
     
(145,058
)
 
$
5.01
 
                                 
Unvested at end of year
   
1,652,060
   
$
6.53
     
1,252,031
   
$
5.45
 

As of December 31, 2019, $ 402 and $ 8,001 unrecognized compensation cost related to stock options and RSUs respectively is expected to be recognized over a weighted average vesting period of 3.01 years.

Under the terms of the above option plans, options may be granted to employees, officers, directors and various service providers of the Company and its subsidiaries. The options vest over a four-year period, subject to the continued employment of the employee. The options generally expire no later than ten years from the date of the grant. The exercise price of the options at the date of grant under the plans may not be less than the nominal value of the shares into which such options are exercised, any options, which are forfeited or cancelled before expiration, become available for future grants. As of December 31, 2019, 34,652 Ordinary shares are available for future issuance under the option plans.

In addition to granting stock options, the Company granted 1,001,000 and 996,200 RSUs in 2019 and 2018, respectively under the 2016 option plan. RSUs vest over a four-year period subject to the continued employment of the employee. RSUs that are cancelled or forfeited become available for future grants.
v3.20.2
TAXES ON INCOME
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
TAXES ON INCOME
NOTE 13:-
TAXES ON INCOME


a.
Corporate tax rates:

The Israeli corporate income tax rate was 23% in 2019, 23% in 2018 and 24% in 2017.

In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which reduces the corporate income tax rate to 24% (instead of 25%) effective from January 1, 2017 and to 23% effective from January 1, 2018

b.        Foreign Exchange Regulations:

Commencing in taxable year 2012, the Company has elected to measure its taxable income and file its tax return under the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income) 1986 ("Foreign Exchange Regulations"). Under the Foreign Exchange Regulations, an Israeli company must calculate its tax liability in U.S. Dollars according to certain rules. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year.


c.
Tax benefits under Israel's law for the Encouragement of Capital Investments, 1959 ("the Law"):

In 1998, the production facilities of the Company related to its computational technologies were granted the status of an "Approved Enterprise" under the Law. In 2004, an expansion program was granted the status of "Approved Enterprise". According to the provisions of the Law, the Company has elected the alternative track of benefits and has waived Government grants in return for tax benefits. The period of tax benefits, detailed above, is limited to the earlier of 12 years from the commencement of production, or 14 years from the approval date.

According to the provisions of the Law under the alternative track, the Company's income may be tax-exempt for a period of two years commencing with the year it first earns taxable income, and subject to corporate taxes at the reduced rate of 10% to 25%, for an additional period of five to eight years depending upon the level of foreign ownership of the Company.

The Law was significantly amended effective April 1, 2005 ("the  2005 - Amendment"). The 2005 - Amendment includes revisions to the criteria for investments qualified to receive tax benefits as a Beneficiary Enterprise and among other things, simplifies the approval process. The Amendment applies to new investment programs. Therefore, investment programs commencing after December 31, 2004, do not affect the approved programs of the Company.

In addition, the Law provides that terms and benefits included in any letter of approval already granted will remain subject to the provisions of the Law as they were on the date of such approval. Therefore, the Company's existing Approved Enterprise will generally not be subject to the provisions of the 2005 - Amendment. The Company elected 2006 and 2009 as "year of election" under the 2005 - Amendment.

The entitlement to the above benefits is contingent upon the fulfillment of the conditions stipulated in the Law, regulations published thereunder and the criteria set forth in the specific letters of approval. In the event of failure to comply with these conditions, the benefits may be canceled and the Company may be required to refund the amount of the benefits, in whole or in part, including interest and linked to changes in the Israeli CPI. As of December 31, 2019, management believes that the Company meets the aforementioned conditions.

If the Company pays a dividend out of exempt income derived from the Approved and Beneficiary Enterprise, it will be subject to corporate tax in respect of the gross amount distributed, including any taxes thereon, at the rate which would have been applicable had it not enjoyed the alternative benefits, generally 10%-25%, depending on the percentage of the Company's Ordinary shares held by foreign shareholders. The dividend recipient is subject to withholding tax at the rate of 15% applicable to dividends from approved enterprises, if the dividend is distributed during the tax exemption period or within twelve years thereafter. The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business.

As of December 31, 2019, there is no income earned by the Company Israel’s “Approved Enterprises” and “Beneficiary Enterprise”.

Income from sources other than the "Approved and Beneficiary Enterprise" during the benefit period will be subject to tax at the regular corporate tax rate.

As of January 1, 2011, new legislation amending the Law came into effect (the "2011 Amendment"). The 2011 Amendment introduced a new status of "Preferred Company" and "Preferred Enterprise", replacing the then existing status of "Beneficiary Company" and "Beneficiary Enterprise". Similarly to "Beneficiary Company", a Preferred Company is an industrial company owning a Preferred Enterprise which meets certain conditions (including a minimum threshold of 25% export). However, under this legislation the requirement for a minimum investment in productive assets was cancelled.

Under the 2011 Amendment, a uniform corporate tax rate will apply to all qualifying income of the Preferred Company, as opposed to the former law, which was limited to income from the Approved Enterprises and Beneficiary Enterprise during the benefits period. The uniform corporate tax rate was 9% in areas in Israel designated as Development Zone A and 16% elsewhere in Israel during 2016 and 2017.

A dividend distributed from income which is attributed to a Preferred Enterprise/Special Preferred Enterprise will be subject to withholding tax at source at the following rates: (i) Israeli resident corporation – 0%, (ii) Israeli resident individual – 20% as of 2014 and thereafter (iii) non-Israeli resident - 20% as of 2014 and thereafter subject to a reduced tax rate under the provisions of an applicable double tax treaty.

In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments ("the 2016 - Amendment") was published. According to the 2016 - Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%).

The December 2016 amendment also prescribes special tax tracks for technological enterprises, the new tax tracks under the amendment are as follows:

Technological preferred enterprise - an enterprise whose total consolidated revenues (parent company and all subsidiaries) is less than NIS 10 billion. A technological preferred enterprise, as defined in the Law, which is located in the center of Israel will be subject to tax at a rate of 12% on profits deriving from intellectual property (in development area A - a tax rate of 7.5%).

Special technological preferred enterprise - an enterprise whose total consolidated revenues (parent company and all subsidiaries) exceeds NIS 10 billion. Such enterprise will be subject to tax at a rate of 6% on profits deriving from intellectual property, regardless of the enterprise’s geographical location.

Under the transition provisions of the 2016 Amendment, the Company may decide to irrevocably implement the new law while waiving benefits provided under the current law or to remain subject to the current law.


d.
Tax benefits under the law for the Encouragement of Industry (Taxes), 1969 (the "Encouragement Law"):

The Encouragement Law, provides several tax benefits for industrial companies. An industrial company is defined as a company resident in Israel, at least 90% of the income of which in a given tax year exclusive of income from specified Government loans, capital gains, interest and dividends, is derived from an industrial enterprise owned by it. An industrial enterprise is defined as an enterprise whose major activity in a given tax year is industrial production activity.

Management believes that the Company is currently qualified as an "industrial company" under the Encouragement Law and as such, enjoys tax benefits, including: (1) deduction of purchase of know-how and patents and/or right to use a patent over an eight-year period; (2) the right to elect, under specified conditions, to file a consolidated tax return with additional related Israeli industrial companies and an industrial holding company; (3) accelerated depreciation rates on equipment and buildings; and (4) expenses related to a public offering on the Tel-Aviv Stock Exchange and on recognized stock markets outside of Israel, are deductible in equal amounts over three years.

Eligibility for benefits under the Encouragement Law is not subject to receipt of prior approval from any governmental authority. No assurance can be given that the Israeli tax authorities will agree that the Company qualifies, or, if the Company qualifies, then the Company will continue to qualify as an industrial company or that the benefits described above will be available to the Company in the future.


e.
Pre-tax income (loss) is comprised as follows:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Domestic
 
$
(8,934
)
 
$
(9,877
)
 
$
(17,539
)
Foreign
   
1,916
     
1,890
     
1,031
 
                         
   
$
(7,018
)
 
$
(7,987
)
 
$
(16,508
)


f.
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Loss before taxes on income
 
$
(7,018
)
 
$
(7,987
)
 
$
(16,508
)
                         
Theoretical tax income computed at the Israeli statutory tax rate
(23%, 23% and 24% for the years 2019, 2018 and 2017, respectively)
 
$
(1,614
)
 
$
(1,837
)
 
$
(3,962
)
                         
Changes in valuation allowance
   
951
     
1,189
     
8,946
 
Increase in losses and temporary differences due to change in Israeli
corporate and “Approved Enterprise" tax
         
659
     
(5,376
)
Previous years
                       
Write off of prepaid and withholding taxes
   
1,536
     
1,828
     
909
 
Foreign tax rates differences related to subsidiaries
   
44
     
50
     
(48
)
Non-deductible expenses and other
   
327
     
65
     
684
 
Non-deductible share-based compensation expense
   
397
     
474
     
411
 
                         
Actual tax expense
 
$
1,641
   
$
2,428
   
$
1,564
 


g.
Income tax expense is comprised as follows:

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
                   
Current taxes
 
$
341
   
$
580
   
$
689
 
Deferred taxes expense (benefit)
   
(236
)
   
20
     
(34
)
Write off of prepaid and withholding taxes
   
1,536
     
1,828
     
909
 
                         
   
$
1,641
   
$
2,428
   
$
1,564
 

h.        Net operating losses carry forward:

The Company has accumulated net operating losses for tax purposes as of December 31, 2019, in the amount of approximately $62,128, which may be carried forward and offset against taxable income in the future for an indefinite period. In December 2014, the Israeli Tax Authorities approved a final tax ruling with respect to the Company’s acquisition of Oversi. According to the ruling, the net operating losses on the merger date may be offset against taxable income annually with a limitation of up to 14% of the total accumulated losses but no more than 50% of the Company's taxable income. As of December 31, 2019, the Company recorded a full valuation allowance with respect to its deferred tax assets in Allot Ltd. and wrote-off prepaid and withholding taxes of $7,182 as the Company does not expect to utilize these tax assets in the near future. In addition, the Company has accumulated capital losses for tax purposes as of December 31, 2019, of approximately $27,243, which may be carried forward and offset against taxable capital gains in the future for an indefinite period but are limited as stated above with regard to the Oversi merger. Management currently believes that since the Company has a history of losses, and uncertainty with respect to future taxable income, it is more likely than not that the deferred tax assets regarding the loss carry forwards will not be utilized in the foreseeable future. Thus, a valuation allowance was provided to reduce deferred tax assets to their realizable value.

The U.S. subsidiary has accumulated losses for U.S. federal income tax return purposes of approximately $ 5,524 and $ 7,438 for state taxes. The federal accumulated losses for tax purposes expire between 2026 and 2037. The state accumulated losses for tax purposes began to expire in 2014. As of December 31, 2019, the Company recorded a partial valuation allowance with respect to its deferred tax assets in the US Subsidiary.

A portion of the losses are subject to limitations of Internal Revenue Code, Section 382, which in general provides that utilization of net operating losses is subject to an annual limitation if an ownership change results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period.  The annual limitations may result in the expiration of losses before utilization.

In December 2017 the U.S. Tax Cuts and Jobs Act of 2017 was signed into law. This legislation makes significant changes to the U.S. Internal Revenue Code. Such changes include a reduction in the corporate tax rate, changes in U.S. international taxation and limitations on certain corporate deductions and credits, among other changes. The deferred tax asset at December 31, 2019 reflects the impact of the US Tax reform.



i.
Deferred income taxes:

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred income taxes are as follows:.

   
December 31,
 
   
2019
   
2018
 
Deferred tax assets:
           
Operating and capital loss carryforwards
 
$
22,353
   
$
21,348
 
Reserves and allowances including lease liability
   
9,071
     
3,723
 
                 
Deferred tax asset before valuation allowance
   
31,424
     
25,071
 
Valuation allowance
   
(25,880
)
   
(24,790
)
Deferred tax asset net of valuation allowance
   
5,544
     
281
 
                 
Deferred tax liability including ROU asset
   
5,027
     
-
 
Net deferred tax asset
 
$
517
   
$
281
 


j.
As of December 31, 2019, the Company’s provision in respect of ASC 740-10 is $243. The accrued interest and penalties related to the provision in income taxes are immaterial.

The Company conducts business globally and, as a result, the Company or one or more of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as Israel, France, and the United States. With a few exceptions, the Company is no longer subject to Israeli tax assessment through the year 2013 and the Spanish and U.S. subsidiaries have final tax assessments through 2014 and 2015, respectively. The Company is currently under audit by the Israeli Tax Authorities for the years 2015– 2016.
v3.20.2
GEOGRAPHIC INFORMATION
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
GEOGRAPHIC INFORMATION
NOTE 14:-
GEOGRAPHIC INFORMATION

Allot operates in a single reportable segment. Revenues are based on the location of the Company's channel partners which are considered as end customers, as well as direct customers of the Company:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Europe
 
$
36,199
   
$
45,730
   
$
40,394
 
Asia and Oceania
   
42,994
     
22,018
     
13,936
 
Americas
   
16,576
     
14,363
     
15,532
 
Middle East and Africa
   
14,331
     
13,726
     
12,130
 
                         
   
$
110,100
   
$
95,837
   
$
81,992
 

The following are the Company’s major customers:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Customer A
   
16
%
   
22
%
   
32
%
Customer B
   
11
%
   
-
     
-
 
                         
     
27
%
   
22
%
   
32
%

A total percentage of 76% of the Company’s revenues for the year ended December 31, 2019 is attributed to network intelligence solutions, while 24% is attributed to security solutions.

The following presents total long-lived assets as of December 31, 2019 and 2018:

   
December 31,
 
   
2019
   
2018
 
Long-lived assets:
           
Israel
 
$
7,614
   
$
5,931
 
Other
   
521
     
317
 
                 
   
$
8,135
   
$
6,249
 
v3.20.2
FINANCIAL INCOME (EXPENSES), NET
12 Months Ended
Dec. 31, 2019
Other Income and Expenses [Abstract]  
FINANCIAL INCOME (EXPENSES), NET
NOTE 15:-
FINANCIAL INCOME (EXPENSES), NET

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Financial income:
                 
Interest income
 
$
2,551
   
$
2,696
   
$
2,513
 
Exchange rate differences and other
   
-
     
305
     
-
 
                         
Financial expenses:
                       
Exchange rate differences and other
   
334
     
-
     
602
 
Amortization/accretion of premium/discount on marketable securities, net
   
257
     
793
     
1,017
 
                         
   
$
1,960
   
$
2,208
   
$
894
 
v3.20.2
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2019
Net loss per share:  
EARNINGS PER SHARE
NOTE 16:-   EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
Numerator:
                 
Net loss
 
$
(8,659
)
 
$
(10,415
)
 
$
(18,072
)
                         
Denominator:
                       
Weighted average number of shares outstanding used in computing basic and diluted net loss per share
   
34,250,582
     
33,710,507
     
33,253,158
 
                         
Basic and diluted net loss per share
 
$
(0.25
)
 
$
(0.31
)
 
$
(0.54
)
v3.20.2
SUBSEQUENT EVENT
12 Months Ended
Dec. 31, 2019
Subsequent Events [Abstract]  
SUBSEQUENT EVENT
Note 17:-       SUBSEQUENT EVENT


a.
In January 2020, inventory stored in the one of the Company’s warehouses suffered water damage. The Company is currently evaluating the effect of the event on its inventories value and does not expect it to have a material impact.
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Use of estimates
a.        Use of estimates:

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Financial statements in U.S. dollars
b.        Financial statements in U.S. dollars:

The majority of the revenues of the Company and its subsidiaries are generated in U.S. dollars ("dollar") or linked to the dollar. In addition, a major portion of the Company's and certain of its subsidiaries' costs are incurred or determined in dollars. The Company's management believes that the dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the dollar.

Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into U.S. dollars in accordance with Accounting Standards Codification No. 830, "Foreign Currency Matters" ("ASC No. 830"). All transactions gains and losses from the remeasurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses as appropriate.
Principles of consolidation
c.        Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.
Cash and cash equivalents
d.        Cash and cash equivalents:

The Company considers all unrestricted highly liquid investments which are readily convertible into cash, with a maturity of three months or less at the date of acquisition, to be cash equivalents.
Restricted deposits
e.        Restricted deposits:

The restricted deposits are held in favor of financial institutions in respect of fulfillment of forward contracts and operating obligations. As of December 31, 2019, a major prepayment received from a client was classified as a restricted deposit due to the contractual terms with the client.
Short-term bank deposits

f.
Short-term bank deposits:

Short-term bank deposits are deposits with maturities of more than three months but less than one year at the balance sheet date. The deposits are in dollars and bear interest at an annual weighted average rate of 2.33% and 2.82% at December 31, 2019 and 2018, respectively. In connection with the Company's hedging transactions, the Company is required to maintain compensating deposits balances in the bank. Out of the short-term bank deposits, a total of $2,500 is due to the hedging transactions as of December 31, 2019 and 2018.
Marketable securities
g.        Marketable securities:

The Company accounts for investments in marketable securities in accordance with ASC 320, "Investments - Debt and Equity Securities". Management determines the appropriate classification of its investments in debt securities at the time of purchase and re-evaluates such determinations at each balance sheet date.

Marketable securities classified as "available-for-sale" are carried at fair value, based on quoted market prices. Unrealized gains and losses are reported in a separate component of shareholders' equity in accumulated other comprehensive income (loss). Gains and losses are recognized when realized, on a specific identification basis, in the Company's consolidated statements of comprehensive loss.

The Company's securities are reviewed for impairment in accordance with ASC 320-10-35. If such assets are considered to be impaired, the impairment charge is recognized in earnings when a decline in the fair value of its investments below the cost basis is judged to be Other-Than-Temporary Impairment (OTTI). Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company's intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. Based on the above factors, the Company concluded that unrealized losses on its available-for-sale securities, for the years ended 2019, 2018 and 2017, were not OTTI.
Inventories
h.        Inventories:

Inventories are stated at the lower of cost or net realizable value. Inventory write-offs are provided to cover risks arising primarily from end of life products and from slow-moving items, technological obsolescence, and excess inventory. Inventory write-offs during the years ended December 31, 2019, 2018 and 2017 amounted to $ 629, $ 2,231 and $ 1,260, respectively, and were recorded in cost of revenues.

Inventory write-off provision as of December 31, 2019 and 2018 amounted to $ 2,839 and $ 2,818, respectively.

Inventory cost is determined using the weighted average cost method.
Property and equipment, net
i.         Property and equipment, net:

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates:

   
%
     
Lab equipment
 
16 - 25
Computers and peripheral equipment
 
33
Office furniture
 
6
Leasehold improvements
 
Over the shorter of the term of the lease or the useful life of the asset
Goodwill impairment

j.
Goodwill impairment:

Goodwill represents the excess of the purchase price over the fair value of net assets of purchased businesses. Under Accounting Standards Codification No. 350, "Intangibles-Goodwill and Other" ("ASC No. 350"), goodwill is not amortized, but rather subject to an annual impairment test, or more often if there are indicators of impairment present. In accordance with ASC No. 350 the Company performs an annual impairment test at December 31 each year.

ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the two-step impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test.

The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step would need to be performed; otherwise, no further step is required. The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill. Any excess of the goodwill carrying amount over the applied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value.

The Company operates in one operating segment, and this segment comprises its only reporting unit. The Company has performed an annual impairment analysis as of December 31, 2019 and determined that the carrying value of the reporting unit was less than the fair value of the reporting unit. Fair value is determined using market capitalization. During years 2019, 2018 and 2017, no impairment losses were recorded.
Impairment of long-lived assets and intangible assets subject to amortization

k.
Impairment of long-lived assets and intangible assets subject to amortization:

Property and equipment and intangible assets subject to amortization are reviewed for impairment in accordance with ASC No. 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Some of the acquired intangible assets are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer relationships as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis.

During the years ended December 31, 2019, 2018 and 2017, no impairment losses were recorded.
Revenue recognition

l.
Revenue recognition:

The Company generates revenues mainly from selling its products along with related maintenance and support services. At times, these arrangements may also include professional services, such as installation services or training. Some of the Company’s product sells is done through resellers, distributors, OEMs and system integrators, all of whom are considered end-users.

The Company adopted accounting standards codification 606, "Revenue from Contracts with Customers" ("ASC 606"), effective on January 1, 2018. The Company recognizes revenue under the core principle that transfer of control to the Company’s customers should be depicted in an amount reflecting the consideration the Company expects to receive. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.

The Company enters into contracts that can include combinations of products and services, that are capable of being distinct and accounted for as separate performance obligations.  The products are distinct as the customer can derive the economic benefit of it without any professional services, updates or technical support. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price out of the total consideration of the contract. For support, the Company determines the standalone selling prices based on the price at which the Company separately sells a renewal contract on a stand-alone basis. For professional services, the Company determines the standalone selling prices based on the price at which the Company separately sells those services on a stand-alone basis. If the SSP is not observable, the Company estimates the SSP taking into account available information such as geographic or regional specific factors, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation.

Maintenance and support related revenues are deferred and recognized on a straight-line basis over the term of the applicable maintenance and support agreement. Other services are recognized upon the completion of installation or when the service is provided.

Deferred revenue includes amounts received from customers for which revenue has not yet been recognized. Deferred revenues are classified as short and long-term based on their contractual term and recognized as revenues at the time the respective elements are provided.

Transaction price allocated to remaining performance obligations represents non-cancelable contracts that have not yet been recognized that include deferred revenue and amounts not yet received that will be recognized as revenue in future periods. The aggregate amount of the transaction price allocated to remaining performance obligations that the Company expects to recognize after the year ending December 31, 2020 is approximately $37,875.

The Company pays sales commissions to sales and marketing personnel based on their certain predetermined sales goals. Sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions earned by its employees are capitalized and amortized in over the revenue recognition period. Amortization expenses related to these costs are included in sales and marketing expenses in the consolidated statements of operations. For the year ended December 31, 2019, the amortization of deferred commission was $1,351. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less.

The Company estimated variable consideration related to product returns based on its experience with historical product returns and other known factors. Such provisions amounted to $163 and $191 as of December 31, 2019 and 2018, respectively. Following the adoption of ASC 606, As of December 31, 2019 and 2018, this provision was recorded as part of other payables and accrued expenses.

Following the adoption of ASC 606 in January 1, 2018, the Company recognizes for term-based license agreements at the point in time when control transfers and the associated maintenance revenues over the contract period. Adoption of the standard has resulted in a reduction of deferred revenues of $712 that was recorded in accumulated deficit due to upfront recognition of license revenues from term licenses.

The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of Topic 606-10 was as follows:

   
December 31, 2017
   
Adjustments
   
January 1, 2018
 
   
(in thousands)
 
Deferred revenue, short term
   
11,370
     
(311
)
   
11,059
 
Deferred revenue, long term
   
3,878
     
(75
)
   
3,803
 
Trade receivables
   
22,737
     
326
     
23,063
 
Accumulated deficit
   
122,247
     
(712
)
   
121,535
 

In accordance with Topic 606-10, the disclosure of the impact of adoption on the consolidated balance sheet as of December 31, 2018 was as follows:

   
Amounts under
Topic 605
   
Impact of Adoption
   
As Reported
 
   
(in thousands)
 
Consolidated Balance Sheet
                 
Deferred revenue, short term
   
14,152
     
(297
)
   
13,855
 
Deferred revenue, long term
   
4,264
     
(17
)
   
4,247
 
Trade receivables
   
25,603
     
490
     
26,093
 
Accumulated deficit
   
132,754
     
(804
)
   
131,950
 

In addition, following the adoption of ASC 606, the Company’s consolidated statement of operations for the year ended December 31, 2018, included an increase of revenue in the amount of $ 92, net, compared to the accounting treatment under ASC 605.
Cost of revenues
m.       Cost of revenues:

Cost of revenues consists primarily of costs of materials and the cost of maintenance and services, resulting from costs associated with support, customer success and professional services.
Advertising expenses
n.       Advertising expenses:

Advertising expenses are charged to the statement of comprehensive loss, as incurred. Advertising expenses for the years ended December 31, 2019, 2018 and 2017 amounted to $ 1,274, $ 1,270 and $ 1,236, respectively.
Research and development costs
o.        Research and development costs:

Accounting Standards Codification No. 985-20, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.

Based on the Company's product development process, technological feasibility is established upon the completion of a working model. The Company does not incur material costs between the completion of a working model and the point at which the products are ready for general release. Therefore, research and development costs are charged to the consolidated statement of comprehensive loss as incurred.
Severance pay
p.        Severance pay:

The liability in Israel for substantially all of the Company`s employees in respect of severance pay liability is calculated in accordance with Section 14 of the Severance Pay Law -1963 (herein- "Section 14"). Section 14 states that Company's contributions for severance pay shall be in line of severance compensation and upon release of the policy to the employee, no additional obligations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee.

Furthermore, the related obligation and amounts deposited on behalf of such obligation under Section 14, are not stated on the balance sheet, because pursuant to the current ruling, they are legally released from the obligation to employees once the deposits have been paid.

There are a limited number of employees in Israel, for whom the Company is liable for severance pay. The Company's liability for severance pay for its Israeli employees was calculated pursuant to Section 14, based on the most recent monthly salary of its Israeli employees multiplied by the number of years of employment as of the balance sheet date for such employees.

The Company's liability was partly provided by monthly deposits with severance pay funds and insurance policies and the remainder by an accrual.

Severance expense for the years ended December 31, 2019, 2018 and 2017, amounted to $ 2,249, $ 1,950 and $ 1,801, respectively.
Accounting for stock-based compensation
q.        Accounting for stock-based compensation:

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification No. 718, "Compensation - Stock Compensation" ("ASC No. 718") that requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statement of comprehensive loss. The Company recognizes compensation expenses for the value of its awards based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures.

The Company accounted for changes in award terms as a modification in accordance with ASC 718. A modification to the terms of an award should be treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value measured at the same date. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances.

The Company estimated the forfeiture rate based on historical forfeitures of equity awards and adjusted the rate to reflect changes in facts and circumstances if any. The Company adopted ASU 2016-09 in the first quarter of the fiscal year 2017 and elected to retain its existing accounting policy and estimate expected forfeitures. The adoption of this ASU did not have a material impact on the Company's consolidated financial statements.

The following table sets forth the total stock-based compensation expense resulting from stock options, restricted share units ("RSUs") and Phantoms granted to employees included in the consolidated statements of comprehensive loss, for the years ended December 31, 2019, 2018 and 2017:
   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Cost of revenues
 
$
264
   
$
316
   
$
362
 
Research and development
   
847
     
678
     
648
 
Sales and marketing
   
1,257
     
928
     
1,166
 
General and administrative
   
1,052
     
940
     
1,190
 
                         
Total stock-based compensation expense
 
$
3,420
   
$
2,862
   
$
3,366
 

The Company selected the binomial option pricing model as the most appropriate fair value method for its stock-based compensation awards with the following assumptions for the years ended December 31, 2018 and 2017:

   
Year ended December 31,
 
   
2018
   
2017
 
             
Suboptimal exercise multiple
   
2.9-3.5
     
2.9-3.5
 
Risk free interest rate
   
2.09%-3.05%

   
0.80%-2.20%

Volatility
   
26%-47%

   
27%-49%

Dividend yield
   
0%

   
0%


The expected annual post-vesting and pre-vesting forfeiture rates affects the number of exercisable options. Based on the Company's historical experience, the annual pre-vesting and post-vesting are in the range of 0%-33% and 0%-41%, respectively, in the years 2018 and 2017. During 2019 no options were granted by the Company.

The computations of expected volatility and suboptimal exercise multiple is based on the average of the Company's realized historical stock price. The computation of the suboptimal exercise multiple and the forfeiture rates are based on the grantee's expected exercise prior and post vesting termination behavior. The interest rate for a period within the contractual life of the award is based on the U.S. Treasury Bills yield curve in effect at the time of grant.

The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business.

The expected life of the stock options represents the weighted-average period the stock options are expected to remain outstanding and is a derived output of the binomial model. The expected life of the stock options is impacted by all of the underlying assumptions used in the Company's model.
Treasury stock
r.         Treasury stock:

The Company repurchases its Ordinary shares from time to time on the open market and holds such shares as treasury stock. The Company presents the cost to repurchase treasury stock as a reduction of shareholders' equity.
Concentration of credit risks
s.         Concentration of credit risks:

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, short-term bank deposits, trade receivables and derivative instruments.

The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits in major U.S. and Israeli banks. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the cash and cash equivalents and short-term bank deposits may be redeemed upon demand, and therefore, bear minimal risk.

Marketable securities include investments in dollar linked corporate and municipal bonds. Marketable securities consist of highly liquid debt instruments with high credit standing. The Company’s investment policy, approved by the Board of Directors, limits the amount the Group may invest in any one type of investment or issuer, thereby reducing credit risk concentrations. Management believes that the portfolio is well diversified and, accordingly, minimal credit risk exists with respect to these marketable debt securities

The Company's trade receivables are primarily derived from sales to customers located mainly in EMEA, as well as in APAC, Latin America and the United States. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and establishes an allowance for doubtful accounts on a specific basis. Allowance for doubtful accounts amounted to $ 1,867 and $ 1,415 as of December 31, 2019 and 2018, respectively.

The Company utilizes foreign currency forward contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financial institutions and its exposure is limited to the amount of any asset resulting from the forward contracts.

The Company has no significant off-balance sheet concentrations of credit risk.
Grants from the Israel Innovation Authority
t.         Grants from the Israel Innovation Authority:

Participation grants from the Israel Innovation Authority (Previously known as the Office of the Chief Scientist) for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 378, $ 374 and $ 392 in 2019, 2018 and 2017, respectively.
Income taxes
u.        Income taxes:

The Company accounts for income taxes in accordance with Accounting Standards Codification No. 740, "Income Taxes" ("ASC No. 740"). ASC No. 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The deferred tax assets and liabilities are classified to non-current assets and liabilities, respectively.

ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income

Basic and diluted net income (loss) per share
v.        Basic and diluted net income (loss) per share:

Basic net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year. Diluted net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus dilutive potential Ordinary Shares considered outstanding during the year, in accordance with FASB ASC 260 "Earnings Per Share".

For the years ended December 31, 2019, 2018 and 2017, all outstanding options and RSUs have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive. See Note 16. The amount of those options and RSU’s was : 3,105,801, 2,998,174, 2,902,387 respectively.
Comprehensive loss
w.        Comprehensive loss:

The Company accounts for comprehensive loss in accordance with Accounting Standards Codification No. 220, "Comprehensive Income" ("ASC No. 220"). This statement establishes standards for the reporting and display of comprehensive loss and its components in a full set of general purpose financial statements. Comprehensive loss represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to shareholders. The Company determined that its items of comprehensive loss relate to unrealized gains and losses on hedging derivative instruments and unrealized gains and losses on available-for-sale marketable securities.

The following table shows the components and the effects on net loss of amounts reclassified from accumulated other comprehensive loss as of December 31, 2019:

   
Year ended
December 31, 2019
 
   
Unrealized gain (losses) on marketable securities
   
Unrealized gains (losses) on cash flow hedges
   
Total
 
                   
Balance as of December 31, 2018
 
$
(349
)
 
$
(418
)
 
$
(767
)
Changes in other comprehensive income (loss) before reclassifications
   
666
     
(332
)
   
334
 
Amounts reclassified from accumulated other comprehensive income (loss) to:
                       
 Cost of revenues
   
-
     
(7
)
   
(7
)
Operating expenses
   
-
     
(89
)
   
(89
)
Financial income, net
   
4
     
-
     
4
 
                         
Net current-period other comprehensive income (loss)
   
670
     
(428
)
   
242
 
                         
Balance as of December 31, 2019
 
$
321
   
$
(846
)
 
$
(525
)
Fair value of financial instruments
x.        Fair value of financial instruments:

The Company measures its cash and cash equivalents, marketable securities, derivative instruments, short-term bank deposits, trade receivables, other receivables, trade payables and other payables at fair value. The carrying amounts of short-term bank deposits, trade receivables, other receivables, trade payables and other payables approximate their fair value due to the short-term maturities of such instruments.

Fair value is an exit price, representing the amount that would be received if the Company were to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

The Company uses a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:


Level 1 -
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.


Level 2 -
Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and


Level 3 -
Unobservable inputs which are supported by little or no market activity.

The Company categorized each of its fair value measurements in one of those three levels of hierarchy. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The Company's earn-out considerations are classified within Level 3. The valuation methodology used by the Company to calculate the fair value consideration is the discounted cash flow using the Monte-Carlo simulation method by taking into account, forecast future revenues, expected volatility of 42.5% for Optenet and 20.7% for Netonomy and the weighted average cost of debt of 2%. As of December 31, 2019 the fair value of the consideration was determined according to discounted cash flow since the earn-out will be completely paid by the third quarter of 2020.
Derivatives and hedging
y.        Derivatives and hedging:

The Company accounts for derivatives and hedging based on Accounting Standards Codifiation No. 815, "Derivatives and Hedging" ("ASC No. 815").

The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value. Derivative instruments that are not designated and qualified as hedging instruments must be adjusted to fair value through earnings.

For derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) in shareholders' equity and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As a result of adopting new accounting guidance discussed in Note 2, " Recently adopted accounting pronouncements," beginning January 1, 2019, gains and losses on the derivatives instruments that are designated and qualify as a cash flow hedge are recorded in accumulated other comprehensive income (loss) and reclassified into in the same accounting period in which the designated forecasted transaction or hedged item affects earnings. Prior to January 1, 2019, cash flow hedge ineffectiveness was separately measured and reported immediately in earnings. Cash flow hedge ineffectiveness was immaterial during 2018 and 2017. To apply hedge accounting treatment, cash flow hedges must be highly effective in offsetting changes to expected future cash flows on hedged transactions.
Business combinations

z.
Business combinations:

The Company accounts for business combinations in accordance with ASC No. 805. ASC No. 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. Any excess of the fair value of net assets acquired over the purchase price is recorded as goodwill and any subsequent changes in estimated contingencies are to be recorded in earnings. In addition, changes in valuation allowance related to acquired deferred tax assets and acquired income tax positions are to be recognized in earnings.
Lease
aa.       Lease:

On January 1, 2019, the Company adopted ASU No. 2016-02, Leases (ASC 842). The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases.

ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses the Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option.

Payments under our lease arrangements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in
the operating lease right-of-use assets and liabilities. Variable lease payments are primarily comprised of payments affected by common area maintenance and utility charges.
Warranty costs
ab.      Warranty costs:

The Company generally provides three months software and a one-year hardware warranty for all of its products. A provision is recorded for estimated warranty costs at the time revenues are recognized based on the Company's experience. Warranty expenses for the years ended December 31, 2019, 2018 and 2017 were immaterial.
Recently Adopted Accounting Pronouncements
 ac.       Recently Adopted Accounting Pronouncements:

In February 2016, the FASB issued ASU No. 2016-02, Leases (ASC 842). The standard requires the recognition of ROU assets and lease liabilities for all leases. The standard requires a modified retrospective transition approach to recognize and measure leases at the initial application.

The Company adopted the standard as of January 1, 2019, using a modified retrospective transition approach and elected to use the effective date as the date of initial application. The Company adopted the ”package of practical expedients”, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. As a result, the consolidated balance sheets as of December 31, 2018 were not restated, continue to be reported under ASC 840, which did not require recognition of operating lease assets and liabilities on the balance sheets, and are not comparative.

The standard had a material impact on the Company’s consolidated balance sheets which resulted in the recognition of ROU assets and lease liabilities of $6.7 million and $6.7 million, respectively, on January 1, 2019, which included reclassifying deferred rent and rent prepayments as components of the ROU assets. The standard did not have a material impact on the Company's consolidated statements of comprehensive income. See also Note 11a.

The Company adopted Accounting Standards Update (“ASU”) No. 2017- 12, “Derivatives and Hedging” (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amended the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements were adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships which existed on the date of adoption were applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and the adoption did not have a material impact on the Company’s consolidated financial statements.

In June 2018, the FASB issued Accounting Standards Update No. 2018-07, "Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting" (ASU 2018-07). ASU 2018-07 was issued to simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, Compensation – Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The Company adopted this standard as of December 31, 2019 and did not have material effect on its consolidated financial statements.
Recently Issued Accounting Pronouncement Not Yet Adopted
ad.      Recently Issued Accounting Pronouncement Not Yet Adopted:

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). The standard changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company will adopt this standard as of January 1, 2020 and does not expect this to have a material effect on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment" ("ASU 2017-04"). ASU 2017-04 eliminates the requirement to measure the implied fair value of goodwill by assigning the fair value of a reporting unit to all assets and liabilities within that unit (the "Step 2 test") from the goodwill impairment test. Instead, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited by the amount of goodwill in that reporting unit. ASU 2017-04 will become effective for the Company beginning January 1, 2020 and must be applied to any annual or interim goodwill impairment assessments after that date. Early adoption is permitted. The new guidance was effective for the Company on January 1, 2020. The adoption did not have a material impact on the Company’s consolidated financial statements.

In December 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): “Simplifying the Accounting for Income Taxes” (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for us in the first quarter of 2021 on a prospective basis, and early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
v3.20.2
GENERAL (Tables)
12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of pro forma revenue and net loss
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

   
Fair value
 
       
Non-current assets
 
$
4
 
Account Payable
   
(11
)
Other Payables
   
(142
)
IPR&D
   
3,659
 
Goodwill
   
121
 
         
Net assets acquired
 
$
3,631
 
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2019
Schedule of Estimated Useful Lives at an Annual Rate
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates:

   
%
     
Lab equipment
 
16 - 25
Computers and peripheral equipment
 
33
Office furniture
 
6
Leasehold improvements
 
Over the shorter of the term of the lease or the useful life of the asset
Schedule of Stock-Based Compensation Expense
The following table sets forth the total stock-based compensation expense resulting from stock options, restricted share units ("RSUs") and Phantoms granted to employees included in the consolidated statements of comprehensive loss, for the years ended December 31, 2019, 2018 and 2017:
   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Cost of revenues
 
$
264
   
$
316
   
$
362
 
Research and development
   
847
     
678
     
648
 
Sales and marketing
   
1,257
     
928
     
1,166
 
General and administrative
   
1,052
     
940
     
1,190
 
                         
Total stock-based compensation expense
 
$
3,420
   
$
2,862
   
$
3,366
 
Schedule of Stock-Based Compensation Assumptions
The Company selected the binomial option pricing model as the most appropriate fair value method for its stock-based compensation awards with the following assumptions for the years ended December 31, 2018 and 2017:

   
Year ended December 31,
 
   
2018
   
2017
 
             
Suboptimal exercise multiple
   
2.9-3.5
     
2.9-3.5
 
Risk free interest rate
   
2.09%-3.05%

   
0.80%-2.20%

Volatility
   
26%-47%

   
27%-49%

Dividend yield
   
0%

   
0%
Schedule of Accumulated Other Comprehensive Income
The following table shows the components and the effects on net loss of amounts reclassified from accumulated other comprehensive loss as of December 31, 2019:

   
Year ended
December 31, 2019
 
   
Unrealized gain (losses) on marketable securities
   
Unrealized gains (losses) on cash flow hedges
   
Total
 
                   
Balance as of December 31, 2018
 
$
(349
)
 
$
(418
)
 
$
(767
)
Changes in other comprehensive income (loss) before reclassifications
   
666
     
(332
)
   
334
 
Amounts reclassified from accumulated other comprehensive income (loss) to:
                       
 Cost of revenues
   
-
     
(7
)
   
(7
)
Operating expenses
   
-
     
(89
)
   
(89
)
Financial income, net
   
4
     
-
     
4
 
                         
Net current-period other comprehensive income (loss)
   
670
     
(428
)
   
242
 
                         
Balance as of December 31, 2019
 
$
321
   
$
(846
)
 
$
(525
)
Accounting Standards Update 606 [Member]  
Schedule of Cumulative Effects of Applying New Accounting Pronouncements
The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of Topic 606-10 was as follows:

   
December 31, 2017
   
Adjustments
   
January 1, 2018
 
   
(in thousands)
 
Deferred revenue, short term
   
11,370
     
(311
)
   
11,059
 
Deferred revenue, long term
   
3,878
     
(75
)
   
3,803
 
Trade receivables
   
22,737
     
326
     
23,063
 
Accumulated deficit
   
122,247
     
(712
)
   
121,535
 

In accordance with Topic 606-10, the disclosure of the impact of adoption on the consolidated balance sheet as of December 31, 2018 was as follows:

   
Amounts under
Topic 605
   
Impact of Adoption
   
As Reported
 
   
(in thousands)
 
Consolidated Balance Sheet
                 
Deferred revenue, short term
   
14,152
     
(297
)
   
13,855
 
Deferred revenue, long term
   
4,264
     
(17
)
   
4,247
 
Trade receivables
   
25,603
     
490
     
26,093
 
Accumulated deficit
   
132,754
     
(804
)
   
131,950
 
v3.20.2
AVAILABLE-FOR-SALE MARKETABLE SECURITIES (Tables)
12 Months Ended
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Summary of Available-for-Sale Marketable Securities
The following is a summary of available-for-sale marketable securities:

   
December 31, 2019
   
December 31, 2018
 
   
Amortized cost
   
Gross unrealized gain
   
Gross unrealized
loss
   
Fair
value
   
Amortized cost
   
Gross
unrealized
gain
   
Gross unrealized
loss
   
Fair
value
 
                                                 
Available-for-sale - matures within one year:
                                               
Governmental debentures
 
$
449
   
$
1
   
$
-
   
$
450
   
$
1,799
   
$
-
   
$
(2
)
 
$
1,797
 
Corporate debentures
   
30,928
     
79
     
(8
)
   
30,999
     
37,808
     
6
     
(98
)
   
37,716
 
                                                                 
     
31,377
     
80
     
(8
)
   
31,449
     
39,607
     
6
     
(100
)
   
39,513
 
Available-for-sale - matures after one year through three years:
                                                               
Governmental debentures
   
855
     
1
     
-
     
856
     
476
     
-
     
(4
)
   
472
 
Corporate debentures
   
23,653
     
197
     
(7
)
   
23,843
     
24,455
     
4
     
(253
)
   
24,206
 
                                                                 
     
24,508
     
198
     
(7
)
   
24,699
     
24,931
     
4
     
(257
)
   
24,678
 
Available-for-sale - matures after three years through five years:
                                                               
Corporate debentures
   
4,806
     
58
     
-
     
4,864
     
101
     
-
     
(2
)
   
99
 
     
4,806
     
58
     
-
     
4,864
     
101
     
-
     
(2
)
   
99
 
   
$
60,691
   
$
336
   
$
(15
)
 
$
61,012
   
$
64,639
   
$
10
   
$
(359
)
 
$
64,290
 
v3.20.2
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis
The Company's financial net assets measured at fair value on a recurring basis, including accrued interest components, consisted of the following types of instruments as of December 31, 2019 and 2018, respectively:

   
As of December 31, 2019
 
   
Fair value measurements using input type
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Available-for-sale marketable securities
 
$
-
   
$
61,012
   
$
-
   
$
61,012
 
Foreign currency derivative contracts
   
-
     
(871
)
   
-
     
(871
)
Earn-out liability
   
-
     
-
     
(1,100
)
   
(1,100
)
                                 
Total financial net assets
 
$
-
   
$
60,141
   
$
(1,100
)
 
$
59,041
 

   
As of December 31, 2018
 
   
Fair value measurements using input type
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Available-for-sale marketable securities
 
$
-
   
$
64,290
   
$
-
   
$
64,290
 
Foreign currency derivative contracts
   
-
     
(324
)
   
-
     
(324
)
Earn-out liability
   
-
     
-
     
(6,051
)
   
(6,051
)
                                 
Total financial net assets
 
$
-
   
$
63,966
   
$
(6,051
)
 
$
57,915
 
Schedule of Fair Value Measurements Using Significant Unobservable Inputs
Fair value measurements using significant unobservable inputs (Level 3):

Balance at January 1, 2019
 
$
6,051
 
         
Earn Out liability adjustments due to exchange rates
   
(113
)
Adjustment due to change in forecast and time value of earn-out consideration
   
(4,838
)
         
Balance at December 31, 2019
 
$
1,100
 
v3.20.2
DERIVATIVE INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2019
Designated as Hedging Instrument [Member]  
Schedule of the Fair Value of Open Foreign Exchange Contracts
The fair value of the outstanding foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2019 and 2018, as assets and liabilities is as follows:

Foreign exchange forward and
     
December 31,
 
options contracts
 
Balance sheet
 
2019
   
2018
 
                 
Fair value of foreign exchange hedge transactions
 
Other receivables and prepaid expenses
 
$
158
   
$
56
 
Fair value of foreign exchange hedge transactions
 
Other payables and accrued expenses
   
(1,041
)
   
(474
)
                     
Total derivatives designated as hedging instruments
 
Other Comprehensive loss
 
$
(846
)
 
$
(418
)
Not Designated as Hedging Instrument [Member]  
Schedule of the Fair Value of Open Foreign Exchange Contracts
The fair value of the outstanding non-designated foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2019 and 2018, as assets and liabilities are as follows:

Foreign exchange forward and
     
December 31,
 
options contracts
 
Balance sheet
 
2019
   
2018
 
                 
Fair value of foreign exchange non-designated hedge transactions
 
Other receivables and prepaid expenses
 
$
12
   
$
94
 
                     
Total derivatives non-designated as hedging instruments
       
12
     
94
 
v3.20.2
OTHER RECEIVABLES AND PREPAID EXPENSES (Tables)
12 Months Ended
Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Accounts Receivable and Prepaid Expenses
 
December 31,
 
   
2019
   
2018
 
             
Prepaid expenses
 
$
3,957
   
$
1,635
 
Government authorities
   
1,773
     
1,327
 
Short-term lease deposits
   
195
     
159
 
Foreign currency derivative contracts
   
170
     
150
 
Others
   
433
     
376
 
                 
   
$
6,528
   
$
3,647
 
v3.20.2
INVENTORIES (Tables)
12 Months Ended
Dec. 31, 2019
Inventory Disclosure [Abstract]  
Schedule of Inventory
 
December 31,
 
   
2019
   
2018
 
             
Raw materials
 
$
1,264
   
$
551
 
Finished goods
   
9,404
     
10,794
 
                 
   
$
10,668
   
$
11,345
 

v3.20.2
PROPERTY AND EQUIPMENT, NET (Tables)
12 Months Ended
Dec. 31, 2019
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment
 
December 31,
 
   
2019
   
2018
 
Cost:
           
Lab equipment
 
$
17,548
   
$
16,038
 
Computers and peripheral equipment
   
22,374
     
20,680
 
Office furniture and equipment
   
1,356
     
1,197
 
Leasehold improvements
   
2,557
     
2,212
 
Lease equipment
   
930
     
-
 
                 
     
44,765
     
40,127
 
Accumulated depreciation:
               
Lab equipment
   
14,548
     
13,273
 
Computers and peripheral equipment
   
20,145
     
19,039
 
Office furniture and equipment
   
659
     
598
 
Leasehold improvements
   
1,162
     
968
 
Lease equipment
   
116
     
-
 
                 
     
36,630
     
33,878
 
                 
Depreciated cost
 
$
8,135
   
$
6,249
 
v3.20.2
INTANGIBLE ASSETS, NET (Tables)
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets
The following table shows the Company's intangible assets for the periods presented:

   
Weighted Average
Useful life
   
December 31,
 
   
(Years)
   
2019
   
2018
 
Original Cost:
                 
                   
 Technology
   
3.8
   
$
9,111
   
$
9,111
 
Backlog
   
2.8
     
1,877
     
1,877
 
Customer relationships
   
4.4
     
3,592
     
3,592
 
IP R&D
   
6
     
3,659
     
3,659
 
                         
           
$
18,239
   
$
18,239
 
Accumulated amortization:
                       
                         
 Technology
         
$
9,111
   
$
8,563
 
Backlog
           
1,877
     
1,877
 
Customer relationships
           
3,592
     
2,838
 
IP R&D
           
305
     
-
 
                         
           
$
14,885
   
$
13,278
 
                         
Amortized cost
         
$
3,354
   
$
4,961
 
Schedule of Estimated Amortization Expense
Estimated amortization expense for the years ending:

Year ending December 31,
     
       
2020
   
610
 
2021
   
610
 
2022
   
610
 
Thereafter
   
1,524
 
         
Total
   
3,354
 
v3.20.2
OTHER PAYABLES AND ACCRUED EXPENSES (Tables)
12 Months Ended
Dec. 31, 2019
Payables and Accruals [Abstract]  
Schedule of Other Payables and Accrued Expenses
 
December 31,
 
   
2019
   
2018
 
             
Advances from customers
 
$
253
   
$
5,700
 
Accrued expenses
   
3,887
     
3,346
 
Government authorities
   
3,061
     
3,356
 
Holdback and contingent earnout
   
1,575
     
484
 
Foreign currency derivative contracts
   
1,041
     
474
 
Provision for returns
   
163
     
191
 
Others
   
234
     
144
 
                 
   
$
10,214
   
$
13,695
 
v3.20.2
COMMITMENTS AND CONTINGENT LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Weighted-Average Remaining Lease Term and Discount Rate
The following table represents the weighted-average remaining lease term and discount rate:

 
Year ended
December 31, 2019
   
Weighted average remaining lease term
     2.52 years
Weighted average discount rate
1.54%
Schedule of Maturities of Operating Lease Liabilities
Maturities of operating lease liabilities were as follows:

Year ending December 31,
     
2020
 
$
3,170
 
2021
   
2,641
 
2022
   
1,019
 
2023
   
211
 
2024 and thereafter
   
78
 
         
Total lease payments
 
$
7,119
 
         
Less - imputed interest
 
$
(148
)
         
Present value of lease liabilities
 
$
6,971
 
v3.20.2
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option Activity
A summary of the Company's stock option activity, pertaining to its option plans for employees and related information is as follows:

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
   
Number
of shares upon exercise
   
Weighted average exercise price
   
Number
of shares upon exercise
   
Weighted average exercise price
   
Number
of shares upon exercise
   
Weighted average exercise price
 
                                     
Outstanding at beginning of year
   
1,736,143
   
$
7.26
     
2,189,297
   
$
7.63
     
1,959,014
   
$
8.24
 
Granted
   
-
   
$
-
     
62,200
   
$
5.91
     
676,550
   
$
4.93
 
Forfeited
   
(59,107
)
 
$
10.05
     
(414,617
)
 
$
9.79
     
(346,750
)
 
$
7.01
 
Exercised
   
(223,295
)
 
$
4.36
     
(100,737
)
 
$
4.07
     
(99,517
)
 
$
3.56
 
                                                 
Outstanding at end of year
   
1,453,741
   
$
7.59
     
1,736,143
   
$
7.26
     
2,189,297
   
$
7.63
 
                                                 
Exercisable at end of year
   
1,240,005
   
$
8.01
     
1,281,665
   
$
8.02
     
1,274,649
   
$
9.26
 
                                                 
Vested and expected to vest
   
1,442,990
   
$
7.61
     
1,464,802
   
$
7.65
     
1,607,782
   
$
8.44
 
Schedule of Stock Options Outstanding
The options outstanding as of December 31, 2019, have been classified by exercise price, as follows:

Exercise price
   
Shares upon exercise of options outstanding as of December 31, 2019
   
Weighted average remaining contractual life
   
Shares upon exercise of options exercisable as of December 31, 2019
 
           
Years
       
                     
$
23.31-27.58
     
64,500
     
2.63
     
64,500
 
$
15.2-17.07
     
49,936
     
1.97
     
49,936
 
$
10.0 -14.68
     
173,250
     
3.92
     
173,250
 
$
5.01-9.7
     
508,083
     
2.84
     
435,487
 
$
0.1-4.95
     
657,972
     
4.00
     
516,832
 
                             
         
1,453,741
             
1,240,005
 
Summary of Restricted Stock Unit Activity
The following provides a summary of the restricted stock unit activity for the Company for the two years ended December 31, 2019:

   
Year ended December 31,
 
   
2019
   
2018
 
   
Number
of shares upon exercise
   
Weighted average share price
   
Number
of shares upon exercise
   
Weighted average share price
 
                         
Outstanding at beginning of year
   
1,252,031
   
$
5.45
     
713,090
   
$
6.04
 
Granted
   
1,001,000
   
$
7.53
     
996,200
   
$
5.54
 
Vested
   
(401,904
)
 
$
7.53
     
(312,201
)
 
$
5.72
 
Forfeited
   
(199,067
)
 
$
7.61
     
(145,058
)
 
$
5.01
 
                                 
Unvested at end of year
   
1,652,060
   
$
6.53
     
1,252,031
   
$
5.45
 
v3.20.2
TAXES ON INCOME (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Pre-tax Income (Loss)
Pre-tax income (loss) is comprised as follows:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Domestic
 
$
(8,934
)
 
$
(9,877
)
 
$
(17,539
)
Foreign
   
1,916
     
1,890
     
1,031
 
                         
   
$
(7,018
)
 
$
(7,987
)
 
$
(16,508
)
Schedule of the Reconciliation of the Theoretical Tax Expenses
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Loss before taxes on income
 
$
(7,018
)
 
$
(7,987
)
 
$
(16,508
)
                         
Theoretical tax income computed at the Israeli statutory tax rate
(23%, 23% and 24% for the years 2019, 2018 and 2017, respectively)
 
$
(1,614
)
 
$
(1,837
)
 
$
(3,962
)
                         
Changes in valuation allowance
   
951
     
1,189
     
8,946
 
Increase in losses and temporary differences due to change in Israeli
corporate and “Approved Enterprise" tax
    -      
659
     
(5,376
)
Previous years
                       
Write off of prepaid and withholding taxes
   
1,536
     
1,828
     
909
 
Foreign tax rates differences related to subsidiaries
   
44
     
50
     
(48
)
Non-deductible expenses and other
   
327
     
65
     
684
 
Non-deductible share-based compensation expense
   
397
     
474
     
411
 
                         
Actual tax expense
 
$
1,641
   
$
2,428
   
$
1,564
 
Schedule of Income Tax Expense
Income tax expense is comprised as follows:

   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
                   
Current taxes
 
$
341
   
$
580
   
$
689
 
Deferred taxes expense (benefit)
   
(236
)
   
20
     
(34
)
Write off of prepaid and withholding taxes
   
1,536
     
1,828
     
909
 
                         
   
$
1,641
   
$
2,428
   
$
1,564
 
Schedule of Deferred Income Taxes
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred income taxes are as follows:.

   
December 31,
 
   
2019
   
2018
 
Deferred tax assets:
           
Operating and capital loss carryforwards
 
$
22,353
   
$
21,348
 
Reserves and allowances including lease liability
   
9,071
     
3,723
 
                 
Deferred tax asset before valuation allowance
   
31,424
     
25,071
 
Valuation allowance
   
(25,880
)
   
(24,790
)
Deferred tax asset net of valuation allowance
   
5,544
     
281
 
                 
Deferred tax liability including ROU asset
   
5,027
     
-
 
Net deferred tax asset
 
$
517
   
$
281
 
v3.20.2
GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Schedule of Revenues by Geographic Location
Allot operates in a single reportable segment. Revenues are based on the location of the Company's channel partners which are considered as end customers, as well as direct customers of the Company:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Europe
 
$
36,199
   
$
45,730
   
$
40,394
 
Asia and Oceania
   
42,994
     
22,018
     
13,936
 
Americas
   
16,576
     
14,363
     
15,532
 
Middle East and Africa
   
14,331
     
13,726
     
12,130
 
                         
   
$
110,100
   
$
95,837
   
$
81,992
 
Schedule of Major Customers
The following are the Company’s major customers:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Customer A
   
16
%
   
22
%
   
32
%
Customer B
   
11
%
   
-
     
-
 
                         
     
27
%
   
22
%
   
32
%
Schedule of Long-Lived Assets by Geographic Location
The following presents total long-lived assets as of December 31, 2019 and 2018:

   
December 31,
 
   
2019
   
2018
 
Long-lived assets:
           
Israel
 
$
7,614
   
$
5,931
 
Other
   
521
     
317
 
                 
   
$
8,135
   
$
6,249
 
v3.20.2
FINANCIAL INCOME (EXPENSES), NET (Tables)
12 Months Ended
Dec. 31, 2019
Other Income and Expenses [Abstract]  
Schedule of Financial Income, Net
 
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
                   
Financial income:
                 
Interest income
 
$
2,551
   
$
2,696
   
$
2,513
 
Exchange rate differences and other
   
-
     
305
     
-
 
                         
Financial expenses:
                       
Exchange rate differences and other
   
334
     
-
     
602
 
Amortization/accretion of premium/discount on marketable securities, net
   
257
     
793
     
1,017
 
                         
   
$
1,960
   
$
2,208
   
$
894
 
v3.20.2
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2019
Net loss per share:  
Schedule of the Computation of Basic and Diluted Net Earnings (Loss) per Share
The following table sets forth the computation of basic and diluted net loss per share:

   
Year ended
December 31,
 
   
2019
   
2018
   
2017
 
Numerator:
                 
Net loss
 
$
(8,659
)
 
$
(10,415
)
 
$
(18,072
)
                         
Denominator:
                       
Weighted average number of shares outstanding used in computing basic and diluted net loss per share
   
34,250,582
     
33,710,507
     
33,253,158
 
                         
Basic and diluted net loss per share
 
$
(0.25
)
 
$
(0.31
)
 
$
(0.54
)
v3.20.2
GENERAL (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 14, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Apr. 02, 2018
Business Acquisition [Line Items]          
Cash paid to acquire entity   $ 3,048  
Acquisition transaction costs   303      
Holdback amount   1,575 $ 484    
Net cash acquired assets   132      
Acquisition costs recorded to operating expenses   49      
Netonomy LTD [Member]          
Business Acquisition [Line Items]          
Acquisition date Jan. 14, 2018        
Cash paid to acquire entity $ 3,180        
Total purchase consideration 3,631        
Fair value of contingent liability $ 282 $ 1,081      
Payment term for contingent consideration 2 years 6 months        
Holdback amount $ 1,100        
Restricted holdback amount $ 797       $ 797
Description of claims for indemnification Paid in three installments consisting each one 40%, 40% and 20% of the Holdback amount following the first, second and 30-months anniversaries of the Closing Date.        
v3.20.2
GENERAL (Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Jan. 14, 2018
Business Acquisition [Line Items]      
Goodwill $ 31,683 $ 32,432  
Netonomy LTD [Member]      
Business Acquisition [Line Items]      
Non-current assets     $ 4
Account Payable     (11)
Other Payables     (142)
IPR&D     3,659
Goodwill     121
Net assets acquired     $ 3,631
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Jan. 02, 2019
Restricted Cash and Cash Equivalents Items [Line Items]        
Short-term deposits, weighted average interest rate 2.33% 2.82%    
Short-term bank deposits due to hedging transacations $ 2,500 $ 2,500    
Inventory write-offs 629 2,231 $ 1,260  
Cumulative inventory write-off 2,839 2,818    
Impairment of intangible assets  
Reserve for sales returns 163 191    
Advertising expenses 1,274 1,270 1,236  
Severance expense 2,249 $ 1,950 $ 1,801  
Annual post-vesting forfeiture rate   33.00% 41.00%  
Annual pre-vesting forfeiture rate   0.00% 0.00%  
Allowance for doubtful accounts 1,867 $ 1,415    
Grants participations excluded from research and development costs $ 378 374 $ 392  
Weighted average cost of debt 2.00%      
Changes in deferred revenue $ 712      
ROU assets and lease liabilites 6,971     $ 6,700
Remaining performance obligations 37,875      
Amortization of deferred commission 1,351      
Revenues $ 110,100 $ 95,837 $ 81,992  
Restricted Stock Units (RSUs) [Member]        
Restricted Cash and Cash Equivalents Items [Line Items]        
Outstanding options and warrants excluded from the calculation of diluted income per share 3,105,801 2,998,174 2,902,387  
Adoption of ASC 606, Effect [Member]        
Restricted Cash and Cash Equivalents Items [Line Items]        
Revenues   $ 92    
Optenet [Member]        
Restricted Cash and Cash Equivalents Items [Line Items]        
Expected volatility 42.50%      
Netonomy [Member]        
Restricted Cash and Cash Equivalents Items [Line Items]        
Expected volatility 20.70%      
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives at Annual Rates) (Details)
12 Months Ended
Dec. 31, 2019
Lab equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives, annual rate 16.00%
Lab equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives, annual rate 25.00%
Computers and peripheral equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives, annual rate 33.00%
Office furniture and equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives, annual rate 6.00%
Leasehold improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives Over the shorter of the term of the lease or the useful life of the asset
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cumulative Balance Sheet Adjustments - Adoption of Topic 606) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 02, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Deferred revenue, short term $ 36,360 $ 11,059 $ 13,855 $ 11,370
Deferred revenue, long term 5,262 3,803 4,247 3,878
Trade receivables 29,008 23,063 26,093 22,737
Accumulated deficit $ (140,609) 121,535 (131,950) $ 122,247
Adjustments [Member]        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Deferred revenue, short term   (311)    
Deferred revenue, long term   (75)    
Trade receivables   326    
Accumulated deficit   $ (712)    
Amounts under Topic 605 [Member]        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Deferred revenue, short term     14,152  
Deferred revenue, long term     4,264  
Trade receivables     25,603  
Accumulated deficit     132,754  
Impact of Adoption [Member] | Accounting Standards Update 606 [Member]        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Deferred revenue, short term     (297)  
Deferred revenue, long term     (17)  
Trade receivables     490  
Accumulated deficit     (804)  
As reported [Member]        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Deferred revenue, short term     13,855  
Deferred revenue, long term     4,247  
Trade receivables     26,093  
Accumulated deficit     $ 131,950  
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Stock-Based Compensation Expense) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense $ 3,420 $ 2,862 $ 3,366
Cost of revenues [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense 264 316 362
Research and development [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense 847 678 648
Sales and marketing [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense 1,257 928 1,166
General and administrative [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense $ 1,052 $ 940 $ 1,190
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Stock-Based Compensation Assumptions) (Details)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accounting Policies [Abstract]      
Suboptimal exercise multiple, minimum 2.9 2.9 2.9
Suboptimal exercise multiple, maximum 3.5 3.5 3.5
Risk free interest rate, minimum 1.55% 2.09% 0.80%
Risk free interest rate, maximum 2.41% 3.05% 2.20%
Volatility, minimum 28.00% 26.00% 27.00%
Volatility, maximum 44.00% 47.00% 49.00%
Dividend yield 0.00% 0.00% 0.00%
v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance $ (767) $ 36  
Changes in other comprehensive income (loss) before reclassifications 334    
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Net current-period other comprehensive income (loss) 242 (803) $ 185
Balance (525) (767) $ 36
Unrealized gains (losses) on cash flow hedges [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance (418)    
Changes in other comprehensive income (loss) before reclassifications (332)    
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Net current-period other comprehensive income (loss) (428)    
Balance (846) (418)  
Unrealized gain (losses) on marketable securities [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance (349)    
Changes in other comprehensive income (loss) before reclassifications 666    
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Net current-period other comprehensive income (loss) 670    
Balance 321 $ (349)  
Cost of revenues [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income (7)    
Cost of revenues [Member] | Unrealized gains (losses) on cash flow hedges [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income (7)    
Cost of revenues [Member] | Unrealized gain (losses) on marketable securities [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income    
Operating expenses [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income (89)    
Operating expenses [Member] | Unrealized gains (losses) on cash flow hedges [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income (89)    
Operating expenses [Member] | Unrealized gain (losses) on marketable securities [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income    
Financial income, net [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income 4    
Financial income, net [Member] | Unrealized gains (losses) on cash flow hedges [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income    
Financial income, net [Member] | Unrealized gain (losses) on marketable securities [Member]      
Amounts reclassified from accumulated other comprehensive income (loss) to :      
Amounts reclassified from accumulated other comprehensive income $ 4    
v3.20.2
AVAILABLE-FOR-SALE MARKETABLE SECURITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]    
Amortized cost $ 60,691 $ 64,639
Gross unrealized gain 336 10
Gross unrealized loss (15) (359)
Fair value 61,012 64,290
Available-for-sale securities matures within one year [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 31,377 39,607
Gross unrealized gain 80 6
Gross unrealized loss (8) (100)
Fair value 31,449 39,513
Available-for-sale securities matures within one year [Member] | Governmental debentures [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 449 1,799
Gross unrealized gain 1
Gross unrealized loss (2)
Fair value 450 1,797
Available-for-sale securities matures within one year [Member] | Corporate debentures [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 30,928 37,808
Gross unrealized gain 79 6
Gross unrealized loss (8) (98)
Fair value 30,999 37,716
Available-for-sale securities matures after one year through three years [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 24,508 24,931
Gross unrealized gain 198 4
Gross unrealized loss (7) (257)
Fair value 24,699 24,678
Available-for-sale securities matures after one year through three years [Member] | Governmental debentures [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 855 476
Gross unrealized gain 1
Gross unrealized loss (4)
Fair value 856 472
Available-for-sale securities matures after one year through three years [Member] | Corporate debentures [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 23,653 24,455
Gross unrealized gain 197 4
Gross unrealized loss (7) (253)
Fair value 23,843 24,206
Available-for-sale securities matures after three year through five years [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 4,806 101
Gross unrealized gain 58
Gross unrealized loss (2)
Fair value 4,864 99
Available-for-sale securities matures after three year through five years [Member] | Corporate debentures [Member]    
Debt Securities, Available-for-sale [Line Items]    
Amortized cost 4,806 101
Gross unrealized gain 58
Gross unrealized loss (2)
Fair value $ 4,864 $ 99
v3.20.2
FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value on a Recurring Basis) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale marketable securities $ 61,012 $ 64,290
Foreign currency derivative contracts (871) (324)
Earn-out liability (1,100) (6,051)
Total financial net assets 59,041 57,915
Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale marketable securities
Foreign currency derivative contracts
Earn-out liability
Total financial net assets
Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale marketable securities 61,012 64,290
Foreign currency derivative contracts (871) (324)
Earn-out liability
Total financial net assets 60,141 63,966
Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale marketable securities
Foreign currency derivative contracts
Earn-out liability (1,100) (6,051)
Total financial net assets $ (1,100) $ (6,051)
v3.20.2
FAIR VALUE MEASUREMENTS (Schedule of Fair value measurements using significant unobservable inputs) (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Fair Value Measurements Schedule Of Fair Value Measurements Using Significant Unobservable Inputs  
Balance at January 1, 2019 $ 6,051
Earn Out liability adjustments due to exchange rates (113)
Adjustment due to change in forecast and time value of earn-out consideration (4,838)
Balance at December 31, 2019 $ 1,100
v3.20.2
DERIVATIVE INSTRUMENTS (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]      
Net losses recognized from currency transactions $ 534 $ 1,480 $ (1,801)
Unrealized gain (loss) on forward contracts, net (846) (418) 159
Outstanding hedge transactions 36,139 20,816  
Non-designated hedge transactions 15,741 16,023  
Gain (loss) on derivative instruments reclassified from OCI to operating expenses (96) 903 $ (796)
Changes in fair value of derivatives not designated as hedging instrument $ 12 $ 94  
v3.20.2
DERIVATIVE INSTRUMENTS (Schedule of the Fair Value Open Foreign Exchange Contracts) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Fair value of foreign exchange hedge transactions $ 158 $ 56
Fair value of foreign exchange hedge transactions (1,041) (474)
Total derivatives designated as hedging instruments $ (846) $ (418)
v3.20.2
DERIVATIVE INSTRUMENTS (Schedule of the Fair value of the outstanding non-designated foreign exchange contracts) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Derivative Instruments Schedule Of Fair Value Of Outstanding Non-designated Foreign Exchange Contracts    
Fair value of foreign exchange non-designated hedge transactions $ 12 $ 94
Total derivatives non-designated as hedging instruments $ 12 $ 94
v3.20.2
OTHER RECEIVABLES AND PREPAID EXPENSES (Schedule of Other Accounts Receivable and Prepaid Expenses) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Prepaid expenses $ 3,957 $ 1,635
Government authorities 1,773 1,327
Short-term lease deposits 195 159
Others 433 376
Other receivables and prepaid expenses 6,528 3,647
Foreign Exchange Contract [Member]    
Foreign currency derivative contracts $ 170 $ 150
v3.20.2
INVENTORIES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 1,264 $ 551
Finished goods 9,404 10,794
Total inventory 10,668 11,345
Cost of goods sold, deferred finished goods inventory $ 1,335 $ 1,336
v3.20.2
PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Property, Plant and Equipment [Line Items]      
Cost $ 44,765 $ 40,127  
Accumulated depreciation 36,630 33,878  
Deprecated cost 8,135 6,249  
Depreciation 2,752 2,203 $ 2,191
Lab equipment [Member]      
Property, Plant and Equipment [Line Items]      
Cost 17,548 16,038  
Accumulated depreciation 14,548 13,273  
Computers and peripheral equipment [Member]      
Property, Plant and Equipment [Line Items]      
Cost 22,374 20,680  
Accumulated depreciation 20,145 19,039  
Office furniture and equipment [Member]      
Property, Plant and Equipment [Line Items]      
Cost 1,356 1,197  
Accumulated depreciation 659 598  
Leasehold improvements [Member]      
Property, Plant and Equipment [Line Items]      
Cost 2,557 2,212  
Accumulated depreciation 1,162 968  
Lease equipment [Member]      
Property, Plant and Equipment [Line Items]      
Cost 930  
Accumulated depreciation $ 116  
v3.20.2
INTANGIBLE ASSETS, NET (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense $ 1,607 $ 1,631 $ 1,477
v3.20.2
INTANGIBLE ASSETS, NET (Schedule of Intangible Assets) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]    
Cost $ 18,239 $ 18,239
Accumulated amortization 14,885 13,278
Total $ 3,354 4,961
Technology [Member]    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful life (Years) 3 years 9 months 18 days  
Cost $ 9,111 9,111
Accumulated amortization $ 9,111 8,563
Backlog [Member]    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful life (Years) 2 years 9 months 18 days  
Cost $ 1,877 1,877
Accumulated amortization $ 1,877 1,877
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful life (Years) 4 years 4 months 24 days  
Cost $ 3,592 3,592
Accumulated amortization $ 3,592 2,838
IP R&D [Member]    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful life (Years) 6 years  
Cost $ 3,659 3,659
Accumulated amortization $ 305
v3.20.2
INTANGIBLE ASSETS, NET (Schedule of Estimated Amortization Expense) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]    
2020 $ 610  
2021 610  
2022 610  
Thereafter 1,524  
Total $ 3,354 $ 4,961
v3.20.2
OTHER PAYABLES AND ACCRUED EXPENSES (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
OTHER PAYABLES AND ACCRUED EXPENSES [Abstract]    
Advances from customers $ 253 $ 5,700
Accrued expenses 3,887 3,346
Government authorities 3,061 3,356
Holdback and contingent earnout 1,575 484
Provision for returns 163 191
Others 234 144
Total other payables and accrued expenses 10,214 13,695
Foreign Exchange Contract [Member]    
OTHER PAYABLES AND ACCRUED EXPENSES [Abstract]    
Foreign currency derivative contracts $ 1,041 $ 474
v3.20.2
COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]      
Rent expense $ 3,129 $ 2,934 $ 3,126
Maturity of operating liability 225    
Bank guarantees 26,000    
Guarantees in favor of lease 501    
Short term leases $ 278    
v3.20.2
COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Weighted-Average Remaining Lease Term and Discount Rate) (Details)
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Weighted-average remaining lease term 2 years 6 months 7 days
Weighted-average discount rate 1.54%
v3.20.2
COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Maturities of Operating Lease Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 02, 2019
Commitments and Contingencies Disclosure [Abstract]    
2020 $ 3,170  
2021 2,641  
2022 1,019  
2023 211  
2024 and thereafter 78  
Total lease payments 7,119  
Less - imputed interest (148)  
Present value of lease liabilities $ 6,971 $ 6,700
v3.20.2
SHAREHOLDERS' EQUITY (Narrative) (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2019
USD ($)
₪ / shares
shares
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2018
USD ($)
₪ / shares
shares
Dec. 31, 2017
USD ($)
shares
Dec. 31, 2017
USD ($)
₪ / shares
shares
Dec. 31, 2019
₪ / shares
Dec. 31, 2018
₪ / shares
Dec. 31, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share capital, amount authorized | $ $ 20,000 $ 20,000              
Ordinary shares, shares authorized | shares 200,000,000 200,000,000 200,000,000 200,000,000          
Ordinary shares, par value per share | ₪ / shares             ₪ 0.1 ₪ 0.1  
Purchase of ordinary shares | $              
Intrinsic value of options outstanding | $ 3,510 $ 3,510 1,518 $ 1,518 $ 1,063 $ 1,063      
Intrinsic value of options exercisable | $ 2,791 2,791 1,058 1,058 684 684      
Intrinsic value of options vested and expected to vest | $ 3,399 $ 3,399 1,246 $ 1,246 819 $ 819      
Intrinsic value of options exercised | $ $ 769   $ 201   $ 176        
Stock options vested during period | shares 226,317                
Weighted average remaining contractual life of options outstanding 3 years 5 months 12 days                
Weighted-average remaining contractual life of exercisable options 3 years 2 months 30 days                
Weighted-average grant-date fair value of the options granted | ₪ / shares   $ 2.89   $ 2.89   $ 2.36      
Options outstanding | shares 1,453,741 1,453,741 1,736,143 1,736,143 2,189,297 2,189,297     1,959,014
Stock options granted | shares   62,200   676,550        
Stock options granted, exercise price | ₪ / shares     $ 5.91   $ 4.93      
Stock Compensation Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unrecognized compensation cost related to non-vested stock options | $ $ 402 $ 402              
Unrecognized compensation cost, recognition period 3 years 4 days                
Shares available for future issuance | shares 34,652 34,652              
Vesting period for plan 4 years                
Options, expiration period 10 years                
Restricted Stock Units (RSUs) [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unrecognized compensation cost related to non-vested stock options | $ $ 8,001 $ 8,001              
Unrecognized compensation cost, recognition period 3 years 4 days                
Number of restricted stock units outstanding | shares 1,652,060 1,652,060 1,252,031 1,252,031 713,090 713,090      
Granted | shares 1,001,000   996,200            
Restricted Stock Units (RSUs) [Member] | 2006 option plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period for plan 4 years                
Restricted Stock Units (RSUs) [Member] | 2016 option plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Granted | shares 1,001,000   996,200            
v3.20.2
SHAREHOLDERS' EQUITY (Schedule of Stock Option Activity) (Details) - ₪ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Number of shares upon exercise      
Outstanding at beginning of year 1,736,143 2,189,297 1,959,014
Granted 62,200 676,550
Forfeited (59,107) (414,617) (346,750)
Exercised (223,295) (100,737) (99,517)
Outstanding at end of year 1,453,741 1,736,143 2,189,297
Exercisable at end of year 1,240,005 1,281,665 1,274,649
Vested and expected to vest 1,442,990 1,464,802 1,607,782
Weighted average exercise price      
Outstanding at beginning of year ₪ 7.26 ₪ 7.63 ₪ 8.24
Granted 5.91 4.93
Forfeited 10.05 9.79 7.01
Exercised 4.36 4.07 3.56
Outstanding at end of year 7.59 7.26 7.63
Exercisable at end of year 8.01 8.02 9.26
Vested and expected to vest ₪ 7.61 ₪ 7.65 ₪ 8.44
v3.20.2
SHAREHOLDERS' EQUITY (Schedule of Options Outstanding) (Details) - ₪ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Shares upon exercise of options outstanding as of December 31, 2019 1,453,741 1,736,143 2,189,297 1,959,014
Weighted average remaining contractual life 3 years 5 months 12 days      
Shares upon exercise of options exercisable as of December 31, 2019 1,240,005 1,281,665 1,274,649  
$23.31-27.58 [Member]        
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise Prices, minimum ₪ 23.31      
Exercise Prices, maximum ₪ 27.58      
Shares upon exercise of options outstanding as of December 31, 2019 64,500      
Weighted average remaining contractual life 2 years 7 months 17 days      
Shares upon exercise of options exercisable as of December 31, 2019 64,500      
$15.43-17.07 [Member]        
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise Prices, minimum ₪ 15.2      
Exercise Prices, maximum ₪ 17.07      
Shares upon exercise of options outstanding as of December 31, 2019 49,936      
Weighted average remaining contractual life 1 year 11 months 19 days      
Shares upon exercise of options exercisable as of December 31, 2019 49,936      
$10.16-14.68 [Member]        
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise Prices, minimum ₪ 10.0      
Exercise Prices, maximum ₪ 14.68      
Shares upon exercise of options outstanding as of December 31, 2019 173,250      
Weighted average remaining contractual life 3 years 11 months 1 day      
Shares upon exercise of options exercisable as of December 31, 2019 173,250      
$5.01-9.13 [Member]        
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise Prices, minimum ₪ 5.01      
Exercise Prices, maximum ₪ 9.7      
Shares upon exercise of options outstanding as of December 31, 2019 508,083      
Weighted average remaining contractual life 2 years 10 months 3 days      
Shares upon exercise of options exercisable as of December 31, 2019 508,083      
$0.1-4.95 [Member]        
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise Prices, minimum ₪ 0.1      
Exercise Prices, maximum ₪ 4.95      
Shares upon exercise of options outstanding as of December 31, 2019 657,972      
Weighted average remaining contractual life 4 years      
Shares upon exercise of options exercisable as of December 31, 2019 657,972      
v3.20.2
SHAREHOLDERS' EQUITY (Summary of Restricted Stock Unit Activity) (Details) - Restricted Stock Units (RSUs) [Member] - ₪ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Number of shares upon exercise    
Outstanding at beginning of year 1,252,031 713,090
Granted 1,001,000 996,200
Vested (401,904) (312,201)
Forfeited (199,067) (145,058)
Unvested at end of year 1,652,060 1,252,031
Weighted average share price    
Outstanding at beginning of year ₪ 5.45 ₪ 6.04
Granted 7.53 5.54
Vested 7.53 5.72
Forfeited 7.61 5.01
Unvested at end of year ₪ 6.53 ₪ 5.45
v3.20.2
TAXES ON INCOME (Narrative) (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Taxes On Income [Line Items]          
Revenues   $ 110,100 $ 95,837 $ 81,992  
Israeli Income tax rate   23.00% 23.00% 24.00%  
Tax-exempt period   2 years      
Dividend, withholding tax rate   15.00%      
Patent use right, period   8 years      
Expense deductible period   3 years      
Net operating loss carry forwards   $ 62,128      
Net operating loss offset limitation, percentage of accumulated losses   14.00%      
Net operating loss offset limitation, percentage of taxable income   50.00%      
Capital loss carry forwards   $ 27,243      
Provision     $ 243    
Deferred tax assets valuation allowance $ 23,601 25,880 $ 24,790 $ 23,601  
Preferred Enterprise [Member]          
Taxes On Income [Line Items]          
Revenues $ 10,000,000        
Israeli Income tax rate 12.00%        
Special Technological Preferred Enterprise [Member]          
Taxes On Income [Line Items]          
Revenues $ 10,000,000        
Israeli Income tax rate 6.00%        
Israel [Member]          
Taxes On Income [Line Items]          
Write-off prepaid and withholding taxes   $ 7,182      
Commencement Of Production [Member]          
Taxes On Income [Line Items]          
Tax benefit period     12 years    
Approval Date [Member]          
Taxes On Income [Line Items]          
Tax benefit period     14 years    
Development Zone A [Member]          
Taxes On Income [Line Items]          
Israeli Income tax rate       9.00% 9.00%
Change in corporate tax rate   7.50%      
Outside Development Zone [Member]          
Taxes On Income [Line Items]          
Israeli Income tax rate       16.00% 16.00%
Israeli resident corporation [Member]          
Taxes On Income [Line Items]          
Dividend, withholding tax rate   20.00% 20.00% 20.00%  
Israeli resident individual [Member]          
Taxes On Income [Line Items]          
Dividend, withholding tax rate   20.00% 20.00% 20.00%  
non-Israeli resident [Member]          
Taxes On Income [Line Items]          
Dividend, withholding tax rate   20.00% 20.00% 20.00%  
Minimum [Member]          
Taxes On Income [Line Items]          
Change in corporate tax rate   24.00%      
Tax-exempt period   5 years      
Minimum [Member] | United States of America [Member]          
Taxes On Income [Line Items]          
Net operating loss carry forwards   $ 5,524      
Expiration of operating loss carry forward   Dec. 31, 2026      
Maximum [Member]          
Taxes On Income [Line Items]          
Change in corporate tax rate   25.00%      
Tax-exempt period   8 years      
Maximum [Member] | United States of America [Member]          
Taxes On Income [Line Items]          
Net operating loss carry forwards   $ 7,438      
Expiration of operating loss carry forward   Dec. 31, 2037      
v3.20.2
TAXES ON INCOME (Schedule of Pre-tax Income (Loss)) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Domestic $ (8,934) $ (9,877) $ (17,539)
Foreign 1,916 1,890 1,031
Pre-tax income (loss) $ (7,018) $ (7,987) $ (16,508)
v3.20.2
TAXES ON INCOME (Schedule of the Reconciliation of the Theoretical Tax Expense) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Loss before taxes on income $ (7,018) $ (7,987) $ (16,508)
Theoretical tax income computed at the Israeli statutory tax rate (23%, 23% and 24% for the years 2019, 2018 and 2017, respectively) (1,614) (1,837) (3,962)
Changes in valuation allowance 951 1,189 8,946
Increase in losses and temporary differences due to change in Israeli corporate and “Approved Enterprise" tax   659 (5,376)
Previous years    
Write off of prepaid and withholding taxes 1,536 1,828 909
Foreign tax rates differences related to subsidiaries 44 50 (48)
Non-deductible expenses and other 327 65 684
Non-deductible share-based compensation expense 397 474 411
Income tax expense $ 1,641 $ 2,428 $ 1,564
Israeli Income tax rate 23.00% 23.00% 24.00%
v3.20.2
TAXES ON INCOME (Schedule of Income Tax Expense (Benefit)) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Current taxes $ 341 $ 580 $ 689
Deferred taxes expense (benefit) (236) 20 (34)
Write off of prepaid and withholding taxes 1,536 1,828 909
Income tax expense $ 1,641 $ 2,428 $ 1,564
v3.20.2
TAXES ON INCOME (Schedule of Deferred Income Taxes) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Deferred tax assets:      
Operating and capital loss carry forwards $ 22,353 $ 21,348  
Reserves and allowances including lease liability 9,071 3,723  
Deferred tax asset net of valuation allowance 31,424 25,071  
Valuation allowance (25,880) (24,790) $ (23,601)
Net deferred tax asset 5,544 281  
Deferred tax liability including ROU asset 5,027  
Net deferred tax asset $ 517 $ 281  
v3.20.2
GEOGRAPHIC INFORMATION (Schedule of Revenue by Geographic Location) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues $ 110,100 $ 95,837 $ 81,992
Europe [Member]      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 36,199 45,730 40,394
Asia And Oceania [Member]      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 42,994 22,018 13,936
Americas [Member]      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 16,576 14,363 15,532
Middle East And Africa [Member]      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues $ 14,331 $ 13,726 $ 12,130
v3.20.2
GEOGRAPHIC INFORMATION (Schedule of Major Customers) (Details)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue, Major Customer [Line Items]      
Concentration risk percentage 76.00%    
Network intelligence solutions [Member]      
Revenue, Major Customer [Line Items]      
Concentration risk percentage 24.00%    
Sales [Member]      
Revenue, Major Customer [Line Items]      
Concentration risk percentage 27.00% 22.00% 32.00%
Sales [Member] | Customer A [Member]      
Revenue, Major Customer [Line Items]      
Concentration risk percentage 16.00% 22.00% 32.00%
Sales [Member] | Customer B [Member]      
Revenue, Major Customer [Line Items]      
Concentration risk percentage 11.00%
v3.20.2
GEOGRAPHIC INFORMATION (Schedule of Long-Lived Assets) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting, Asset Reconciling Item [Line Items]    
Long-lived assets $ 8,135 $ 6,249
Israel [Member]    
Segment Reporting, Asset Reconciling Item [Line Items]    
Long-lived assets 7,614 5,931
Other [Member]    
Segment Reporting, Asset Reconciling Item [Line Items]    
Long-lived assets $ 521 $ 317
v3.20.2
FINANCIAL INCOME (EXPENSES), NET (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Financial income:      
Interest income $ 2,551 $ 2,696 $ 2,513
Exchange rate differences and other 305
Financial expenses:      
Exchange rate differences and other 334 602
Amortization/accretion of premium/discount on marketable securities, net 257 793 1,017
Financial and other expenses, total $ 1,960 $ 2,208 $ 894
v3.20.2
EARNINGS PER SHARE (Schedule of Basic and Diluted Net Earnings (loss) Per Share) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Numerator:      
Net loss $ (8,659) $ (10,415) $ (18,072)
Weighted average number of shares used in per share computations of net earnings (loss):      
Weighted average number of shares outstanding used in computing basic and diluted net loss per share 34,250,582 33,710,507 33,253,158
Basic and diluted net loss per share $ (0.25) $ (0.31) $ (0.54)